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RESUME 
Les gènes des immunoglobulines (Ig) s’expriment spécifiquement dans les cellules 
B. Pour devenir fonctionnels, les gènes d’Ig murins subissent deux types de 
réarrangements intra-géniques : les réarrangements V(D)J aux stades précoces du 
développement de la lignée B et la commutation isotypique (CI), restreinte au locus des 
chaînes lourdes (IgH), suite à une rencontre avec un antigène. Ces deux processus 
contribuent à l’extrême diversité des anticorps et à la vigueur de la réponse immunitaire. 
La CI nécessite l’intervention d’une enzyme appelée AID (Activation-Induced 
cytidine Deaminase) et la transcription des gènes cibles. Au niveau cellulaire, la CI se 
traduit par une transition de cellules B exprimant des IgM à des cellules B exprimant IgE, 
IgA ou une des quatre sous-classes d’IgG. Au niveau moléculaire, la CI est médiée par des 
séquences particulières (dites régions S, pour switch). L’accessibilité des séquences S aux 
recombinaisons est précédée de leur transcription dite transcription germinale (GL). Cette 
dernière facilite la genèse de structures secondaires qui fournissent des substrats pour 
AID. Mais les mécanismes de ciblage spécifique d’AID sont toujours inconnus.  
Dans une première étude, nous avons remplacé dans une lignée murine l’intron Iµ-
Cµ par un gène de sélection Neo
R
. La mutation entraine un blocage drastique dans le 
développement B.  Cependant, les réarrangements V(D)J sont normaux. L’analyse des 
transcrits nous a permis de mettre en évidence des interactions complexes entre 
activateurs transcriptionnels du locus IgH, en fonction du stade de développement et de 
l’état d’activation des cellules. 
Dans une deuxième étude, nous avons analysé l’élongation transcriptionnelle à 
travers les séquences Sµ et Sγ3 dans deux modèles murins dans lesquels l’élongation a été 
altérée par l’insertion d’un site de polyadénylation et de pause transcriptionnelle en 
amont de Sµ ou de Sγ3. La transcription GL de Sγ3 est bloquée malgré une initiation 
normale. La CI à IgG3 est complètement et spécifiquement bloquée. Par contre, la 
transcription GL à travers la région Sµ et la CI aux différents isotypes sont seulement 
diminués. Nos résultats démontrent que l’élongation à travers Sµ et Sγ3 est régulée de 
manière différentielle in vivo et suggèrent des capacités différentes des activateurs 
transcriptionnels à contrôler l’élongation transcriptionnelle au locus IgH. 
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SUMMARY 
Immunoglobulin genes (Ig) are expressed specifically in B cells. In order to become 
functional, mouse Ig genes undergo two types of intra-genic rearrangements: V(D)J 
recombination in early developing B cells which is antigen-independent and class switch 
recombination (CSR),  specific to the heavy chains locus, which may occur after antigen 
encounter. These two processes contribute to the extreme diversity of antibodies and the 
strength of the immune response. 
CSR requires the intervention of the Activation-Induced cytidine Deaminase (AID) 
and the transcription of targeted genes. At the cellular level, CSR translates the transition 
from IgM-expressing B cells to B cells expressing IgE, IgA or one of the four sub-classes of 
IgG. At the molecular level, CSR is mediated by special sequences called switch regions (S). 
CSR is preceded by germline (GL) transcription of target S sequences. The GL transcription 
is thought to favor the² generation of secondary structures that provide optimal 
substrates for AID. However, the mechanisms responsible for AID targeting are still 
unknown. 
In a first study, we have replaced in a mouse line the intron Iµ-Cµ by the selectable 
marker NeoR gene. The mutation led to a drastic block in B cell development. However, 
V(D)J rearrangements was normal. Transcripts’ analysis revealed complex interactions 
between transcriptional enhancers of the IgH locus that depend on the B cell 
developmental stage and activation status. 
In a second study, we analyzed the transcriptional elongation through Sµ and Sγ3 
sequences in two murine models in which elongation was altered by the insertion of a 
polyadenylation and transcriptional pause sites upstream of Sµ or Sγ3. GL transcription of 
Sγ3 was abrogated despite normal initiation. CSR to IgG3 was totally and specifically 
blocked. In contrast, GL transcription through Sµ region and CSR to different isotypes was 
only diminished. Our results show that elongation through Sµ and Sγ3 is differentially 
regulated in vivo and suggest different capacities of IgH transcriptional enhancers to 
control elongation through IgH locus. 
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ABREVIATIONS 
 
AID  Activation-induced deaminase 
APE  Apyrimidinic endonuclease 
ATM   Ataxia telangiectasia mutated 
BCR  B cell antigen receptor 
BER  Base excision repair 
bHLH   Basic helix-loop-helix 
Blimp-1 B lymphocyte-induced maturation protein-1 
BSAP  B cell-specific activator protein 
C  Cytidine 
C/EBP  Enhancer binding proteins 
CD40L   CD40 ligand 
CE  Coding end 
CH  Constant region in a heavy-chain 
CH3   Methyl group 
CJ   Coding joint 
CL   Constant region in a light-chain 
CRM1   Chromosome region maintenance-1 
CSR   Class switch recombination 
D   Diversity segment 
DNA   Deoxyribonucleic acid 
DnMT   DNA (cytosine-5)-methyltransferase 
DSB   Double strand break 
dsDNA   Double-stranded DNA 
Eµ   Intronic enhancer 
EBF   Early B cell factor 
ELISA   Enzyme-linked immunosorbent assay  
ES   Embryonic stem 
Exo1   MMR exonuclease 
GC   Germinal center 
GL  Germline 
H3K27me2 Dimethylated lysine 27 on histone 3 
H3K4me2 Dimethylated lysine 4 on histone 3 
H3K9ac Acetylated lysine 9 on histone 3 
H3K9me2 Dimethylated lysine 9 on histone 3 
HAT  Histone acetyltransferase 
HC  Heavy chain 
HDAC  Histone deacetylases 
HMG  High mobility group  
hMT  Human metallothionein II 
  3
hPRT  Human hypoxanthine phosphoribosyltransferase 
Ig  Immunoglobulin 
IKK  IκB-specific kinase complex 
IL-7R  Intrleukin-7 receptor 
INFγ  Interferon gamma 
IRF-4  Interferon regulatory factor 4 
ITAM  Immunoreceptor tyrosine-based activation motif 
LC  Light chain 
LEF-1  Lymphocyte enhancer factor-1 
LPS  Lipopolysaccharide 
MAR  Matrix attachment region 
MBD  Methyl-cytosine-binding domain 
MeCP2 Methyl CpG binding protein 2 
MMR  Mismatch repair 
MRN  Mre11/Rad50/Nbs1  
MZ  Marginal zone 
Neo
r
  Neomycin resistance gene 
NES  Nuclear export signal 
NHEJ  Nonhomologous end-joining 
NLS  Nuclear localization signals 
PALS  Periarteriolar lymphoid sheath 
PCNA  Proliferating cell nuclear antigen 
PGK  Phosphoglycerate kinase promoter 
PHD  Plant homeodomain 
PKA  Protein kinase A 
PTIP  Transactivation-domain interacting protein 
PVH  Heavy chain variable promoters 
RAG  Recombination activating genes  
RF  Reading frames 
RNA  Ribonucleic acid 
RPA  Replication protein A 
RSS  Recombination signal sequence 
SE  Signal end 
SHM  Somatic hypermutation 
SL  Surrogate light chains 
SSB  Single-stranded break 
ssDNA  Single-stranded DNA 
TBP  TATA binding protein 
TdT  Terminal-desoxynucleotidyl-Transferase 
TF  Transcription factors 
TGF-β1 Transforming Growth Factor-β1 
TI  T cell-independent 
TRD  Transcriptional repression domain 
TSA  Trichostatin A 
U  Uracil 
UNG  Uracil-DNA glucosylase 
USF  Upstream TF 
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VH   Variable region in a heavy-chain 
VL   Variable region in a light-chain 
WT    Wild type 
XBP-1   X-box-binding protein-1 
λ   Lambda 
κ   Kappa 
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A. STRUCTURE  OF  IMMUNOGLOBULINS  
 
The defining feature of the B cells is their exclusive ability to synthesize 
Immunoglobulins (Ig) which are an extremely diverse family of proteins, each made up of 
two related types of polypeptides called heavy chains (HCs) and light chains (LCs). The 
chains are held together by non covalent bonds as well as covalent interchain disulfide 
bridges to form a bilaterally symmetrical structure as represented in Figure 1. 
The N-terminal domain in a heavy- or light-chain is called the variable region, 
abbreviated VH or VL respectively. The other domains are termed the constant region 
abbreviated CH or CL.  
 
Disulfide
bridge
Antigen 
Binding Site
Heavy 
Chain
Light 
Chain
VL VH
CH
CL
 
 
 
 
Figure 1: Immunoglobulin Structure. 
The constant heavy chains (CH) are depicted in dark blue. The constant light (CL) chains are coloured in 
light blue. The variable heavy (VH) and light (CL) regions are in violet. Disulfide bridges are in red. 
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I. Light chains 
LCs are divided into two isotypes encoded by separate loci, kappa (κ) and lambda 
(λ). In mice, LC κ locus is located on chromosome 6 and it has nearly 300 V for Variable 
genes and 5 J for joining genes and one C for constant genes (Figure 2). Jκ3 segment is not 
functional.  
LCs λ arise from a gene complex on chromosome 16, there is four subtypes of λ 
chains corresponding to the four Cλ exons each associated with a nearby Jλ segment.  
There are three Vλ genes, Vλ1 is rearranged to and expressed together with either 
Cλ1 or Cλ3; Vλ2 is associated with Cλ2 and Vλ3 is a pseudogene. The Cλ4 gene is also a 
non functional pseudogene due to an inactive RNA splice site (Figure 2). 
 
II. Heavy chains 
All murine Ig HCs are derived from a single region on chromosome 12. In contrast 
to the LC, a third type of gene segment, called the diversity (D) segment, is used in 
forming a HC variable region. There is almost 150 VH 
(1)
, 12 D 
(2, 3)
 and 4 JH segments. CH 
sequences for each of the 8 HC isotypes are arrayed in tandem along the chromosome in 
the following order: Cµ, Cδ, Cγ3, Cγ1, Cγ2b, Cγ2a, Cε and Cα. Every CH is encoded by a 
cluster of several short exons, Cµ for example, is divided among 6 exons each coding for a 
functional unit of the µ chain protein. 
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Vκ1                          Vκn Jκ1-5 Cκ
Vλ2 Jλ2 Cλ2 Jλ4 Cλ4 Vλ1 Jλ3 Cλ3 Jλ1 Cλ1
VH1                    VHn JH1-4 Cµ Cδ Cγ3 Cγ1 Cγ2b Cγ2a Cε CαDH1-12
Igκ Locus
Igλ Locus
IgH Locus
Vλ3
 
 
Figure 2: Immunoglobulin gene loci.  
Violet coloured rectangles represent the variable (V) genes, green rectangles represent the joining (J) 
genes, the grey rectangles represent the diversity (D) genes and the blue rectangles represent the 
constant region genes. The dashed rectangles represent the non-functional gene segments. 
 
 
B. ONTOGENY OF B CELLS 
Like all other blood cells, B lymphocytes arise from a common stem cell precursor 
through a process called hematopoiesis. Hematopoietic activity begins in mesenchyme 
surrounding the yolk sac during early embryogenesis but soon moves to the fetal liver and 
spleen. Thereafter, the process shifts increasingly to the bone marrow, where it continues 
throughout life. In the adult, hematopoiesis is confined largely to marrow of spinal 
column, proximal femurs and humeri, iliac bones, ribs and sternum.  
The bone marrow along with the thymus (where T cells arise) are referred to as 
primary lymphoid organs, they provide unique microenvironment and stromal cells that 
are essential for lymphopoiesis. Immature B lymphocytes that emerge from bone marrow 
are in quiescent “resting” state: they are mitotically inactive, when dispersed into the 
bloodstream, these so called “naïve” or “virgin” lymphocytes migrate to secondary 
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lymphoid organs such as the spleen, where they can encounter antigens and then be 
activated to undergo additional gene rearrangements leading to further diversification of 
antibodies. 
In the bone marrow, B cells differentiate through ordered steps: Pre-pro B cell, 
early pro-B cell, late pro-B cell, large pre-B cell, small pre-B cell, immature B cell, 
transitional B cell, mature B cell and plasma cell (Figure 3). At each step of lymphocyte 
development, the progress of gene rearrangement is monitored and only one successful 
gene rearrangement leads to the production of a protein chain that serves as a signal for 
the cell to progress to the next stage. Although a developing B cell has opportunities for 
multiple rearrangements, there are specific checkpoints so that each B cell expresses just 
one receptor specificity. 
 
I. Pre-pro-B cell 
In this stage the cell is committed to the B cell lineage, the earliest B precursors 
express B220 (CD45R), c-Kit and CD43 on their surface 
(4-6)
. They have not yet begun to 
rearrange their Ig gene segments yet 
(4)
, they are in the germline configuration. Pre–pro-B 
cells have low expression of the recombination activating genes Rag-1 and Rag-2 (see 
below) 
(7, 8)
. Several transcription factors have been identified as key regulators of B cell 
development such as IKAROS 
(9)
, PU.1
(10, 11)
, c-Myb 
(12)
, the early B cell factor (EBF) 
(13)
, 
E2A
(14)
 and the paired  domain factor B cell-specific activator protein (BSAP) known as 
Pax5, which is essential for B cell commitment and repression of alternative lineage 
differentiation 
(15)
. 
 
II. Pro-B cell 
Early pro-B cells can be differentiated from previous precursors by the expression 
of CD19 on their surface. They are also the first B lineage cells to express a precursor form 
of the B cell antigen receptor (BCR) composed of Igα (CD79a), Igβ (CD79b), and calnexin 
thus forming the pro-BCR 
(16)
. The heterodimer, Igα and Igβ are required for initiation of 
the signal transduction cascade activated by binding of a ligand to the BCR. 
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 In Early pro-B cell, the expression of RAG-1, RAG-2 and the terminal-
desoxynucleotidyl-transferase (TdT) is augmented (see below). Variable genes start to 
rearrange by first joining a D gene segment to a JH gene segment on both alleles 
generating late pro-B cells. Then only on one allele there is a rearrangement of a VH, to the 
newly recombined DJH segment. Once the IgH locus has assembled and expressed its 
variable genes, the VHDJH exon is spliced onto the adjacent Cµ exon potentially leading to 
the production of a HC µ protein.  
 
Cµ
+
Mature B Immature BSmall Pre-BLarge Pre-BLate Pro-BEarly Pro-BPre-Pro-B
IgM expressed 
on cell surface
V-J rearranged
VDJ rearranged
IgD and IgM are 
expressed
Intracellular µ
chain
µ chain 
transiently at the 
surface as a part 
of Pre-BCR
AbsentAbsentAbsentSurface Ig
V-J rearrangedV-J rearrangingGermlineGermlineGermlineGermlineL-chains genes
VDJ rearrangedVDJ rearrangedVDJ rearranged
V-DJ 
rearranging
D-J rearrangingGermlineH-chains genes
C-kit
IL7
CD25
CD19
CD45R
IL7
Ikaros
Pax5
E2A & EBF
RAG
Igα, Igβ
Stem 
Cell
IgM IgM IgDPre-BCR
Calnexine
Igα Igβ
VpreB
λ5
BILL
cadherin
CD43
 
 
Figure 3: The development of B-cell lineage. 
The top represents developmental stages of B lymphopoiesis. Rearrangements on both heavy and light 
chain loci and surface expression of the B cell receptor are detailed in the table. The bottom represents 
the expression of surface proteins, receptors, acting enzymes and transcription factors corresponding to 
each stage of B-cell development. 
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Upon DJH recombination, there are three possible reading frames (RF) from 
initiation codons ATG at the 5’ end of D. If the rearrangement is in RF2, a truncated 
protein called Dµ will be generated and will block B cell development 
(17)
 leading to 
apoptosis by a negative signal transduced by the transmembranic heterodimer Igα/Igβ 
through their cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM)
(18)
. If 
the subsequent VH to DJH rearrangement (DJH being in RF1 or 3) is in the right frame 
(referred to as productive rearrangement), the µ HC is produced and is found mainly in 
the cytoplasm and to some degree on the cell surface. 
Pro-B cells also express on their surface two polypeptides λ5 
(19)
 and VpreB 
(20)
 in 
association with a glycoprotein BILL-cadherin 
(21, 22)
 to form what’s called “surrogate light 
chains” (SL). These SL can pair with the membranic µ chain to form the pre-BCR that 
signals to the pro-B cell that a productive rearrangement has been made and marks then 
the transition to the pre-B cell 
(23)
.  
 
III. Pre-B cell 
At this stage we have a new surface marker which is CD25 and a progressive loss of 
c-kit and CD43
(24)
. Upon surface µ HC expression and signaling, Rag genes are rapidly 
down regulated in large pre-B-cells and further VH to DJH recombination is precluded; this 
is an important component of the HC allelic exclusion mechanism in order to maintain B 
cell monospecificity
(25)
. Several rounds of rapid proliferation follow, large pre-B cells then 
cease dividing and become small resting pre-B cells; at this stage they cease expression of 
the surrogate light chains and express the µ HC alone in the cytoplasm. Then, they re-
express the RAG proteins and start to rearrange the LC genes without inducing further HC 
recombination on either allele
(26, 27)
. At first an Igκ is rearranged on one allele but if there 
is no productive rearrangement on both alleles, the cell starts to rearrange Igλ locus. 
These cellular and molecular processes are impaired if any component of the pre-
BCR has its gene deleted. In µMT mice (surface IgM is not expressed), B development is 
blocked at the pro-B stage, however, the cross-linking of Igα/β blocks HC recombination, 
induces B cell differentiation and LC recombination. The analysis of bone marrow cells of 
these mice strongly suggest that the signaling through the Igα/β heterodimer of the pre-
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BCR is involved in the ordered Ig gene rearrangement regulation by altering the 
recombinase accessibility at the Ig loci
(28)
. 
 
IV. Immature B cell 
Upon successfully assembling a LC (κ or λ) gene, a cell becomes an immature B cell 
that expresses a complete IgM molecule at the cell surface that associates with Igα/β to 
form a functional BCR which gives the cell the ability to recognize an antigen. 
At this stage, B cells are tested for autoreactivity before leaving the bone marrow. 
In fact; in bone marrow, the fate of an immature B cell is determined by the BCR signals. 
Igα signaling is very important for the export of B cells from the bone marrow and their 
survival in the periphery, because mice that express Igα with a truncated cytoplasmic tail 
have an impairment of immature B cells and a severe decrease in peripheral B cells
(29)
.  
Almost half of BCRs carry high degrees of reactivity to self antigens 
(30, 31)
 but only 
immature B cells that have no strong autoreactivity are allowed to mature, thus 
autoreactive B cells must be silenced. Studies using transgenic mice showed that there are 
four fates for these B cells: clonal deletion which results in the elimination of the 
immature B cell by apoptosis 
(32, 33)
 and receptor editing where maturation of the B cell 
stops, Rag genes are re-expressed and essentially LC rearrangement restarts, this can 
rescue the self-reactive B cell by deleting the autoreactive LC and replacing it with a new 
non-reactive LC 
(34-36)
. If the rearrangements are exhausted and the receptor remains 
autoreactive, the immature B cell will undergo apoptosis 
(37)
.  The third fate is anergy 
where B cells can populate the periphery in a state of unresponsiveness along with 
retaining antigen binding capacity 
(32, 38)
 , these cells have a weak life span and cannot be 
activated by T-cells 
(39)
. The fourth fate is clonal ignorance, where B cells express weakly 
cross-linking receptors by self antigens; they succeed to gain the periphery as normal non-
self-reactive B cells 
(40, 41)
. However, these cells can be activated due to high 
concentrations of antigens or inflammation and then cause  autoimmunity. 
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V. Transitional B cell 
Only 10% of the 20 millions of immature B cells produced daily can emigrate from 
the bone marrow to the periphery and about 30% of these émigrés can achieve maturity 
(42, 43)
. These cells are designated as transitional B cells. They can be distinguished from 
mature B cells in that their cell surface markers CD22 and B220 are lower whereas IgM is 
higher compared to their mature counterparts 
(44)
. There is evidence that transitional B 
cells express low levels of Rag mRNA 
(45)
. BCR signaling appears to be an important 
determinant in this transition. In vivo ablation of surface IgM on mature B cells aborts all 
further development from the transitional to mature B cell stages 
(46)
. Also, in the absence 
of functional Igα, CD45, CD19 or other molecules, BCR signaling is insufficient to induce 
transitional B cells to differentiate into mature B cells 
(47-50)
.  
 
VI. Mature B cell 
Positively selected transitional B cells gain the spleen by the blood. They enter the 
red pulp of the spleen through the terminal branches of the central arterioles.  
Depending on signals from the BCR and on different growth factors, B cells 
differentiate into mature B cells that produce a δ-HC as well as a µ-HC, by a mechanism of 
alternative splicing of µ-δ pre-mRNA, and are marked by the additional appearance of IgD 
on their surface.   
According to their surface markers, function and anatomical localization (Figure 4), 
mature B cells can be divided into 3 subclasses
(51)
: B2 cells or follicular B cells which are 
localized in the spleen’s follicles and in the lymph nodes
(52)
, these cells are recirculating
(53)
 
B cells and they participate in the T cell-dependent antibody responses
(54)
. The marginal 
zone (MZ) B cells are located within the spleen at the periphery of the periarteriolar 
lymphoid sheath (PALS), at the border between white and red pulp. MZ B cells represent a 
link between innate and adaptive immune responses as they respond to, and become 
activated by, T cell-independent (TI) antigens such as bacterial capsules or cell wall 
components 
(55-57)
. The non-recirculating self-renewing B1 cells are found in the peritoneal 
and pleural cavities
(58)
 and they also contribute to the initial rapid TI antibody response 
and form a first line of defense against antigen 
(59, 57)
.  
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Figure 4: Schematic representation of the spleen. 
The white pulp of the spleen consists of the periarteriolar lymphoid sheath (PALS), B-cell follicles, a central 
arteriole and the marginal zone. Blood arrives at the spleen at the marginal sinus through branches of the 
central arteriole and from there it flows to the red pulp through the marginal zone or to the white pulp 
through the conduit network (Batista and Harwood, 2009)
(60)
 
 
VII. Plasma cell 
The binding of the antigen to B cells in secondary lymphoid tissues causes the rapid 
proliferation of these cells and the formation of structures termed germinal centers (GC). The 
B cells that have successfully gone through the different checkpoints in GCs may either 
mature to non-secreting memory B cells or to terminally differentiated, antibody-secreting 
plasma cells. 
Long-lived plasma cell develop from MZ B cells after receiving survival signals during 
affinity maturation, then exit the GC 
(61)
. Plasma cells precursors complete their terminal 
differentiation either within the GCs, or after having reached the bone marrow. A small 
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number of these cells remain in the bone marrow where they can survive and secrete 
antibodies for many months. The regulation of several transcription factors is crucial for 
lymphocyte differentiation into plasma cells: The expression of a number of B cell-specific 
transcription factors required in earlier stages of B cell development is decreased or 
extinguished in plasma cells including EBF, Pax5 and c-myb. Concomitantly, a large set of B 
cell specific surface proteins is down-regulated at the plasma cell stage, including Igα, B220, 
CD19, CD21, CD22 and CD40. In contrast, a smaller number of transcription factors are up-
regulated in plasma cells, including the key regulators of plasma cell differentiation, XBP-1 (X-
box-binding protein-1), Blimp-1 (B lymphocyte-induced maturation protein-1) and IRF-4 
(interferon regulatory factor 4). 
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C. IGH ACCESSIBILITY AND EXPRESSION IN EARLY B CELL 
DEVELOPMENT 
 
 
The variable domains of Ig loci undergo V(D)J recombination prior to antigen 
challenge. V(D)J recombination is mediated by RAG-1/RAG-2 complex, which harbors an 
endonuclease activity that introduces DNA nicks at V, D, and J segments. The V(D)J reaction is 
completed by the ubiquitously expressed non-homologous end-joining (NHEJ) factors that 
join the broken V, D, and J segments together. 
 
I. Mechanism of V(D)J rearrangement 
V(D)J recombination occurs in two phases, the recognition-cleavage phase and the 
joining of the broken ends. The first phase is performed by the lymphoid-specific RAG 
proteins
(62)
. The RAG complex recognizes conserved DNA motifs that flank V, D and J gene 
segments (Figure 5). These motifs, named recombination signal sequences (RSSs), consist of 
well-conserved heptamer (5’ CACAGTG 3’) and nonamer (5’ ACAAAAACC 3’) elements 
separated by less-conserved spacers of 12 ± 1 bp (both sides of D genes) and 23 ± 1 bp (one 
side of J and V genes). Recombination occurs efficiently only between 12-RSS and 23-RSS 
(63, 
64)
 following the 12-23 rule, so that in normal conditions,  direct VH to JH recombination is not 
compatible; however this rule has been broken in mice lacking canonical D elements in their 
IgH locus where there are direct VHJH rearrangements but in a very low frequency 
(65)
. 
VH1-n JH1-4DH1-12
H 23 N H 12 N H 12 N N 23 H
 
 
Figure 5: RSS sequences. 
Violet rectangles represent V gene segments, blue rectangles represent D gene segments and green rectangles 
represent J gene segments. White triangles represent the 23-RSS and black triangles represent the 12-RSS. H 
and N represent the heptamer and nonamer elements respectively. 
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RAG-1 and RAG-2 form a heterodimer that recognizes the 12-RSS and then captures a 
23-RSS to form a synaptic paired complex
(66)
. The RAG complex cleaves precisely at 5’ of the 
heptamer (at its border flanking the coding gene), yielding a 5’-phosphate and a 3’-hydroxyl 
group
(62)
. The coding gene’s 3’ hydroxyl group then attacks the opposite strand of DNA 
generating two blunt 5’-phosphorylated signal ends (SEs) and two hairpin covalently sealed 
coding end (CE)
(67)
. The high mobility group proteins HMG1 and HMG2 stabilize and stimulate 
the cleavage complexes in vitro 
(68, 69)
. They enhance V(D)J recombination of episomal 
substrates  if they are overexpressed in transfected cell
(70)
.  
The second phase recruits the ubiquitous NHEJ pathway (Figure 6) which includes 
Ku70
(71, 72)
, Ku80
(73, 74)
, XRCC4
(75)
, DNA-PKcs
(76, 77)
, Artemis
(78, 79)
, DNA LigaseIV
(80, 81)
 and 
Cernunnos (XLF)
(82, 83)
. RAG proteins may also play a role in this repair stage. Other proteins 
such as ATM (ataxia telangiectasia mutated) and the Mre11/Rad50/Nbs1 complex (MRN) 
might be involved in the repair of the double-strand breaks (DSBs)
(84, 85)
. In ATM-/- mice, V(D)J 
recombination is abnormal and DSBs resulting from incomplete recombination during 
development are maintained over several cell generations 
(84, 86)
.  
Ku70/80 bind to the cleavage products then DNA-PKCs binds to Artemis and undergoes 
autophosphorylation, enabling Artemis to cut the hairpin CEs in order to make them available 
for joining 
(87, 88)
. Artemis-/- mice are immunodeficient because of impaired V(D)J 
recombination
(79)
, and cells defective in either DNA-PKCS or Artemis display reduced hairpin 
opening 
(89, 90)
. SEs and CEs are not processed in the same way. SEs ligate to form Signal joints 
(SJs) that are precise end-to-end association of two heptamer sequences. In contrast, CEs are 
joined to form the coding joints (CJs) that are much more diverse because of the random 
deletion or insertion of new nucleotides in the junction of the coding genes
(91)
. These features 
make the antigen binding site even more variable but have the consequence that almost 2/3 
of all antigen receptor genes are assembled out of frame. These ligations of the joints are 
catalyzed by the XRCC4-XLF- DNA LigaseIV complex 
(81, 92, 93)
. 
Processed CEs are joined to create imprecise CJs that may have gained palindromic 
(P)
(94, 90)
 or non-templated (N) nucleotides through asymmetric hairpin opening or TdT-
mediated addition, respectively, or lost nucleotides through end processing reactions. 
Insertion of up to 15 nucleotides in length can be added by the lymphoid-specific enzyme TdT. 
TdT adds deoxynucleotides to the ends of DNA chains without the need for a template, but 
with a preference for G residues. Co-expression of RAG, TdT and a recombination substrate in 
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fibroblastoid cells results in the appearance of N-regions at CJs, indicating that TdT is able to 
participate in V(D)J recombination even in a nonlymphoid environment
(95)
. Moreover, in mice 
with targeted deletion of the TdT gene, there is an absence of N-regions in CJs
(96, 97)
. 
It has been suggested that the removal of nucleotides is due to the exonuclease 
and/or endonuclease activity of the Artemis protein
(98)
. MRN can nick DNA hairpins in vitro, 
and so could serve as a backup activity for Artemis as Artemis-/- mice are not fully defective 
in breaking the hairpin
(79)
. MRN can also bridge DNA ends, similarly to Ku and DNA-PKCS. Such 
bridging has been shown for Mre11 alone
(99)
 and for an Mre11-Rad50 complex
(100)
. 
 
Cleavage Phase
NNN
NNN
Coding Joint Signal Joint
RAG1/2
HMGB1/2?
Joining Phase
Coding Ends
(Hairpinned)
Signal Ends
(Blunt)
RAG1/2
Artemis
DNA-PKcs
TdT
KU70/80
XRCC4
DNA ligaseIV
ATM, MRN,XLF
Binding
Synapsis
Cleavage
Synaptic Paired
Complex (PC)
 
 
Figure 6: Summary of V(D)J recombination. 
In the cleavage phase, coding segments (rectangles), flanked by a 12- or 23-RSS (small or large triangles, 
respectively) are assembled into a synaptic paired complex by the RAG proteins (ovals). Cleavage yields blunt 
Signal ends (SEs) and coding ends (CEs) sealed as DNA hairpins. In the joining phase, sealed CEs are resolved by 
an Artemis/DNA-PKcs complex. Processed CEs are joined to create imprecise coding joints that may have 
gained nontemplated (N) nucleotides (see other cases in the text). SEs are joined to create precise signal 
joints. 
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II. Allelic exclusion 
As mentioned earlier, in order to have a complete antigen receptor, the Ig locus 
undergoes ordered rearrangement 
(101)
; first it rearranges its HC locus then the LC locus (see 
Figure 7). When a B cell is committed to the B lineage, efficient DJH rearrangement occurs 
on both alleles; then VHDJH occurs on one allele and if it is productive, rearrangement on 
the other allele is blocked. Nevertheless, if the rearrangement on the first allele is out of 
frame, the second allele undergoes VHDJH rearrangement. If this coding joint is in-frame, 
the cell expresses µHC on the surface, which in combination with SLC forms a pre-BCR. Once 
formed, the pre-BCR signals the differentiation of the pro-B-cell to the pre-B stage, which 
then completes LC gene assembly in an ordered manner as well; at first Vκ to Jκ but if both 
Igκ alleles are out of frame then Vλ to Jλ rearrangement is induced(102). The phenomenon is 
referred to as “Allelic exclusion” as far as the two alleles of the same locus are concerned and 
“isotypic exclusion” for κ to λ transition. These processes forbid the generation of two 
productive IgH and IgL chains which ensures the monospecificity of antigen receptors on 
mature B cells, a fundamental feature of the adaptive immune response.  
CHDJHVH1-n
Eµ
JH4
CHVHDJHVHn
Eµ
JH4L
PVH
AAA
µHC-mRNA
JH1-4 CHD 1-12VH1-n
Eµ
A
B
C
 
Figure 7: Mechanism of V(D)J rearrangement and µ gene expression. 
(A). In the first stage of rearrangement, a D segment is joined to a JH segment with deletion of the intervening 
DNA. (B). The DJH assembly is followed by a rearrangement that joins a VH segment to the DJH leading to the 
formation of a VHDJH HC variable region. (C). Transcription initiates from a PVH promoter upstream of the 
rearranged VHDJH segment. Straight lines represent the coding sequences and the oblique lines represent the 
spliced sequences. 
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Allelic exclusion is thus imposed at the VHDJH step which is tightly regulated; DJH 
rearrangement is not lineage restricted, but occurs in T cells also though at a low frequency. 
In contrast VHDJH rearrangement occurs only in B cells
 (103)
.  
Gene targeted experiments support a feed-back mediated mechanism for allelic 
exclusion; allelic exclusion was abrogated in mice carrying a mutation in the transmembrane 
region of the µHC gene
(104)
. Likewise, expression of the membrane form of a µHC transgene in 
mice prevents endogenous VH DJH rearrangements
(105)
. Mechanisms that control allelic 
exclusion are still elusive. However, allelic exclusion is accompanied by a down-regualtion of 
RAG
(26)
, decontraction of the IgH locus, recruitment of the non-functional allele to repressive 
pericentromeric heterochromatin
 (106, 107)
  and loss of accessibility of the IgH locus as indicated 
by down-regulation of VH germline transcripts
 (108, 28, 109)
 and of marks of active chromatin (See 
below). 
 
III. Accessibility control elements 
Even though the mechanisms of IgH locus rearrangement and allelic exclusion remain 
to be fully elucidated; they seem based on differential accessibility of variable gene segments 
to the recombinase machinery. How the latter can target different loci in a lineage- and stage-
specific manner
(110)
 is still unclear. The present paradigm, namely the accessibility hypothesis, 
is based on the finding that transcriptional control elements (mainly enhancers and 
promoters) are also involved in the regulation of V(D)J rearrangement. There are actually 
several correlates to the accessibility hypothesis: germline (GL) transcription, nuclear 
positioning, histone modifications, DNA methylation and DNase hypersensitivity.  
1) Germline transcripts 
Two major types of RNA transcripts are produced in the variable domain of the Ig 
locus: transcripts of the fully assembled genes (coding transcripts) and those of unrearranged 
or partially rearranged V(D)J regions termed GL transcripts which are sterile transcripts. There 
are two classes of GL transcripts: sense and antisense transcripts. 
Two major transcriptional enhancer elements are found in the IgH locus, one lies in 
the intron between  JH segments and Cµ region called the intronic enhancer (Eµ)  and the 
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3’Regulatory Region (3’RR) located downstream of the constant regions (Figure 8). Promoter 
elements are found upstream of each V, D and C segment. Prior to gene rearrangement, the 
promoter upstream of DQ52 (PDQ52) and Eµ become active and generate µ0 
(111, 112)
 and Iµ
(113, 
114)
 GL transcripts respectively.  After DJH rearrangement, the promoter upstream of the 
chosen rearranged D is activated, the assembled DJH exon is transcribed and spliced on the Cµ 
exons generating the Dµ transcript 
(111, 115)
. GL transcripts can also be detected originating 
from the individual VH promoters (PVH)
(110)
 but upon the assembly of a functional VHDJH exon, 
these transcripts are silenced
(108, 116)
. 
JH1-4 CHDQ52
VH VH
Eµ
DFL16.1L
PVH
AAA Iµ
AAA
µ0
D-JH antisense transcriptsVH antisense transcripts
VH sense transcripts
AAA
JH4 CH
DJH
Eµ
PDQ52
PDH
AAA
Dµ
A
B
 
Figure 8: Germline transcripts within the IgH locus. 
VH, D, JH gene segments and CH exons are shown as rectangles. Promoters are represented by small ovals and 
the Eµ enhancer by a big oval. 12- and 23-RSS are also represented as black and white triangles, respectively. 
(A) The IgH locus in GL configuration is transcribed from the promoter of DQ52 (PDQ52) to produce the µ0 
transcript and from within Eµ to generate the Iµ transcript both of which are getting spliced (oblique lines) 
and polyadenylated. VH, D and JH elements are transcribed in the antisense orientation; suggested start sites 
are represented by dashed arrows. (B) Upon D to JH recombination, the assembled DJH exon gets transcribed 
from the DH promoter (PDH) and spliced to the Cµ exons to generate the Dµ transcript. 
 
 
The D, JH and VH (genic and intergenic regions) are also transcribed in the antisense 
orientation. Potential start sites of D and JH seem to be located upstream of Eµ 
(117, 118)
.   
Antisense transcripts’ promoters start sites and termination sites are unknown. Therefore, 
each transcript can comprise one or more adjacent segments. Strikingly, whereas anti-sense 
transcripts spanning unrearranged D segments are readily detectable, sense D transcripts 
corresponding to the unrearranged D segments (with the exception of DQ52) have not been 
detected yet. Upon VH DJH rearrangements, the assembled VHDJH exon and the adjacent JH 
region are also transcribed in the antisense orientation
(119)
. 
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The precise role of GL transcripts has been debated, an extensive body of literature 
supports the notion that active transcription plays a role in rendering RSSs accessible to the 
recombinase machinery
(120)
. One can also speculate that these transcripts could be just a 
byproduct of locus accessibility. 
At first, linkage between GL transcripts and recombination has been proven in studies 
of LC recombination. Igκ GL transcripts and VκJκ  rearrangements were increased in pre-B 
cells after their treatment with lipopolysaccharide (LPS)
(121)
, the introduction of PGK promoter 
into the LC locus caused a dramatic increase in Jλ GL transcripts and in VλJλ
(122)
. 
Overexpression of transcription factors in lymphoid and non-lymphoid cell lines resulted in 
the upregulation of GL transcripts and rearrangement 
(123, 124)
. Moreover, the deletion of Eµ 
resulted in reduction of µ0 transcripts and rearrangement 
(125-127)
. 
Nevertheless, transcription is not sufficient for recombination; in Pax5-/- pro-B cells, 
distal VH gene segments are transcribed but fail to undergo recombination 
(128)
. In studies 
using TCRβ miniloci, mutation of Vβ promoter proved that recombination can take place in 
the absence of GL transcripts
(129)
. 
In contrast, studies on the TCRα locus showed that the introduction of a strong 
transcription terminator cassette in the Jα region induced almost a complete inhibition of 
transcription and a severe impairment of TCRα VJ rearrangement
(130)
. This proves that 
transcriptional elongation across RSSs of distal gene segments is required for recombination 
in vivo and suggests a potential link between transcription and accessibility to the 
recombinase. 
In conclusion, GL transcription might render the locus more accessible for 
rearrangements in two different ways. On one hand, transcription may directly provide long-
range accessibility at promoter-distal RSSs, probably through chromatin remodeling. On the 
other hand, transcription may regulate the activity of additional promoters which themselves 
can provide accessibility to proximate RSSs 
 As for the antisense transcripts, their exact function has not been fully clarified. Due 
to the correlation between VH DJH recombination and active antisense transcription it is 
presumed that antisense transcripts also foster an active chromatin state generating a more 
accessible locus
(108)
. Likewise, the decreased though controversial D antisense transcripts in 
Eµ-/- mice, led to somewhat similar conclusions
(131, 117)
. On the other hand, it has been 
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postulated that antisense transcripts could pair with the nascent GL sense transcripts and 
trigger RNA interference-mediated transcriptional gene silencing 
(118, 132)
. 
2) Nuclear positioning  
In non-B cells and hematopoietic progenitors, the IgH locus is at the nuclear periphery 
which is correlated with a repressive effect on transcription 
(133-135)
. Then in pro-B cells, the 
IgH locus moves to a more central compartment where D to JH recombination can now occur
 
(136, 137)
. In addition, for rearrangement of the distant VH elements, long-range contraction and 
looping seem to be crucial
(138)
. In pax5-/- pro-B cells, there is no rearrangement of 
intermediate and distal VH families due to the lack of locus contraction
(136, 139)
. Studies of 
interactions between IgH and Igκ loci showed that in pre-B cells the IgH locus is repositioned 
to centromeric heterochromatin
(140)
. Thus, there is a transition from accessible IgH locus to 
accessible Igκ locus. 
 
3) Histone modifications 
The nucleosome, the basic unit of chromatin, has 147 bp of genomic DNA wound 
around an octamer of the four core histones: H3, H4, H2A and H2B. The histone tails (N-
terminal ends) can undergo several modifications: acetylation, methylation, phosphorylation, 
ubiquitylation, etc. These modifications translate a “histone code” into repression or 
activation of chromatin. For example, H3K9ac (acetylated lysine 9 on histone 3) and H3K4me2 
(dimethylated lysine 4 on histone 3) are marks of active chromatin, whereas H3K27me2 
(dimethylated lysine 27 on histone 3) and H3K9me2 (dimethylated lysine 9 on histone 3) are 
found in silent chromatin
(141)
. These modifications can affect genome regulation in several 
ways; for instance, histone acetylation alters the charge of the tails and reduces their 
interaction with DNA and neighboring nuscleosomes. Also, they can disrupt chromatin 
contacts or affect the recruitment of binding proteins to chromatin (remodeling complexes, 
ATPases…).  
In early pro-B cells poised to undergo rearrangement, marks of active chromatin are 
present in the D-JH region peaking around DQ52, DFL16.1 (the 5’most D segment) and JH 
elements 
(118, 142)
. Following the primary recombination, the proximal VH elements and then 
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the distal VH segments become hyperacetylated 
(143, 144)
. After successful VDJ rearrangement, 
histone acetylation is lost rendering the VH cluster inaccessible in the pre-B cells
(144)
. In pro-B 
cells, H3K9me2 is absent in the D-JH region
(118) 
. H3K9me2 is inversely correlated with Pax5 
expression; in non-B cells H3K9me2 is present in VH regions and in B cells H3K9me2 is lost 
(145)
. 
One of the histone modifications associated with transcriptional start regions is H3K4me3
(146)
. 
Within the noncore region of RAG-2 lies a noncanonical plant homeodomain (PHD) by which 
RAG-2 binds to H3K4me3 
(147, 148)
.  Mutation of a conserved tryptophan residue within the 
PHD abrogates RAG-2 binding to H3K4me3 and impairs V(D)J recombination
(147, 148)
. These 
studies provide the first direct link between epigenetic control of V(D)J rearrangement and 
RAG recombinase accessibility. 
4) DNA Methylation 
Methylation consists of adding a methyl (-CH3) group to the cytosine in CpG 
dinucleotides by DNA (cytosine-5)-methyltransferase (DnMT). Generally, DNA methylation is 
correlated to gene silencing. Thus, heterochromatin, retrotransposons, endogenous 
retroviruses, the inactivated X-chromosome and silent imprinted genes are hypermethylated 
(149, 150)
; whereas, promoter regions of expressed genes are found in an unmethylated state. 
DNA methylation interferes with transcription in two ways: by inhibiting regulatory proteins 
from binding to DNA
(151) 
or by recruiting proteins interacting with, for example, histone 
deacetylases (HDAC) which remove the acetyl groups and thus enforce a silent chromatin 
state
(152)
. The link between chromatin silencing and methylation seems to be the methyl CpG 
binding protein 2 (MeCP2) 
(153, 154)
. This protein has two functional domains: a methyl-
cytosine-binding domain (MBD) and a transcriptional repression domain (TRD). By the MBD 
domain, MeCP2 attaches to the methylated CpG sites on the DNA strands and through its TRD 
region recruits HDAC
(155)
. In addition to binding methylated DNA, TRD can also interact with 
the transcriptional machinery
(156)
 and DnMT1 to maintain a repressive transcriptional state 
(157)
. 
There is a strong correlation between V(D)J recombination and hypomethylation; the 
introduction of a methylated DNA into cells leads to formation of a chromatin configuration 
that is refractory to transcription and to V(D)J recombination
(158)
. Methylated RSSs can abolish 
RAG cleavage and V(D)J recombination
(159)
. The D-JH cluster is demethylated before the start 
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of DJH rearrangements 
(160, 161)
. However, demethylation alone is not sufficient to induce 
V(D)J recombination
(162)
. Studies of the Igκ locus showed that in early B lineage cells, the κ 
locus is methylated while in mature B cells, it is unmethylated
(163)
. In this context, the JCκ 
regions is monoallelically demethylated and this allele undergoes recombination first 
(164)
 and 
if the rearrangement is not successful, the second allele gets demethylated
(165)
.  
Nonetheless, there are contradictory results; the targeted deletion of Eµ blocked 
rearrangement but not demethylation of the locus 
(166)
. Furthermore, in TCRβ miniloci 
containing a recombinase inducible promoter, V(D)J recombination was activated although 
the locus remained methylated
(167)
. 
Overall, DNA methylation and demethylation serve an essential epigenetic function in 
the maintenance of an open or closed chromatin configuration during V(D)J recombination.  
5) DNaseI hypersensitivity 
During transcription, chromatin remodeling occurs making it more accessible, i.e. less 
compacted; hence DNA becomes more sensitive to nuclease and restriction enzymes. 
Hypersensitive sites are found in highly accessible regions of DNA where nucleosomes have 
been removed, such as promoters and enhancers.  
The introduction of miniloci into lymphoid cell lines allowed for a correlation between 
DNase sensitivity and rearrangement 
(168)
. Moreover, studies performed on pro- and pre-B cell 
lines showed that DNaseI sensitive chromatin structures of the IgH, Igκ and Igλ constant-
region loci correlate closely with the ability of the genes to undergo recombination: these loci 
become DNase I sensitive before any DNA rearrangement event occurs
(169)
.  In this context 
also, the region between DQ52 and Eµ is DNase sensitive before DJH recombination and JH 
RSSs show higher sensitivity and are likely to be nucleosome free
(170)
. The VH region becomes 
nuclease sensitive before VHDJH rearrangement and reverts to a refractory state after 
successful VHDJH recombination
(171)
. 
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IV. Cis-regulatory elements 
Differentiation events that take place in the bone marrow are tightly regulated. After 
the commitment to the B lineage, the following steps of rearrangement and maturation 
depend on a huge number of factors; here we will only discuss promoters and enhancers that 
are proven to regulate V(D)J recombination. 
 
 
 
 
 
 
 
Figure 9: Genomic organization of IgH locus (murine 129 strain). 
VH gene segments are assembled in 15 families; 7183 represent the proximal families and J558 represent the 
distal families. (Jung et al., 2006)
(172) 
 
 
1) VH Promoters 
Upstream each VH element, there is a promoter (PVH) from which VH GL transcripts 
initiate before VHDJH rearrangement as well as transcripts of the assembled VHDJH exon 
(Figure 7). PVH can generate a GL transcript, in which a leader exon gets spliced to a VH exon. 
Upstream of TATA box lies a very conserved element across PVH : the octamer ATGCAAAT
(173)
. 
This sequence has been shown to be necessary for VH transcription
(174)
,  and it binds 
transcription factors (TF) of the POU family (see below). 
The promoter of a recombined VH element remains active throughout B-cell 
development, and experiments using cell lines showed that the 5’ most unrearranged VH 
segment can also be continuously expressed at reduced levels
(175)
. Promoter activity of a 
functionally rearranged VH element was shown to be partially dependent on the 3’RR
(176)
. 
Thus, VH promoters might fulfill a dual role: to help confer accessibility to GL VH segments and 
to drive expression of the assembled HC gene. 
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Eµ 
2) DQ52 Promoter 
DQ52 is the 3’ most D segment of the IgH locus, situated 500bp upstream of the JH 
segments
(177)
. Many features distinguish it from the rest of the twelve D segments; it was 
shown that it has the capacity to act as a promoter and an enhancer independent of Eµ. 
DQ52’s promoter gets activated and generates µ0 transcripts before any rearrangement 
(111, 
178)
. These µ0 transcripts which disappear after DJH recombination are considered as one of 
the early indicators of the engagement in the B lineage
(179)
. Moreover, DQ52 is preferentially 
utilized in the primary DJH rearrangements 
(180, 181)
. Analysis of protein complexes 
associated with DQ52 element showed the existence of clusters of interaction sites 5' to 
DQ52 suggesting that this region is involved in the regulation of heavy chain gene 
assembly
(182)
.The deletion of DQ52 causes a selective decrease of D recombination to JH3 and 
JH4 
(131, 183)
. Thus the possible role of DQ52 is to enhance locus accessibility or the efficiency of 
the recombinatorial machinery. Yet, in these mice, basal transcription of µ0 was still 
detectable and DJH recombination was only mildly affected suggesting the existence of 
other non identified control elements. 
3) Intronic enhancer Eµ 
As seen in the figure 9, the Eµ enhancer is located in the intron separating JH segments 
from the first constant exons Cµ. It is the first eukaryotic cellular enhancer element described 
(184-186)
. Eµ is constituted of an enhancer core (cEµ=220 bp) and two flanking matrix 
attachment regions (MARs)
(187)
 ; These two sequences are thought to constitute anchor 
points of the DNA for the chromatin scaffold and serve to organize the chromatin into 
structural domains (Figure 10). 
 
 
 
Figure 10: Eµ responsive elements. 
Control elements within Eµ include the 
C/EBP, µE1, µE5, µE2, µA, µE3, µB, µE4, and 
octamer elements. Proteins that have been 
shown to bind to these elements are 
indicated. (Ernst and smale1995) 
(188)
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The importance of MARs is controversial. In transgenic mouse lines with deleted 
MARs, it has been shown that they collaborate with Eµ and extend enhancer-dependent 
accessibility at more distal position 
(189, 190)
. On the other hand, the targeted deletion of both 
MARs showed that they are unnecessary for efficient V(D)J recombination
(126)
. 
Eµ was suggested to play a role in regulating antisense transcripts through D and JH 
region 
(131, 117)
. The replacement of Eµ 
 
by an oligonucleotide
(127)
 or its deletion lead to a 
reduced DJH recombination and severely impaired VHDJH rearrangement 
(131, 126, 127)
. This 
incomplete blockade of rearrangements might suggest that there are other regulatory regions 
or elements that act in synergy with Eµ and are required to fully activate the recombination 
machinery and regulate the accessibility of the IgH locus. The puzzling thing is how in Eµ-/- 
mice, DJH recombination is only reduced while VHDJH rearrangement is severely 
decreased knowing that GL transcripts of intermediate and distal families are intact
(125)
. On 
one hand, PVH might play a role in regulating VHDJH rearrangement but it’s not proven yet. 
On the other hand, Eµ might not be the direct cause of the impairment of VHDJH 
rearrangement, but that the diminished DJH recombination resulted in limited DJH targets 
for the VHDJH recombination.  
Recent studies showed that deletion of cEµ in pro-B cell lines reduced H3K9ac, H4ac, 
RNA polymerase II, GL transcripts and DNaseI hypersensitive sites (DQ52, 3’and 5’ of cEµ and 
JH segments) and augmented H3k27me2 through D-JH-Cµ region; all being marks of a 
repressed chromatin
(191)
. Thus, Eµ is critical for generation of DQ52 hypersensitive sites, 
recruits RNA Pol II to the IgH locus and overall controls local chromatin accessibility. 
4) IgH 3’ Regulatory Region 
The 3’RR is located downstream of the CH exons at the 3’ end of the IgH locus, this 
regulatory region have a palindromic structure and consists of 4 DNaseI hypersensitive (hs) 
sites, having lymphoid-specific transcriptional enhancer activity, scattered over 35 kb:  hs3a; 
hs1,2 ; hs3b and hs4 
(192-195)
, additional 3 hs sites without enhancer activity were described 
downstream of hs4 and are thought to signal the 3’ border of the IgH locus
 (196)
 (Figure 9).  
In transgenic rats and mice, hs1,2 is active at plasma cell stage 
(192, 193, 195)
. In 
transgenic mice where hs1,2 was inserted upstream of reporter genes, high-level expression 
was achieved in activated B cells but also in other non-B cell 
(197, 198)
. Transient transfection 
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assays showed that hs3a is a weak enhancer, with only 5–15% as active as Eµ in plasma 
cell
(194)
. Hs4 is also considered to be weak activator 
(199, 200)
. By contrast, the distant hs4 
enhancer seems to be active throughout B cell differentiation
(200)
. This expression pattern 
correlates with the methylation pattern of the 3’RR;  In general, the 3’RR is hypermethylated 
in pre-B cell line and became progressively demethylated as B cell differentiation continued, 
but it is not clear whether this applies to hs4
(201)
. 
The joint deletion of hs3b and hs4 slightly diminished µ gene expression in resting B 
cells
(176)
. Thus the 3’RR may be necessary for efficient expression of the rearranged VDJ 
segments by functioning over a distance of almost 200 kb.  
It has been hypothesized that 3’RR is implicated in IgH gene transcription via  physical 
interaction between VH sequences  and the 3' RR with DNA loop formation
(202)
. Up to now, 
3’RR was not shown to play a role in V(D)J recombination. However, the detectable DJH 
rearrangement upon Eµ deletion, might be caused by a cooperative function of 3’RR and Eµ 
but the double knockout has not been performed yet. In the κ locus, where Eκ and 3’Eκ are 
analogous to Eµ and 3’RR, the deletion of Eκ reduces Vκ to Jκ recombination(203); while the 
double knockout of Eκ and 3’Eκ completely blocks recombination of the Igκ locus(204).  
5) Neo effect 
The neomycin resistance (neo
r
) gene is a widely used selection marker in the 
homologous recombination-based transfection experiments of embryonic stem (ES) cells. 
Usually, it is under the control of the phosphoglycerate kinase (PGK) promoter.  
The replacement of the 700 bp downstream of the cEµ (including part of the 3’ MAR 
and the Iµ exon) by a PGK-neo
r
 gene had no obvious effect on rearrangement. In contrast, 
replacement of Eµ resulted in a complete cis-acting block of rearrangement, demethylation 
and a complete loss of µ0 transcripts. Moreover, insertion of the neo
r
gene 100 bp upstream 
of c Eµ (into the 5' MAR) also dramatically decreased recombination of the JH locus
(166)
.  A 
similar result was obtained after GL transmission in mice
(125)
 and, together with the results 
with Eµ-/- mice, suggests that the insertion of PGK-neo
r
 may have interfered with the function 
of cis-regulatory elements that enforce DJH recombination, a potential candidate being the 
3’RR known to have a long-range activity
(176)
 .Other aspects of Neo effect are reported and 
discussed in the first manuscript. 
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V. Transcription factors  
1) PU.1 and Ets Family Factors 
PU.1 is a member of the Ets family of TF, it binds the µB site of Eµ  
(Figure 10) and activates transcription from this enhancer 
(188, 205, 206)
. It is expressed 
throughout B cell development. PU.1-/- mice either died during fetal development and lacked 
B cells entirely
(207)
, or were stillborn with some B220+ cells expressing RAG and µ0 only in 
fetal liver
(208)
. Other members of the Ets family, such as Ets-1, ERG-3, FLI-1, ERP, and ELF-1, 
are capable of binding the µA site in Eµ and of activating transcription. These proteins are all 
expressed in early B lineage cell lines. Ets-1 -/- mice shows defects only in late B cell 
differentiation but no defects in early B cell development 
(209, 210)
, perhaps due to redundancy 
with other Ets family members. Ectopic expression of PU.1 in pre-T or fibroblast cell lines 
(already expressing Ets-1) triggered Iµ sterile transcription and increased sensitivity of Eµ to 
digestion with restriction enzymes 
(211)
. Therefore, PU.1 and Ets-1 are able to bind to Eµ and 
induce transcription and local changes in chromatin structure.  
2) E2A and EBF 
The E2A gene is alternatively spliced to encode two of the basic helix-loop-helix 
(bHLH) proteins TF family: E47 and E12. They bind µA motif known as the E-box and they play 
important role in B cell development by controlling transcription and V(D)J recombination. Eµ 
contains several sites that bind E47 and E12 (Figure 10). 
E2A-/- mice exhibit a complete block in early B cell differentiation; Iµ and µ0 GL 
transcripts are reduced and rearrangements are undetectable 
(212, 213)
. Overexpression of E47 
in a pre-T cell line increased Iµ GL transcripts and DJH rearrangements (up to 60% and 10% 
respectively of those found in a pro-B cell line). Ectopic expression of E47 in a murine 
fibroblast cell line induced Iµ GL transcripts and increased TdT transcripts
(214)
. Combined 
expression of RAG and E2A genes in an embryonic kidney cell line resulted in DJH 
recombination, high levels of VJκ rearrangement(123). Targeted mutation of the E-box 
motifs in Eµ resulted in a significant reduction in V(D)J recombination
(215)
. E2A seems to be 
also implicated in chromatin modifications; E47 and E12 interact and enhance transcription in 
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conjunction with HAT or histone acetyltransferase (CBP/p300)
(216, 217)
. In addition, one of the 
activation domains of E2A interacts with other HAT (SAGA complex)
(218)
.  
Expression of E2A in a lymphoid cell line lead to upregulation of the early B cell factors 
(EBF), Pax5, VpreB and RAG-1
(219)
. In EBF-/- mice, differentiation of B cells is blocked before 
the start of V(D)J rearrangements
(220)
. The small amount of early pro-B cells in these mice 
express both the Iµ and µ0 GL transcripts, but little if any RAG-1
(220)
. Thus in the absence of 
EBF, IgH D and J gene segments are transcribed and hence accessible, but fail to recombine 
due to a lack of RAG expression and/or because of the developmental arrest. Forced 
expression of EBF along with Rag genes in embryonic kidney cell line proteins is sufficient to 
trigger DJH and inducing selective LC VλJλ rearrangements
(123)
. Thus, E2A and EBF appear 
to play important and selective roles in the regulation of Ig gene rearrangement, possibly by 
influencing loci accessibility. 
Inhibitor of differentiation (Id1 to Id4) proteins form inactive heterodimers with bHLH 
proteins such as E2A proteins, and block their activity by preventing transcription
(221)
 and thus 
perturb B cell developpement. Id expression is inversely correlated with Iµ expression and 
inhibit Eµ function in B cell lines 
(222)
.In addition, overexpression of Id1 in transgenic mice 
blocks B cell differentiation at the pro-B cell stage, a phenotype similar to that caused by E2A 
deficiency
(212, 223)
. Ids also associate with Pax5 blocking its ability to bind DNA
(224)
. Moreover, 
Notch signaling (key regulator of T cell specification) induces expression of Hes1, a 
transcriptional repressor, which can also heterodimerize with E47 and antagonize its function 
(225, 226)
. 
3) C-Myb 
Another TF involved in very early cell fate decisions is c-Myb. Deletion of c-Myb in 
mice is lethal 
(227)
. c-Myb cooperates with other TFs to transactivate its target promoters. For 
example, it associates with the HAT CBP/p300 which then acts as transcriptional coactivator 
(228)
. Other interaction partners include Ets factors Ets-2 
(229)
, the CCAAT enhancer binding 
proteins (C/EBP), the and PU.1 
(230)
. All this reveals a c-Myb network of transcriptional 
regulation of lymphopoiesis. 
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4) LEF-1 
LEF-1 or lymphocyte enhancer factor-1 is a member of a family of proteins containing 
an HMG-box as their DNA-binding domain. These include LEF-1, TCF-3, TCF-4 and the Sryl-ike 
TF Sox-4, which is important for very early B cell differentiation. LEF1 -/- mice have several 
developmental defects, including a defect in pro-B cell differentiation 
(231)
. LEF-1 binds and 
activates the RAG-2 promoter together with c-Myb and Pax-5 in immature B cells
(232)
.  
5) µE3 Binding Proteins 
µE3 sites are located within the Eµ (Figure 10) and PVH. TFE3, TFEB and USF (Upstream 
TF) are ubiquitously expressed proteins that bind the µE3 sites. While TFE3 and TFEB activate 
transcription, USF is a negative regulator of IgH transcription (233, 234) Such functions could 
play a role in V(D)J recombination by bringing VH gene segments into close proximity of the 
DJH gene segment. Inactivation of TFE3 in ES cells and analysis by RAG-2 -/- blastocyst 
complementation results in mice with defects in B cell activation but normal bone marrow B 
cell development and V(D)J recombination
(235)
. Redundancy with other related proteins, such 
as TFEB, could help to explain this phenotype. Double mutation of an Eµ µE3 site and an E2A 
factor binding site blocks V(D)J recombination
(236)
. It is unclear which/if both of the two sites 
were critical for rearrangement in B cells, and hence the connection between this µE3 site 
and the regulation of IgH recombination remains slight. Moreover, in the vicinity of µE3 site, a 
binding site for C/EBP is found. C/EBP is expressed in early B cell lines and can activate IgH Eµ-
based transcription 
(237)
.  
6) Octamer Binding Proteins 
The octamer motifs have been found in GL promoters and Eµ as well as in other 
elements in Ig loci. Many studies have shown that these sites are essential for transcriptional 
regulation of IgH and other B cell specific genes 
(238)
. There is also some suggestion of a 
connection between a functional octamer site and efficient V(D)J recombination 
(239)
. Two 
Pou-domain proteins, the ubiquitously expressed Oct1 and the B-cell-specific Oct2 bind to 
and activate transcription from Ig octamers sites
(240)
. Another factor, OBF-1, is a B-cell specific 
coactivator that interacts and stimulates Oct1- and Oct2-dependent Ig-specific transcription 
once these two factors are bound to their sites 
(241)
. Surprisingly, Oct2- and OBF-1-deficient 
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mice have normal V(D)J recombination and transcription but late-stage B cell differentiation 
and antibody production are affected 
(242, 243)
. Given the potential for redundancy between 
Oct1 and Oct2 and the fact that IgH and IgL transcription was normal in these mice, it remains 
uncertain whether these proteins or the octamer site play any role in regulating VDJH 
rearrangement. 
7) Pax5 
It is now well established that Pax5 acts as a transcriptional repressor of lineage-
inappropriate genes and thus commits the progenitor cells to the B-lymphoid lineage and 
maintains that commitment by suppressing alternative cell fates 
(219, 15, 244)
. Mice with Pax5 
deficiency die at the age of 3 weeks and present an arrested B cell development at the early 
pro-B stage
(245)
. Also, in pax5-/- pro-B cells, DJH recombination is normal while distal but not 
proximal VHDJH recombination is abrogated
(246)
. B cell commitment is reversible upon 
deletion of Pax5 as Pax5-/- pro-B cells can differentiate in vitro into natural killer cells, 
dendritic cells, macrophages, osteoclasts and granulocytes
(15)
. 
Pax5 can directly act as a transcriptional activator of several lymphoid genes such as 
CD19 and LEF-1 
(247)
. It has been shown that Pax5 bind to the VpreB and λ5 promoters as well 
as to sites upstream of the Jκ genes (248) and possibly contribute to their activation. Also Pax5 
can bind distinct proteins that act as a transcriptional co-repressors such as the TATA binding 
protein (TBP) and the transactivation-domain interacting protein (PTIP). Intriguingly, he 
transcription factor PU.1 is a direct target of the Pax5-mediated repression and, inversely the 
PU.1 transcription factor is a direct target of the Pax5-mediated repression and, inversely, 
PU.1 can inhibit Pax5 transactivation 
(249)
. Blimp-1, the master transcription factor involved in 
plasma cell differentiation, represses the expression of Pax5 
(250)
. 
8) The cytokine IL7 Receptor 
The intrleukin-7 receptor (IL-7R) plays a very important role in lymphopoiesis; in fact, 
the common lymphoid progenitors that express IL-7R on their surface give rise exclusively to 
lymphocytes 
(251)
. The IL-7R is composed of two proteins: the unique α subunit and the 
common γ chain which is shared by many interleukin receptors. Targeted deletion of the IL-
7Rα gene results in a severe early block in lymphocytes development 
(252)
. In IL-7Rα-/- mice, 
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DJH rearrangement occurs normally, but VDJH rearrangement exhibits a selective defect: 
proximal VH gene families undergo rearrangement, while more distal VH gene families do not. 
This is probably due to the decreased GL transcripts that originate from distal VH families
(253)
. 
Intriguingly, bone marrow cells from IL-7Rα-/- mice express lower levels of Pax5 than do IL-
7Rα+/- controls. This, along with the defect in VDJH recombination in Pax5-/- mice, suggests 
that maybe IL-7R signaling modulates accessibility of the VH segments by influencing Pax5 
levels. 
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D. IGH ACCESSIBILITY AND EXPRESSION IN LATE B CELL 
DEVELOPMENT 
 
Upon antigen challenge and activation, a mature B cell undergoes two processes of Ig 
diversification: somatic hypermutation (SHM) and class switch recombination (CSR). These 
mechanisms are both triggered by activation-induced deaminase (AID)
(254)
. This enzyme is 
mainly, but not exclusively, expressed in activated B cells and catalyses deamination of 
cytosines  into uracils. 
 
I. Somatic Hypermutation 
In secondary lymphoid tissues, SHM occurs in GCs after the binding of antigens to B 
cells. The process targets the variable regions allowing the maturation of the receptor and thus 
the selection of B cells that express antibodies with higher affinity for foreign antigens.  
1) Mechanism of SHM: an outline 
SHM introduces mainly single nucleotide substitutions or more on both DNA strands. 
SHM starts some 150 nucleotides downstream the VH promoter, continues within the 
rearranged VHDJH and ends 1.5-2 kb downstream of the promoter, at a frequency of 1 mutation 
each 1000 bp. The four bases of DNA can be targeted by mutation with approximately the same 
frequency to the two pairs C:G and A:T. Still there are more transitions (e.g., CT, GA) than 
transversions (e.g., CA or G; GC or T).  
The SHM requires transcription of the target sequences. AID deaminates the C in a G:C 
pair located mainly in hotspots within a WRC consensus (where W=A/T and R=A/G). This 
deamination changes deoxycytidine into deoxyuridine and consequently transforms C:G pairs 
into U:G mispairs (Figure 11). There are different opinions regarding the mechanism of AID 
function 
(255)
 but the majority of evidence is consistent with the model that AID acts by 
deaminating cytidines into uridines in the target DNA within the Ig loci
(256)
. 
Within the framework of DNA deamination model 
(257)
, two major phases can be 
outlined: in phase 1a, the uracil (U) is simply considered as a thymidine which leads to a CT 
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and GA transition mutations upon replication. In Phase 1b, the Base excision repair (BER) 
pathway is involved. The uracil is excised by an uracil-DNA glucosylase (UNG) leaving the 
deoxyribose-phosophate backbone intact thus creating an abasic site which may be replicated 
over probably by involving translesional polymerases 
(258, 259)
. Alternatively, an Apyrimidinic 
endonuclease (APE) can nick the phosphate backbone producing single-stranded breaks (SSBs). 
Then error-prone polymerases can fill the gap by inserting any nucleotide in place of the U, 
leading to transitions and transversions at G:C bases. UNG-/- mice had severely impaired 
antibody diversity
(260)
. In Phase 2, the MSH2/MSH6 mismatch repair (MMR) heterodimer can 
also recognize the U:G mispair and triggers a patch-repair process. The U-bearing strand is 
excised by the MMR exonuclease (Exo1) and proliferating cell nuclear antigen (PCNA) recruits 
error-prone polymerases (certainly pol η) to fill the large gap, potentially leading to transition 
and transversion mutations at A:T bases as well as at neighboring G:C bases. Mice deficient in 
MSH2 exhibit an altered spectrum of mutations with a marked reduction in mutations at A:T
(261)
 
but not total elimination. Upon the double deletion of MSH2 and UNG in mice, A:T mutations 
disappear and the only mutations that remain are those initiated by AID at the G:C pair (dashed 
line in phase 2)
(262)
. 
2) Role of cis-acting elements 
SHM depends on V gene transcription as suggested by the severely decreased frequency 
of mutations in the IgH locus when the VH promoter is removed 
(263)
, yet if this promoter is 
replaced by a transcriptionally active exogenous promoter, SHM is normal 
(264)
.  
Cis-acting sequences may recruit AID, BER, and MMR to the VH regions. The 3’ enhancer 
of the κ LC is required for SHM in ectopically located LC genes 
(264)
, however gene targeting 
indicates that this is not the case for the endogenous gene 
(265)
. Moreover, studies in which the 
cEµ was deleted resulted in mice that had a small if any insignificant effect on SHM 
(149)
. In 
contrast, if cEµ is deleted in an ectopic HC gene in Ramos cells, there is a 2-fold reduction in 
SHM. If hs1,2 is added, SHM is partially restored and mutations occur primarily in A:T bases 
rather then G:C bases but if hs3b and hs4 are added, there is no significant increase in SHM but 
enforced bias in mutation 
(266)
.  However, the joint deletion of endogenous hs3b and hs4 in 
mice had no effect on SHM
 (267)
, but recent studies showed that the 3’RR was necessary for SHM 
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as the frequency of mutation was severely dropped in the absence of the entire 3’RR in a 
transgenic system
(268)
. 
Little is known concerning the chromatin modifications associated with SHM in vivo. All 
the modifications and cis-acting elements that target AID influence SHM (Detailed below). 
Phosphorylation of histone H2B-Ser14 is tightly associated with SHM and is AID dependent; 
suggesting that this chromatin modification is unlikely to be responsible for the initial 
recruitment of AID but it could play a role in the recruitment of error-prone BER or MMR 
(269)
. 
 
 
Figure 11: Mechanism of somatic Hypermutation. 
The U:G mispair created by AID deamination can be resolved by DNA repair mechanisms BER or MMR or can 
simply be replicated over. (Peled et al., 2008)
(270)
. 
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II. Class switch recombination 
1) Outline 
Mature B cells express µ and/or δ chains on their surface; once activated these cells can 
change the effector function of the Ab by undergoing CSR and thus switching to express the 
downstream C regions γ3, γ1, γ2b, γ2a, ε or α.  Upstream of each C region, besides Cδ, there are 
sequences with G-rich tandem repeats (5-80 bp) termed switch (S) sequence (Figure 11). 
Transcription is driven across transcription units made up of an I exon, a S region and a constant 
region. Thus there are seven transcription units in the murine IgH locus (Figure 11). GL 
transcripts are induced from promoters upstream of each switch region. GL transcripts start at 
an I exon located 5’ of the S region and then gets spliced on the constant region and 
polyadenylated (Figure 12).  
CSR absolutely requires AID, GL transcription and proliferation. Regarding the cell cycle, 
most of the data indicate that CSR is probably resolved during the G1 phase of the cell cycle 
(271-
273)
. 
 
VHDJH Cµ Cδ Cγ3 Cγ1 Cγ2b Cγ2a Cε Cα
Sµ Sγ3 Sγ1 Sγ2b Sγ2a Sε Sα
Iγ3 Iγ1 Iγ2b Iγ2a Iε Iα
MAR MAR MAR
hs
3a      1,2 3b 4 5 6 7
3’RR
IµVHP
Eµ
 
Figure 12: Schematic representation of the murine IgH locus 
Constant regions are depicted in blue rectangles. MAR regions are in pink rectangles. Promoters and enhancers 
are represented by grey ovals. Hypersensitive sites are represented by green ovals. Black arrows represent the 
orientation of GL transcription. 
 
 
AID is induced in germinal centers of B cells 
(274)
 after antigen encounter in a T-
dependent or -independent manner. Activation stimuli by CD40 ligand (CD40L), mitogens 
(LPS…) or cytokines (IL4, IL5…) can promote AID expression in splenic B cells in vitro and induce 
GL transcription. For example, when induced by LPS cultured IgM
+
 B cells switch to IgG3, IgG2b 
and in a small degree to IgA. IL4 induces GL γ1 and ε and blocks γ3 and γ2b transcription. The 
same result is obtained if B cells are stimulated with IL4 and CD40L. Stimulation by TGF-β1 
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(Transforming Growth Factor-β1) induces GL α and γ2b transcription. Stimulation with INFγ 
induces GL γ2a transcripts. These activators induce transcription factors that bind their 
responsive elements on I promoters 
(275) 
(Figure 16).  
CSR consists of introducing DSBs in the donor S region,  Sµ, and in an acceptor S region 
(Sε in Figure 13); then removing the intervening DNA and joining the two S regions ultimately 
leading to a cell that can express an ε HC on its surface. The reaction is catalyzed by the classical 
NHEJ (c-NHEJ) pathway or by the alternative (a-EJ) pathway. 
 
 
 
 
 
Figure 13: Schematic representation of CSR 
CSR exchanges µHC with one of the downstream C genes (CSR to IgE is shown). It is preceded by GL transcription 
(red arrows). CSR leads to a rearranged CH locus and deletion of the intervening sequence as an episomal circle. 
(Chaudhuri and Alt, 2004)
(276) 
 
 
2) Mechanism of CSR 
The first steps of CSR are probably like those in SHM, after deamination by AID; the BER 
produces SSBs in S regions on both strands. If these SSBs are near each other on opposite DNA 
strands, they will form DSBs, but if they are distant then the following step engages the MMR 
complex in order to convert SSBs into DSBs. The MSH2/MSH6 heterodimer bound to a U:G 
mispair recruits the Mlh1-Pms2 heterodimer 
(277)
. The heterotetramer would recruit Exo1 to a 
nearby 5’ SSB and start excising DNA in 5’ 3’ oriented manner until it encounters another SSB 
on the opposite strand
(278)
, thus creating a DSB (Figure 14). This leaves 5’ or 3’ overhangs which 
are either excised, potentially by the structure-specific endonuclease ERCC1-XPF that was found 
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to excise 3’ overhangs and has a minor role in CSR(279); or filled in to create blunt, or nearly blunt 
DSBs convenient for an end-joining recombination with the partner S region. The fill in is 
probably catalyzed by translesion Polymerases such as pol µ or Pol ζ (258, 277, 259). 
 
 
 
 
Figure 14: Creation of DSB in CSR. 
AID starts to deaminate C residues into U in S regions. U residues are excised by UNG creating abasic sites that 
are nicked by APE. The U:G mismatches that remain would be substrates for Msh2-Msh6 along with Mlh1-Pms2. 
the tetramer then recruits Exo1 that creates a DSB with a 5’ single-strand overhang, which can be filled in by 
DNA polymerase. (Stavnezer et al.,  2008)
(280)
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After formation of the DSBs in both the donor (Sµ) and the acceptor S regions, the two S 
regions are joined together using the ubiquitous proteins of c-NHEJ or the ill-defined 
components of the a-EJ. 
Ku70-Ku80 binds DNA ends at the DSBs and mediates synapsis of the two DNA ends, 
positioning the ends to allow end processing and direct end-to-end joining 
(281)
. After binding, 
Ku slides away from the ends, allowing DNA-PKcs, to bind to each end 
(282)
. DNA-PKcs is 
transphosphorylated by the other DNA-PKcs bound at the other end of the DSB and also 
phosphorylates Ku70, Ku80, and XRCC4 
(283)
. The MRN complex probably binds next and travels 
along the DNA duplex scanning for DNA breaks 
(284)
, then it recruits and activates the kinase 
ATM that binds MRN by Nbs1. ATM then phosphorylates Nbs1, H2A variant (H2AX), the 
transcriptional coactivator of 53 (53BP1), and the mediator of DNA damage checkpoint protein 
1 (Mdc1). Phosphorylated 53BP1, Nbs1, and Mdc1 bind the phosphorylated tail of H2AX (γ-
H2AX), which serves as a docking site for these proteins resulting in accumulation of large 
amounts of these proteins and MRN around the DSB sites 
(285-287)
.  
After the DNA ends are brought sufficiently near to each other, Ku recruits XRCC4-
ligaseIV that effect the recombination
(288)
. XRCC4-ligaseIV ligates incompatible ends, consistent 
with the lack of microhomology at S-S junctions in WT cells 
(289)
. 
These proteins are all important for correct S-S recombination, and they inhibit aberrant 
recombinations and translocations as seen from the KO mice (see below).  
 
 
 
Figure 15: Binding Factors to DSBs during CSR.  
Ku and DNA-PKcs, bind DSB ends first. MRN probably binds next, then it recruits and activates ATM which 
phosphorylates H2AX, 53BP1, and Mdc1. Eventually, LigaseIV binds the ends together. ATM also phosphorylates 
proteins that regulate the cell cycle and induce apoptosis, but nothing is known about how important this is 
during CSR. (Stavnezer et al.,  2008)
(280)
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CSR is reduced by 95% in B cells from UNG-/- mice 
(260)
. Examination of APE1- and/or 
APE2- deficient mouse splenic B cells activated to switch in culture demonstrated that both of 
these enzymes contribute to CSR 
(290)
.  
In mice that lack one of the MMR genes (Msh2, Msh6, Mlh1, Pms2, or Exo1), CSR is 
reduced by two- to five fold except for Exo1-/- mice where CSR is even more severely decreased 
(291, 292)
. In WT cells S-S junctions occur upstream of Sμ and throughout the tandem repeats but 
in MSH2-/- B cells most of S-S junctions occur within Sμ tandem repeats 
(293)
. In the S-S junctions 
there is more microhomology between the synapsed S sequences. This suggests that MMR is 
involved in end processing from the sites of the SSBs, resulting in different lengths of single-
stranded tails that can participate in homology search during S-S recombination 
(294)
.  
Ku-/-cells die upon induction of CSR, CSR in the few viable ku80-/- cells was found to be 
nearly ablated 
(295)
. XRCC4 or ligaseIV deficiency is lethal 
(80, 296)
. In double mutant mice for 
XRCC4 and the tumor suppressor protein p53, B cells have ∼25% of normal levels of CSR, 
indicating that XRCC4 is important but not essential for CSR 
(297)
.  
Null mutations in any component of MRN are lethal, and hypomorphic mutations result 
in aberrant chromosomes and translocations
(298)
. CSR is reduced two- to threefold in cultured 
splenic B cells from mice in which the Nbs1 gene is inactivated by a conditional mutation
(299, 298)
. 
c-myc translocation occurs six times more frequently in Nbs1-hypomorph B cells than in wild-
type B cells
(300)
. The finding of increased translocations with c-myc in MRN-deficient B cells 
suggests that the MRN complex is involved in organizing efficient and accurate S-S 
recombination.  
In ATM-/- mice, CSR is reduced while transcription is normal
(301)
, also c-myc 
translocation occurs eight times more than in WT and S junctions have increased 
microhomology 
(300)
. In 53bp1-/-mice, CSR is reduced of about 90% and switch junctions are 
normal 
(302, 303)
. 53BP1 may enhance synapsis and long-range interactions between two distal 
DSBs 
(302, 304, 303)
, possibly by altering local chromatin structure or increasing chromatin mobility. 
H2AX-/- mice have markedly reduced CSR  but can still repair DSBs
(305)
, although with lower 
efficiency probably because the initial assembly of repair proteins does not depend on γ-H2AX 
(306)
. CSR in cultured MDC1-/- B cells is only mildly reduced, to about 50%-70% of WT B cells 
(307)
. 
As mentioned before, C-NHEJ ligates DSBs with little or no microhomology and appears 
to be the dominant pathway involved in CSR, based on the physiological predominance of blunt 
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or small microhomology (<4bp) at switch joins 
(308, 309, 297)
. In contrast, little is known about the 
factors that mediate A-EJ (Haber, 2008). However, this is a robust pathway that makes 
extensive use of junctional microhomologies (5-25 bp) and can reconstitute substantial CSR in 
the absence of C-NHEJ for example in the absence of Ku70 and DNA LigaseIV, CSR to IgG1 is up 
to 60% and to IgG3 is up to 30% relatively to WT 
(308, 309, 297)
. A-EJ appears to be kinetically 
slower than C-NHEJ and mediates many of the translocations that occur during V(D)J 
recombination and CSR 
(308-310)
. 
3) Regulation of CSR 
a) GL transcription 
 GL Promoters and exons 
GL transcripts are induced by the action of extracellular signals including T-cell 
dependent and independent signals, cytokines and regulatory factors. GL promoters have 
cytokine-responsive elements within them. 
IL4 and CD40L activate the canonical signaling cascade of the Jak/STAT pathway (Janus 
Kinase/signal transducer and activator of transcription) 
(311)
. STAT6-/- mice lack IgG1 and IgE 
and after stimulation of splenocytes with IL4 coupled to CD40L, γ1 and ε transcripts are absent 
(312)
. Binding of IL4 or CD40L to their relative receptors leads to the activation of Jaks that 
phosphorylate certain tyrosine residues on the receptor chains, which generates docking sites 
for STAT6 monomers. Having bound to the phosphotyrosines on the receptor, a STAT6 
molecule become phosphorylated on tyrosine residues, which enables it to form a dimer with 
another STAT6 molecule. The active STAT dimer translocates rapidly to the nucleus and binds 
DNA and activates the expression of target genes (γ1 and ε). STAT6 cannot activate 
transcription by itself but requires an adjacent binding site for C/EBP (CCAAT/Enhancer Binding 
Protein). Induction of γ1 and ε promoters also requires the presence of three (γ1) and two (ε) 
binding sites for the nuclear factor(NF)-κB (275). 
In most cells, the major proportion of NF-κB proteins reside in the cytoplasm in a latent 
state, sequestered by inhibitory proteins, called IκB proteins. A broad range of signals, including 
mitogens and cytokines activate an IκB-specific kinase complex (IKK) that mediates the 
degradation of IκB proteins, thereby liberating Rel/NFκB transcription factors to enter the 
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nucleus, bind specifically κB motifs and activate gene transcription. All Ig promoters have 
binding sites for NF-κB, which are induced in response to, among other, LPS and CD40L 
signaling (Figure 16).  
TGF-β1 engages a heterotetrameric TGF-β receptor (TGFβR) complex composed of type I 
and type II transmembrane proteins that have serine/threonine kinase activity. Signals 
emanating from the TGFβR induce both activating and inhibitory effects. In B cells, low 
concentrations of TGF-β1 initiate Cα gene transcription, whereas high concentrations suppress 
B cell proliferation and differentiation, including antibody secretion.  
TGFβR signals through the phosphorylation of SMAD proteins, which form homo- and 
hetero-oligomeric complexes that bind to SMAD binding elements on the promoters of target 
genes. The activated SMAD complexes are translocated into the nucleus and in conjunction 
with other nuclear factors regulate (activate or repress) the transcription of target genes
(313)
.  
 
Iγ3 GL promoter
Iγ1 GL promoter
Iε GL promoter
κB1 IkSTAT6/EBP κB2 κB3 Ik
PU-boxκB C-EBPκB5Ets
κB1STAT6/EBP/IK κB2Ik Pax5E1 E2
Iα GL promoter κB Pax5RBE RBE Ets RBESmad CRESmad
 
 
Figure 16: Responsive elements at germline Promoters.  
Cytokines, mitogens and TFs regulate Ig GL promoters by binding to response elements lying in the GL 
promoters. For example, over-expression of Pax5 in B cell lines stimulates transcription from the Igε GL promoter 
thus promoting CSR to IgE and conversely it inhibits GL α transcripts and switching to IgA
(314)
. 
 
 
There are two types of sterile sense transcripts transcribed through S regions; the first 
ones are expressed after activation of the promoters but before CSR; they are termed pre-
switch transcripts. They originate from each I promoter, are elongated through the S and C 
genes, and terminate at the normal termination sites of mature mRNA. After removing intronic 
regions by splicing, mature pre-switch transcripts contain an I exon spliced to its C region splice 
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acceptor (Ix-Cx). The second types of transcripts are called post-switch transcripts and they are 
transcribed after CSR; they initiate from Iµ, elongate through the chimeric S sequences and get 
spliced on the newly recombined C region (Iµ-Cx). These processed transcripts lack an open 
reading frame and thus do not encode any known protein
(315)
.   
Iµ GL transcript is the only constitutively expressed transcript and is not responsive to 
any form of B cell activation, perhaps this is in relation to the fact that Iµ promoter is 
embedded within the Eµ enhancer
(315)
. 
Recently, anti-sense, presumably unspliced, transcripts have been detected at Sµ, Sγ1 
and Sγ2b (119) and may be a general feature of S regions.  However, neither their promoters nor 
their termination sites have been characterized and their role in CSR and/or in the targeting of 
AID is still unclear. 
Several studies have shown that the accessibility of S sequences depends on their 
transcription. In this context, gene-targeting experiments in which a single I exon and/or 
promoter for a specific GL transcript is deleted showed that GL transcription of the acceptor S 
region is required for CSR to that isotype. The targeted deletion of the region 5’ of Sγ1 including 
Iγl promoter
(316)
 , the replacement of Iγ2b 
(317)
 in mice and  the deletion of the Iε region
(318)
 
result in the complete shutdown of CSR to the corresponding isotypes. In other experiments, Iα 
exon was replaced by a human hypoxanthine phosphoribosyltransferase (hPRT) minigene, CSR 
to IgA was normal
(319)
. The same result was obtained when Iγl promoter was replaced by a 
human metallothionein II (hMT) promoter. Intringuingly, if the 5’ donor splice site is deleted, 
CSR is abolished
 (320) 
suggesting that maturation of GL transcripts contributes to the regulation 
of CSR but the mechanism remains elusive. 
 Perhaps conversely, the mutation of Iµ splice donor site leaves CSR intact, even in the 
absence of detectable canonical spliced Iµ transcripts. In this context, two novel cryptic sites 
upstream of Sµ region were activated and shown to mediate splicing to Cµ 
(321)
.  
 
 S sequences 
S sequences are G-rich sequences on the non template strand, are reiterated over 2 to 
10 kb and are more or less homologous to each other. Sµ, Sε, and Sα are composed of 
pentameric tandem repeats such as GGGGT, GGGCT, and GAGCT, while Sγ sequences consist of 
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repeats of a 49 bp sequence
(322)
. S regions are likely to be accessible and to engage in switch 
recombination throughout their entire length as breakpoints were found across all the S 
sequences but no consensus sequence has been identified at the junctions of recombined DNA 
fragments
(323)
. 
RNA-DNA hybrid structures have been shown to form during transcription of S regions in 
vitro and in vivo. The newly synthesized transcript remains associated with the S region 
template DNA
 (324)
. The G-rich non template strand is thought to form several structures that 
provide ssDNA stretches as substrate for AID deamination and thereby enhance the efficiency 
of CSR: R-loop, Stem-loops
(325)
, G-quartet
(326)
 and Replication Protein A (RPA) dependent 
transcription coupled structures (Figure 17)
(327)
. However, up to now, R-loops are the only ones 
whose presence was demonstrated in vivo 
(328)
.  
 
 
 
 
Figure 17: Models of secondary structures at switch sequences. 
S-region transcripts can stably associate with the template strand to form RNA–DNA hybrids, in which the non-
template strand can theoretically assume several structures (G quartets or stem loops) or can remain single 
stranded (R loops). RPA is thought to form a complex with AID that binds to ssDNA of small transcription bubbles 
leading to AID-mediated deamination (Chaudhuri and Alt,2004) 
(276)
. 
 
 
Deletion of the core Sµ shows that the tandem repeats are important but not essential 
for efficient CSR 
(329)
. Deletion of most Iµ-Cµ intron severely impairs but still does not abrogate 
CSR; this may pinpoint to the specificity of Sµ region in CSR
 (330)
 as deletion of most of Iγ1-Cγ1 
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intron totally blocks CSR to IgG1
(331)
. The inversion of Sγ1 decreased CSR to IgG1 by 75% 
(331)
.The 
replacement of Sγ1 by a 1 kb G-rich sequence capable of forming R-loops but lacking the 
tandem repeats was capable of partially substituting for Sγ1 with a 7% CSR relative to wild type 
(WT). If the same replacement sequence is inverted, CSR drops to 0.8% compared to WT, thus 
CSR was observed in the orientation that favored R-loops formation
(331)
. Mouse Sγ1 was also 
replaced by Xenopus Sµ sequence which is AT rich thus is not prone to form R-loops but this 
sequence is rich with RGYW motifs (SHM hotspots); these mice were capable to undergo some 
CSR to IgG1
(332)
.  
In mice where endogenous 10 kb Sγ1 region was replaced with a WT or synthetic 2-kb 
Sγ3 sequences, Sγ3 can function similarly to Sγ1 in mediating endogenous CSR to IgG1
(333)
. In 
another recent study, endogenous Sγ3 region was replaced with a size-matched Sγ1 sequence.  
The Sγ1 mutant allele engages in CSR to IgG3, whereas the intact allele is repressed
(334)
. The 
preferential usage of the Sγ1 replacement allele is IL4-dependent, demonstrating that Sγ1 is not 
simply a better substrate for switching but rather differentially targeted for CSR under those 
conditions.  
All these studies highlight the importance of S regions and R-loops for CSR. Yet they do 
not explain how AID is able to target the variable region during SHM knowing that the V(D)J 
sequence is not G-rich and there is no R-loop formation. In addition, the remaining 25% of CSR 
found when Sγ1 is inverted indicate that other mechanisms might exist to reveal ssDNA 
structures to AID. 
 
 Neo effect 
The implication of 3’RR in CSR was first shown via the effects of PGK-neo
r
 cassette 
inserted into the 3’RR. It was suggested that 3’RR functions as a long-range control region that 
regulates GL promoters following appropriate stimuli 
(335, 336)
. Replacement of either hs3a or 
hs1,2 with a PGK-neo
r
 gene disrupted GL transcription of and CSR to most C genes
(336)
.  
Insertion of a PGK-neo
r
 cassette at various sites within the C locus inhibited CSR to 
upstream, but not downstream C genes (with the exception of Cγ1), supporting the notion that 
the PGK-neo
r
 cassette insertion into the locus alters the effect of 3’RR on I promoters and 
blocks its ability to facilitate CSR of dependent C genes upstream of neo
r
 insertion
(337)
.  It has 
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been proposed that the neo
r
 promoter compete with GL promoters for the control elements 
that regulate CSR 
(335, 336)
. 
All these analyses indicate that the key elements of the 3’RR are downstream from 
hs1,2. In a study seeking to localize the 3’boundary of the 3’RR, PGK-neo
r
 gene cassette was 
inserted 2 kb downstream of hs4. The KI mice had normal GL transcription and normal ability to 
undergo CSR
 (338)
. These results suggested that key elements of the 3’RR lie within a 17 kb 
region between hs1,2 and 2 kb downstream of hs4. 
In mice where a PGK-neo
r
 cassette was inserted downstream of Iγ3, two cryptic splice 
sites were used in the mutated mice, one located in the neo
r
 gene and the other located in the 
intron sequence between neo
r
 insertion site and Sγ3. In both cases, the donor sites were 
normally spliced to the canonical Cγ3 splice acceptor site 
(339)
. These results strengthen the idea 
that processing of GL transcripts is a critical parameter in the molecular mechanisms leading 
from germ line transcription to CSR. 
 
 Cis regulatory elements  
Transcription of switch regions is necessary to CSR but not sufficient for CSR. In this 
regard, the deletion of cEµ decreased CSR by two fold although Sµ transcription was relatively 
normal
(340)
.  The 3’RR was found to be involved in the control of CSR but not all the 4 hs sites 
have the same function. In fact, replacement of hs3a or hs1,2 with a loxP sequence had no 
effect on CSR indicating that these elements are not critical for CSR 
(336)
. Conversely, the single 
deletion of hs4 or hs3b had no effect on CSR 
(341, 342)
.  However, the joint deletion of hs3b and 
hs4 had a severe impact on CSR and GL transcripts; they were profoundly affected regarding γ3 
and γ2b, reduced by 90% for γ2a, ε  and α but CSR to γ 1 and transcription of the Cµ gene were 
slightly decreased 
(176)
, suggesting that these enhancers act in synergy to control CSR by acting 
on GL transcription. Recent studies in transgenic mice showed that deletion of the entire 3’RR 
region severely decreases CSR to all isotypes
(268)
 indicating that 3’RR controls GL transcription 
and CSR to all the C regions and that enhancers are strongly synergistic in transgenes but 
redundant in their endogenous context if considered individually. 
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b) Chromatin modifications 
How Aid targets switch regions is still unknown. Chromatin modifications involving 
remodeling of nucleosomes and post-translational modifications of histones can affect 
sequence accessibility for DNA binding proteins or recruitment of TFs, recombination, and DNA 
repair. 
Histone acetylation of the S region was shown to correlate with the level of GL 
transcription and the frequency of CSR 
(343)
. In this study the authors found that in unstimulated 
B cells, the I promoters and S regions are hypoacetylated with the exception of µ sequences 
which was normal as Iµ was expressed in a steady-state throughout development and even 
after activation. Then upon stimulation with LPS or with LPS and IL4, Iγ3-Sγ3 and Iγ1-Sγ1 
become respectively hyperacetylated. These results suggest an important role for histone 
acetylation in the induction of GL transcription by regulating locus accessibility during CSR. H2B-
ser14 and γ-H2AX were found to be associated with CSR 
(269, 344)
. Treatment of BL2 cells with 
Trichostatin A (TSA), an inhibitor of histone deacetylation that causes global hyperacetylation of 
histones, resulted in the mutation of the C region and increased the mutation of the V 
region
(344)
. H3K9ac and H3K9me3 were identified to correlate with the recombining pair of 
donor and recipient S regions. The involvement of H3K9me3 with active transcription is 
surprising because usually it is thought to mark silent genes and heterochromatin
(345)
.  
Genome-wide analyses indicate that H3k4me3, H3k4ac and initiating RNA polymerase II 
(RNAP II) phosphorylated at serine 5 (p-ser5) are enriched on promoter-proximal sites; whereas 
levels of H3K36me3 and elongating RNAP II p-ser2 are elevated in the downstream coding 
regions of active genes
(346, 146)
. Studies in yeast demonstrate that a protein integral to the NuA3 
HAT complex binds with H3K4me3, indicating a mechanistic link between H3K4 methylation 
and histone hyper-Ac 
(347)
. A detailed study of the Iγ3-Sγ3-Cγ3 murine locus demonstrated that 
acetylated histones are focused to the Iγ3 exon and the Sγ3 region but not to the intergenic 
areas. Histone H3ac is strongly correlated with GL transcripts expression at four S regions, 
whereas H4ac was better associated with B cell activation and AID expression
(348)
. Other 
studies
(349)
, showed that after transcription activation of GL transcripts, I promoters and S 
regions are a focus of increased H3K4me3, H3Ac and chromatin remodeling and accessibility; 
whereas C regions accumulate the repressive marks H3K36me3 and H4K20me1, H3 
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hypoacetylation and chromatin inaccessibility. S sequences were found to facilitate retention of 
RNAP II p-ser5 and is correlated with an extended zone of H3K4me3 modification.  
There are several possible yet hypothetical mechanisms by which RNAP II can be 
retained in S regions. RNA-DNA hybrid structures in R-loops may obstruct transcription 
elongation 
(350-352)
. It is also possible that antisense transcripts play a role in this retention. 
 
III. The Activation-Induced cytidine Deaminase 
1) Characteristics of AID  
AID is a 198 aa protein encoded by aicda gene that shows homology with members of 
the APOBEC family 
(274)
 which play a role in RNA editing. AID is mostly localized in the cytoplasm 
and is largely expressed before the start of CSR following B cell activation in vitro
 (353)
. In vitro 
studies on purified AID proved that it preferentially  acts on ssDNA but it has been shown in 
vivo that both strands are targeted 
(354)
. No RNA deamination activity has been found yet for 
AID. Interestingly, APOBEC1 was found to deaminate DNA in vitro 
(355)
. 
 
 
 
 
Figure 18: Functional domains in AID. 
Critical residues are indicated and functional domains are drawn below. Known phosphorylation sites are 
represented by yellow or orange sunbursts (Peled et al., 2008)
(270)
. 
 
 
The C-terminal portion of AID is required for CSR but dispensable for SHM 
(356)
 and 
contains consensus nuclear export signal (NES) 
(357) 
recognized by the exporting chromosome 
region maintenance-1 (CRM1) that binds and exports NES-containing proteins out of the 
nucleus. Mutation of the AID NES or inhibition of CRM1, with the specific inhibitor leptomycin 
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B, results in an accumulation of nuclear AID 
(358)
. The N-terminal region of AID is more 
important for SHM than for CSR 
(356)
 and contains a sequence similar to bipartite nuclear 
localization signals (NLS). AID-GFP chimeras carrying deletions of the N-terminal region fail to 
accumulate in the nucleus even when nuclear export is inhibited
(359)
.  
In biochemical assays, RPA, a ssDNA-binding protein, associates with phosphorylated 
AID from activated B cells and enhances AID activity on transcribed dsDNA containing SHM or 
CSR target sequences 
(327)
 . This AID-RPA association, which requires phosphorylation at Serine-
38 (S38)
(360)
, may provide a mechanism for allowing AID to access ssDNA targets in activated B 
cells. AID-S38 lies within a cAMP-dependent protein kinase A (PKA) consensus motif. Mutation 
of AID-S38 to alanine (AID-S38A) diminished the phosphorylation ability of PKA thus impaired 
the ability of AID to interact with RPA and mediate deamination of a transcribed SHM substrate 
in vitro without affecting the basic catalytic activity of AID
(360)
. AID-Ser38A, expressed from 
retroviral vectors, was only able to restore 10-20% of CSR activity to stimulated AID-/- B cells 
(361, 362)
. Thus phosphorylation of AID at Ser38 plays an important role for optimal CSR in vivo. 
The quantity of nuclear AID is important for its activity as uncontrolled expression of AID 
is potentially mutagenic
(363)
. AID+/- mice have impaired competence for CSR and SHM, which 
indicates that AID gene dose is limiting for its physiologic function
(364)
. Thus the nuclear 
exportation and/or elimination of AID by the proteasome are important factors for the 
regulation of AID
(365)
. 
JAK/STAT and NF-κB pathways have been shown to be involved in IL-4-induced AID 
expression in B cells 
(311, 366)
. E47 can induce the expression of AID in B cells through the 
activation of an intronic enhancer in the aicda gene. This activation seems negatively regulated 
by Id3. Accordingly, E47 deficiency and Id3 overexpression result in a decrease in CSR 
(367)
. Id2 
has been reported to repress AID expression by antagonizing the activity of Pax5 
(368)
. 
Furthermore, Blimp1 represses the expression of AID 
(369)
 and in the absence of the Blimp1 
regulator IRF-4 CSR and AID expression are severely impaired 
(370)
. These results provide 
evidence that regulation of AID expression is intertwined in B cell activation and developmental 
programs to ensure a tight restriction. 
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2) Targeting of AID 
A major unresolved issue is how AID is targeted to both DNA strands of the Ig loci during SHM 
and CSR while avoiding the widespread of mutations throughout the genome.  
Specific DNA motifs do not seem to target AID to V region as in transgenic mice studies, 
any sequence situated between the VH promoter and Eµ will be targeted by AID for SHM
(371)
. 
Transcription is well correlated with SHM and CSR (discussed above) but it is not known if 
transcription targets AID to Ig loci or just it renders the loci more accessible. However, it has 
been reported that AID immunoprecipitates with RNA pol II in activated B cells, suggesting a 
physical interaction between AID and the transcription complex 
(343)
.  
Only transcribed Ig genes can be targeted but the V and S regions are not the exclusive 
regions that are mutated; other transcribed Ig-associated genes can be mutated too such as Igα 
and Igβ 
(372)
; these genes have E-Box motifs (CAGGTG) in their promoters. Non Ig genes can also 
be targeted by AID such as proto-oncogenes (c-myc, PHO…). These genes were found to contain 
CAGGTG in their promoter as well
(373)
. The addition of two CAGGTG motifs in an Igκ transgene 
greatly enhanced the frequency of SHM without increasing transcription 
(374)
. Recent studies 
showed that replacing CAGGTG with AAGGTG (that do not bind E47) in the construct without 
any other E47 binding site eliminates SHM
(375)
. As suggested by the authors, E-box proteins 
bound to CAGGTG motifs in Ig enhancers may associate with the transcription complex and 
facilitate binding of AID to the RNA polymerase
(374)
. 
Extensive sequencing of transcribed non-Ig genes in murine B cells showed that AID is 
widely mistargeted in normal B cells. These genes are efficiently repaired by the action of BER 
and MMR but SHM and CSR are somehow the result of a breakdown of protective high fidelity 
repair
(376)
. 
In S regions, R-loop structures seem to play an important role in disposing the non-
template strand as a substrate for AID but that does not explain how AID targets the 
presumably protected template strand in vivo. The deamination of both DNA strands in 
supercoiled plasmids upstream of transcription bubbles may suggest that AID is inherently able 
to target both transcribed and nontranscribed strands
 (377)
. 
Given the high mutation rate that is generated by AID in V regions, it seems likely that 
numerous mechanisms cooperate to protect other genes from its mutagenic affect. The need 
for such rigorous control was dramatically illustrated when AID was ubiquitously overexpressed 
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in mice which died primarily of T cell lymphomas and lung adenomas 
(363)
. One mechanism for 
limiting potential damage by AID in B cell lineage is that its expression is restricted to germinal 
center B cells 
(274)
. Most of the AID protein in centroblast B cells is located in the cytoplasm, so 
the activity of AID may also be restricted by factors that limit its residence in the nucleus. 
Mutational analyses suggested that there are proteins that associate with AID and facilitate its 
transport into the nucleus. Recent studies showed that the catalytic and regulatory subunits of 
PKA can be specifically recruited to S regions to promote the localized phosphorylation of AID, 
which led to binding of replication protein A and subsequent propagation of the CSR cascade. 
Accordingly, inactivation of PKA resulted in considerable disruption of CSR because of 
decreased AID phosphorylation and recruitment of RPA to S regions. The authors propose that 
PKA nucleates the formation of active AID complexes specifically on S regions to generate the 
high density of DNA lesions required for CSR
(378)
.  
AID was found to interact with CTNNBL1, a factor associated with spliceosomes, and 
given the link of AID function with transcription and splicing, CTNNBL1 may play a role in 
bringing AID to its targets 
(379)
. 
Transcriptional control, phosphorylation, nuclear localization and interacting proteins 
seem to contribute to AID targeting but do not explain how other regions are spared such as C 
regions. This suggests that there are additional factors required to AID targeting that need to be 
elucidated. 
  
3) AID and c-myc translocation 
Chromosomal translocation requires formation of paired DSBs on heterologous 
chromosomes. In Burkitt’s lymphomas in humans and plasmacytomas in mice, c-myc is 
translocated into the IgH locus. AID and UNG were found to be required for c-myc/IgH 
translocation 
(300, 380)
.  
Many of the factors that mediate DNA repair (such as ATM, Nbs1, Ku, ligaseIV…) also 
suppress translocation in normal cells. In the absence of these factors, mice and humans are 
prone to cancer-inducing chromosomal translocations 
(308, 381, 297)
.  
C-myc/IgH translocations trigger oncogenic stress 
(382)
. Deregulated expression of 
oncogenes causes activation of the tumor suppressors ARF and ATM, which in turn trigger p53-
dependent cell death 
(382)
. Loss of H2AX or 53BP1 increases IgH-associated translocations to 
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targets other than c-myc 
(381, 300)
. One potential explanation for this paradox is that the 
oncogenic stress signal triggered by c-myc/IgH eliminates cells that carry this translocation, 
whereas Ig translocations to other regions may not be toxic. Support for this notion comes from 
the observation that the rate of translocation between IgH and Igβ is not altered by loss of p53 
in the same cells that suffer increased c-myc/IgH translocations 
(383)
.   
Mutations in ARF/p53 promote myc-induced lymphomagenesis 
(384, 385)
. Deregulated AID 
expression was found to cause cancer when p53 is disrupted 
(380)
. 
Physical proximity between translocated loci in the nucleus is an additional factor that 
may impact the frequency of translocation between chromosomes. c-myc and IgH are 
frequently colocalized in primary B cells but not in other cell types 
(386, 387)
. Importantly, this 
colocalization is found in resting B cells prior to AID-induced damage at c-myc and IgH, 
indicating that these loci are spatially proximal before DSBs are formed 
(387)
.  
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AIM OF THE THESIS 
 
During my thesis, I investigated the role of transcriptional elongation at the IgH locus 
during B cell development. Despite its potential importance for V(D)J recombination and CSR, 
transcriptional elongation has not been studied before. Most of the published work addressed 
the role of transcriptional elements (promoters, enhancers, IgH 3’RR) in transcription initiation 
and expression of the IgH locus, but not in elongation. More specifically, we asked whether S 
regions differ in their abilities to sustain an efficient elongation in vivo and if so, whether Eµ 
enhancer may account for such different capacities. 
Our approach to tackle these questions relied on the analysis of three mutant mouse 
lines. In one line, Sµ region was replaced by the selectable marker neo
r
 gene with its own 
regulatory elements and polyadenylation sites (referred as pA). In the other two lines, we 
attempted a premature termination of µ or γ3 GL transcription. We did so by inserting a 
polyadenylation and pause sites (referred as pAp) between Iµ and Sµ or between Iγ3 and Sγ3.  
The main results are reported in one published article and in one manuscript in 
preparation. I also contributed to an analysis of a mouse line with a combined deficiency in 
MSH2 and Sµ region. The corresponding manuscript has been submitted. But in my PhD 
manuscript and discussion, I only focused on the topic of transcription elongation.  
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MANUSCRIPT . 1 
 
 
Replacement of Iµ-Cµ intron by Neo
R
 gene alters Iµ germ-line expression but has 
no effect on V(D)J recombination. 
 
Dania Haddad, Hei-Lanne Dougier, Nathalie Laviolette, Nadine Puget and Ahmed Amine 
Khamlichi. 
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Résumé: 
 
Le gène de la résistance à la néomycine (néo
R
) est couramment utilisé comme marqueur 
de sélection dans les expériences de recombinaison homologue. Il est également utilisé comme 
révélateur des mécanismes sous-jacents aux interactions de longue distance dans les loci 
complexes comme le locus IgH. 
Initialement, nous avions cherché à générer des souris incapables d’effectuer la 
commutation de classe. Une manière d’y parvenir était de déléter tous les motifs répétés de la 
séquence Sµ qui est le site donneur initial de la commutation de classe. Nous avons généré des 
souris mutantes dans lesquelles la quasi-totalité de l’intron Iµ-Cµ a été délétée par 
recombinaison homologue (en laissant intactes les séquences nécessaires à un épissage correct 
des pré-messagers µ). L’analyse de ces souris dépourvues de néo
R
 a montré qu’elles étaient 
toujours capables d’effectuer la commutation isotypique bien que fortement diminuée 
(330)
. 
Nous nous sommes ensuite intéressés aux souris portant le marqueur néo
R
 pour voir si 
l’insertion du gène néo
R
 affecte la transcription à partir du promoteur Iµ, les effets sur la 
transcription germinale et la commutation de classe, éventuellement comment l’interaction 
longue distance avec la LCR pourrait être affectée et de voir si néo
R
 affecte les réarrangements 
V(D)J.  
Nous avons trouvé que le compartiment B était profondément altéré avec un blocage 
prononcé au stade pro-B. Toutefois, la recombinaison V(D)J dans les cellules triées pro-B et pré-
B est non-affectée ce qui exclue une interférence avec la fonction du control de l’accessibilité 
de Eµ. L’initiation de la transcription germinale à partir de µ0 est seulement diminuée mais la 
maturation est fortement affectée probablement par une terminaison prématurée au niveau 
des sites de poly-adenylation de la cassette néo
R
. Cependant, l’initiation de la transcription de 
Iµ est altérée ce qui suggère que néo
R
 interfère avec les enhancers qui contrôlent l’expression 
de Iµ. En revanche, après la stimulation par le LPS, l’initiation de Iµ est restaurée au normal, ce 
qui contraste l’effet Néo dans le locus constant. Nos résultats suggèrent qu’après la stimulation 
par LPS, l’enhancer Eµ lève l’inhibition de l’effet Néo sur l’expression d’Iµ. Ce qui révèle des 
interactions complexes entre activateurs transcriptionnels du locus IgH, en fonction du stade de 
développement et de l’état d’activation des cellules. 
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The NeoR gene has often been used to unravel the mechanisms underlying long-range interactions
between promoters and enhancers during V(D)J assembly and class switch recombination (CSR) in the
immunoglobulin heavy chain (IgH) locus. This approach led to the notion that CSR is regulated through
competition of germ-line (GL) promoters for activities displayed by the 3′ regulatory region (3′RR). This
polarized long-range effect of the 3′RR is disturbed upon insertion of NeoR gene in the IgH constant (CH)
region, where only GL transcription derived from upstream GL promoters is impaired. In the context of
V(D)J recombination, replacement of E enhancer or E core enhancer (cE) by NeoR gene fully blocked
V(D)J recombination and0 GL transcription which originates 5′ of DQ52 and severely diminished I GL
transcription derived from E/I promoter, suggesting a critical role for cE in the regulation of V(D)J
recombinationandof0and Iexpression.Herewe focuson theeffect ofNeoRgeneon0and IGL tran-
scription in a mouse line in which the I-C intron was replaced by a NeoR gene in the sense-orientation.
B cell development was characterized by a marked but incomplete block at the pro-B cell stage. However,
V(D)J recombination was unaffected in sorted pro-B and pre-B cells excluding an interference with the
accessibility control function of E.0 GL transcription initiation was relatively normal but the matura-
tion step seemed to be affectedmost likely through premature termination atNeoRpolyadenylation sites.
In contrast, I transcription initiation was impaired suggesting an interference of NeoR gene with the IgH
enhancers that control I expression. Surprisingly, in stark contrast with the NeoR effect in the CH region,
LPS-induced NeoR expression restored I transcript levels to normal. The data suggest that E enhancer
may be the master control element that counteracts the down-regulatory “Neo effect” on I expression
upon LPS stimulation. More importantly, they reveal a complex and developmentally regulated interplay
between IgH enhancers in the control of I expression.
© 2009 Elsevier Ltd. All rights reserved.
1. Introduction
B cell differentiation proceeds through several ordered steps
that begin with the assembly of Ig variable gene segments (VH, D
and JH) through a genetic process called V(D)J recombination. The
Abbreviations: 3′RR, IgH 3′ regulatory region; BCR, B cell receptor; CH, con-
stant region; CSR, class switch recombination; GL, germ-line; HC, heavy chain;
IgH, Ig heavy chain; LPS, lipopolysaccharide; NeoR, neomycine resistance; PolyA,
polyadenylation; S, switch; TK, thymidine kinase; WT, wild type.
∗ Corresponding author at: CNRS UMR 5089, IPBS, Equipe “Instabilité génétique
et régulation transcriptionnelle”, 205 route de Narbonne, 31077 Toulouse Cedex 4,
France. Tel.: +33 561 175 522; fax: +33 561 175 997.
E-mail address: ahmed.khamlichi@ipbs.fr (A.A. Khamlichi).
assembly is initiated at the IgH locus, first by rearrangement of a D
to a JH followed by joining of a VH gene segment to the DJH com-
plex. A V to J rearrangement next occurs on Ig and Ig encoding
light chains. These ordered recombination events are mediated by
the lymphocyte-specific complex RAG-1/2 that binds to conserved
recombination signal sequences (RSS) which flank all V, D, and J
segments (reviewed in Hesslein and Schatz, 2001; Krangel, 2003;
Cobb et al., 2006; Jung et al., 2006). V(D)J recombination is reg-
ulated by transcriptional promoters and enhancers which largely
control chromatin accessibility of Ig gene segments to the RAG-1/2
recombinase complex. The accessibility of VH, D, and JH substrates
correlates with transcriptional activity of these unrearranged, GL
gene segments (Hesslein and Schatz, 2001; Krangel, 2003; Cobb et
al., 2006; Jung et al., 2006).
0161-5890/$ – see front matter © 2009 Elsevier Ltd. All rights reserved.
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Table 1
List and sequence of the primers used in this study.
Primer Sequence 5′ →3′ Tm Reference
RT-PCR assay
3′DQD1-Fw GGTCAGGAGACAGTGCAGAGAAGAACGAG 71 Dudley et al. (2003)
DDJH1-Rev GATGTTTGGAGAGATCTCCACC 58 Dudley et al. (2003)
0-Fw GGACTTTGGGCTGGGTTTGG 60 Perlot et al. (2008)
Im-Fw TTCCAATACCCG AAG CATTTAC 53 Perlot et al. (2008)
Im-Rev GTCCATGAGCAGCCAGGTG 53 Perlot et al. (2008)
Cmr GAAGACATTTGGGAAGGACTGACT 62 Pinaud et al. (2001)
VH-J558 GCGAAGCTTARGCCTGGGRCTTCAGTGAAG 60 Perlot et al. (2008)
VH-7183 GCGAAGCTTGTGGAGTCTGGGGGAGGCTTA 60 Perlot et al. (2008)
Ig3f TGGGCAAGTGGATCTGAACA 62 Pinaud et al. (2001)
Cg3r CTCAGGGAAGTAGCCTTTGACA 60 Pinaud et al. (2001)
Ig2bf CACTGGGCCTTTCCAGAACTA 60 Pinaud et al. (2001)
Cg2br CACTGAGCTGCTCA TAGTGTAGAGTC 60 Pinaud et al. (2001)
Ig1f GGCCCTTCCAGATC TTTGAG 60 Pinaud et al. (2001)
Cg1r GGATCCAGAGTTCCAGGTCACT 60 Pinaud et al. (2001)
Actin-4 TACCTCATGAAGATCCTGA 50 Pinaud et al. (2001)
Actin-5 TTCGTG GATG CCACAGGAC 62 Pinaud et al. (2001)
AK8 GTGCAATCCATCTTGTTCAATGGCCGATCC 77 Samara et al. (2006)
ATG Neo ATGGGATCGGCCATTGAACAA 65 Samara et al. (2006)
Neo-Rev CAAGCAGGCATCGCCATGGGTC 72 Samara et al. (2006)
5-F TCAGCAGAAAGGAGCAGAGCT 55 Perlot et al. (2008)
5-R ACACACTACGTGTGGCCTTGT 55 Perlot et al. (2008)
VDJ rearrangement assay
JH-4e AGGCTCTGAGATCCCTAGACAG 60 Perlot et al. (2008)
DH-L TTTTTGTCAAGGGATCTACTACTGTG 60 Perlot et al. (2008)
VH-J558 GCGAAGCTTARGCCTGGGRCTTCAGTGAAG 60 Perlot et al. (2008)
VH7183 GCGAAGCTTGTGGAGTCTGGGGGAGGCTTA 60 Perlot et al. (2008)
HS4-5′ CCAAAAATGGCCAGGCCTAGG 60 Perlot et al. (2008)
HS4-3′ AGGTCTACACAGGGGCTCTG 60 Perlot et al. (2008)
A major transcriptional enhancer, Ewhich consists of the core
enhancer (cE) flanked by 5′ and 3′ matrix attachment regions and
located in the intron between JH segments and C exons, plays a
critical role in GL transcription and V(D)J recombination (reviewed
in Jung et al., 2006). Several sense and anti-sense GL transcripts
were detected before the onset of V(D)J recombination: I tran-
scripts that initiate at a promoter associated with E enhancer
(LennonandPerry, 1985; SuandKadesch, 1990),0 transcripts that
initiate at a promoter upstream of the DQ52, the most proximal D
segment (Alessandrini and Desiderio, 1991) and VH transcripts ini-
tiating from VH promoters in the sense direction (Yancopoulos and
Alt, 1985). Recently, anti-sense transcripts of both genic and inter-
genic VH, D and JH regions have been detected (Bolland et al., 2004;
Chakraborty et al., 2007; Perlot et al., 2008; reviewed in Perlot and
Alt, 2008). Deletion of the E enhancer led to a partial inhibition
of D to JH recombination, but to a severe impairment of VH to DJH
recombination and of sense and anti-sense transcription with the
exception of VH transcripts (Perlot et al., 2005; Afshar et al., 2006;
Bolland et al., 2007) implying a critical role for this enhancer both
as a transcriptional and recombinational control element.
The IgH locus is the site of another type of gene rearrangement
termed class switch recombination (CSR) that enables antigen-
activated B cells to express downstream isotypes (IgG, IgE and
IgA) (reviewed in Stavnezer et al., 2008). CSR occurs between
highly repetitive S sequences located upstream of all the C genes
except Cwhose expression is regulated at the post-transcriptional
level (reviewed in Blattner and Tucker, 1984). CSR requires GL
transcription that initiates from GL promoters upstream of S
sequences. Previous gene-targeted mutational studies demon-
strated the importance of GL promoters for CSR in vivo (Jung et al.,
1993; Zhang et al., 1993; Bottaro et al., 1994; Harriman et al., 1996;
Seidl et al., 1998) as well as of the 3′RR located downstream of the
locus (reviewed in Khamlichi et al., 2000). The 3′RR was suggested
to function as a long-range control region that regulates various GL
promoters (reviewed in Khamlichi et al., 2000; Manis et al., 2002).
Insights into the mechanisms by which the IgH enhancers con-
trol V(D)J recombination andCSR came from the analyses ofmutant
mice in which an expressed NeoR gene was inserted at various sites
within the IgH locus (Chen et al., 1993; Bottaro et al., 1994; Cogné et
al., 1994;Manis et al., 1998; Seidl et al., 1998, 1999; Qiu et al., 1999;
Pinaud et al., 2001; Manis et al., 2003; Delpy et al., 2002; Samara
et al., 2006; Vincent-Fabert et al., 2009). With regard to CSR, this
approach led to the notion that GL promoters compete for activi-
ties displayed by the 3′RR. This long-distance effect of the 3′RR is
disturbed upon insertion of NeoR gene in the IgH C region, where
only GL transcription derived from GL promoters upstream of NeoR
insertion site is impaired (reviewed in Manis et al., 2002). How-
ever, whenever the NeoR gene was deleted, the phenotype proved
milder or normal (Bottaro et al., 1998; Manis et al., 1998; Pinaud et
al., 2001; Vincent-Fabert et al., 2009) suggesting some redundancy
among known elements or the existence of additional unknown
regulatory elements.
In the context of V(D)J recombination, replacement of E
enhancer or cE by NeoR gene fully blocked V(D)J recombination
and0GL transcription but had no obvious effect on VH transcripts
(Chen et al., 1993; Perlot et al., 2005). Insertion of the NeoR gene
upstream of E had different effects depending on the distance
from cE. Insertion of the NeoR gene some 100bp upstream of
the cE core enhancer led essentially to the same effect as the E
replacement concerning V(D)J recombination and JH GL transcrip-
tion (Chenet al., 1993),whereas an insertion some500bpupstream
yielded a relatively normal V(D)J assembly but a complete abroga-
tion of JH GL transcription (Delpy et al., 2002). In contrast, insertion
just 3′ of cE enhancer or replacement of C1 and C2 exons had
no obvious effect on V(D)J assembly and expression (Chen et al.,
1993; Zou et al., 2001). Again, deletion of NeoR insertion upstream
of E restored normal B cell development (Delpy et al., 2002). In
mice with a clean deletion of either E or cE, V(D)J recombina-
tion and 0 and I GL transcription were still affected but clearly
less than with the NeoR gene suggesting that an interaction with
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Fig. 1. FACS analysis of bone marrow cells. (A) Bone marrow cells from WT or SN mice were stained with anti-B220-APC. The percentages of positive cells from a
representative experiment are indicated. Standard deviations (n=4) are shown on the right panel. (B) Bone marrow cells from WT or SN mice were stained with anti-
B220-APC and anti-IgM-FITC antibodies. The percentages of positive cells from a representative plot are indicated. Standard deviations (n=4) are shown on the right panel.
(C) For pro-B and pre-B cell populations, bone marrow cells were stained with anti-B220-APC, anti-IgM-FITC and anti-CD43-PE and gated on IgM− population. Pro-B cells
and pre-B cells were identified as B220+IgM−CD43high and B220+IgM−CD43low, respectively. The percentages of positive cells from a representative FACS plot are indicated.
Standard deviations (n=4) are shown on the right panel. (D) Bone marrow cells were stained with anti-B220-APC and anti-CD117-PE. Pro-B cell population was identified
as B220+CD117+. The percentages of CD117+ cells among the B220+ population from a representative FACS plot are shown. Standard deviations (n=4) are reported on the
right panel.
the 3′RR or other ill-defined elements is required for optimal V(D)J
assembly and JH GL transcription (Perlot et al., 2005; Afshar et al.,
2006).
It is noteworthy that the “Neo effect” in the IgH locus does
not seem to depend on the orientation or on the promoter of the
NeoR gene (discussed in Samara et al., 2006). Additionally, it is not
restricted to the IgH locus and has been described in other com-
plex loci (e.g. Fiering et al., 1995; Pham et al., 1996; Sun and Storb,
2001). Thus, although the precise mechanism by which the “Neo
effect” disturbs thefine-tuned interactions betweenpromoters and
964 D. Haddad et al. / Molecular Immunology 47 (2010) 961–971
Fig. 2. V(D)J rearrangement assay.GenomicDNAswere prepared from sorted pro-B andpre-B cells andwere subjected to PCR to amplifyD to JH andVH toDJH rearrangements.
The PCR was performed on serial 3-fold dilutions. PCR products were detected and quantified after SYBR1 green staining. A PCR on HS4 enhancer from the 3′RR was used for
normalization of DNA input and kidney DNA was used as a negative control. A PCR for VJ rearrangement was performed to check for the purity of sorted populations.
enhancers in complex loci is still unknown, this approachmay shed
some light on the mechanisms at work in those loci.
In this study, we analyze a mutant mouse line in which I-C
intron was replaced by an expressed NeoR gene and describe the
effect of the mutation on B cell development and on the transcripts
derived from a set of endogenous IgH promoters.
2. Materials and methods
2.1. Targeting vector and mice
The targeting vector and the generation of the mutant mouse
line were described in detail elsewhere (Khamlichi et al., 2004).
2.2. FACS analysis of bone marrow cells
Bones from 6- to 8-week-old mice were flushed with 10%
foetal calf serum (FCS)-containing RPMI 1640. After disaggre-
gation and washing, cells were stained with APC-conjugated
anti-B220, PE-conjugated anti-CD43, PE-conjugated anti-CD117
and FITC-conjugated anti-IgM (Biolegend). Pro-B and pre-B pop-
ulations were identified and sorted as B220+IgM−CD43high and
B220+IgM−CD43low, respectively. Data were obtained on 3×104
viable cells by using a Becton Dickinson apparatus (FACSAria II cell
Sorter).
2.3. V(D)J rearrangement assay
B cells from bone marrow were first sorted by using CD19-
magneticmicrobeads and LS columns (Miltenyi Biotec) and labeled
with APC-conjugated anti-B220, PE-conjugated anti-CD43 and
FITC-conjugated anti-IgM. The sorted pro-B (IgM−B220+CD43high)
and pre-B (IgM−B220+CD43low) cell fractions were harvested and
genomic DNAs were prepared by using Puregene Core Kit A (Qia-
gen). Genomic DNAs were resuspended and diluted for the PCR
assay. The primers used to detect V(D)J rearrangements (Table 1)
and normalization of DNA amount in the diluted samples were as
described (Dudley et al., 2003; Perlot et al., 2005). The purity of the
sorted populationswas checked by FACS and by the rearrangement
status of the  locus. Quantification was performed as described
below.
2.4. FACS analysis of spleen cells
After removal of red blood cells, a single-cell suspension
from spleens of 6- to 8-week-old mice was obtained. Unstim-
ulated splenocytes (5×105 cells/assay) were labeled by using
APC-conjugated anti-B220, FITC-conjugated anti-IgM and PE-
conjugated anti-IgD (Biolegend). For in vitro stimulation, the
single-cell suspension was incubated with anti-CD43 magnetic
beads, naïve B cells were purified by magnetic cell sorting using
LS columns (Miltenyi Biotec). Negatively sorted B cells were acti-
vated in RPMI 1640 medium supplemented with 10% FCS, 50M
of 2 -mercaptoethanol, 1mM sodium pyruvate and 20g/ml of
LPS (S. typhimurium; lot 038K4024; Sigma) supplemented or not
with IL-4 (R&D systems) at 5ng/ml or with anti-CD40 (R&D sys-
tems) at 1g/ml, at a density of 106 cells/ml. At days 0 and 2,
aliquots of cells were removed for RNA preparation. After 2 days
post-stimulation, the cell death was checked by microscopy and
FACS by using propidium iodide.
2.5. RT-PCR
Total cellular RNA preparation was carried out as described
(Oruc et al., 2007). The primers used in this study are listed in
Table 1. The RT-PCR conditions and the expected sizes of the PCR
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Fig. 3. GL transcription and VDJ expression in the bone marrow. (A) A scheme showing the position of DQ52 segment, JH region, E enhancer and C region relative to
NeoR gene. The position of the primers used in this assay is indicated. The arrows indicate the orientation of the transcription derived from DQ52 promoter, E/I promoter
and NeoR gene promoter. Dashed lines indicate the splicing of 0 exon on C1 exon and of I exon on C1 exon, the resulting spliced products are indicated as 0 and I
transcripts, respectively. pA denotes the polyadenylation site. The triangles flanking the NeoR gene represent the loxP sites (not to scale). (B) B220+ cells were sorted from
the bone marrows of WT, SN and Rag2−/− mice and RT-PCR was performed on total RNA from B220+ cells. The PCR was performed on 5-fold serial dilutions. Contamination
by genomic DNA was excluded by using a minus RT control for each reaction (−RT). The 5 surrogate light chain transcript was used for normalization of single-strand DNA
input. For 0 and I GL transcripts, the localization of the primers used is shown in (A). For VDJ expression, the primers used are degenerate primers that allow detection
of transcripts from distal VH-J558 or from the proximal VH-7183 families. (C) Transcript levels were quantified on 1/5 or 1/25 dilutions only. For GL transcription, 0 and I
GL transcript levels from Rag2−/− controls were set up as 100%. For  expression, VDJ-C transcript levels from WT were set up as 100% and were undetectable in Rag2−/−
controls. When applicable, the standard deviations are shown (n=3).
products have been described (Pinaud et al., 2001; Dudley et al.,
2003; Perlot et al., 2005; Samara et al., 2006). For quantification,
agarose gels were dried for 1h at 80 ◦C using a gel dryer (BioRad),
stainedwith SYBR1 green (InVitrogen) for 1h and scanned by using
a phosphor imager (Molecular dynamics). After subtracting back-
ground levels, the signals in the diluted lanes (1/5 or 1/25) were
normalized against either 5 or actin signals.
2.6. cDNA cloning and sequencing
The three amplicons amplified from independent PCRs by using
Imf and Cmr primers were eluted, cloned in TopoI vector (InVit-
rogen) and transfected in DH5- bacterial strain. Sequences were
determined on both strands by using M13 universal and internal
primers.
3. Results
3.1. Generation of mice carrying a NeoR cassette in the I-C
intron
We have previously described a floxed mutant mouse line
devoid of the major part of I-C intron. From the endogenous
sequence, only 172bp were left downstream of I exon and 75bp
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upstream of C1 exon, including the donor and the acceptor splice
sites, respectively (Khamlichi et al., 2004). Here we analyze the
same mouse line bearing an expressed NeoR gene in the sense-
orientation, driven by TK promoter. All analyses were performed
on homozygous mice that will be referred to as SN.
3.2. Impaired B cell development in the bone marrow
B cell development in the bone marrow was analyzed by flow
cytometry using a specific set of surfacemarkers.We found roughly
a 4-fold decrease in B220+ population in SNcompared toWTmice
(Fig. 1A). ∼7% of cells were IgM+ in WT whereas surface IgM was
virtually absent in SN bone marrow (Fig. 1B). With regard to pro-
B cells (B220+IgM−CD43high and B220+CD117+), we found a 3- to
5-fold accumulation in B220+ population from SN (Fig. 1C and
D). For pre-B cells (B220+IgM−CD43low), a ∼2.5-fold decrease was
detected in B220+ population from SN compared to WT (Fig. 1C).
Thus, the replacement mutation leads to a severe impairment of B
cell development in the bone marrow featuring an accumulation of
pro-B cells, a decrease in pre-B population and a background level
of immature IgM+ B cells.
3.3. Normal V(D)J recombinational in SN
The E enhancer acts both as a transcriptional and an accessibi-
lity control element duringV(D)J recombination. The compromised
B cell development seen in the SN bone marrow led us to ask by
which mechanism NeoR gene interferes with B cell development.
One possibility is that the NeoR gene somehowaffects V(D)J recom-
binationby interferingwith theE enhancerwhich largely controls
thisprocess andperhapswithotherunknownelements expected to
be involved. Inorder toclarify this issue,we lookedat the rearrange-
ment status of VH, D and JH segments at the IgH locus from sorted
pro-B (B220+IgM−CD43high) and pre-B (B220+IgM−CD43low) cells.
As can be seen from Fig. 2, there is no obvious difference between
V(D)J assembly in both populations when we compare SN with
WT control, be it at the D to JH recombination step or at the VH
to DJH recombination step (Fig. 2). Similarly, V to J rearrange-
ment was normal (Fig. 2). We conclude that the mutation does not
seemtoaffectB cell development at theV(D)J recombinational level
suggesting that NeoR gene does not interfere with the accessibility
control function of E enhancer or of other unknown regulatory
elements.
3.4. Germ-line transcription in SN bone marrow
The normal assembly of VH, D, and JH segments in sorted pro-B
and pre-B cells from SN mice suggests a normal transcriptional
activity of these gene segments in their GL configuration. How-
ever, the correlation between transcription and rearrangement is
not strict and there are many instances in which transcription
and recombination could be dissociated (reviewed in Hesslein and
Schatz, 2001; Cobb et al., 2006). Since E enhancer regulates 0
and I GL transcription, we asked whether NeoR would alter the
transcriptional activity of these segments which would be indica-
tive of an interference with the transcriptional regulatory function
of E enhancer.
In an attempt to approach this question, B220+ cellswere sorted
from the bone marrow of WT, SN and Rag2−/− mice and total
RNA was prepared and subjected to RT-PCR in semi-quantitative
conditions. Two sets of primer pairswere used, one set that enables
amplification of 0 exon (3′DQD1-Fw and DDJH1-Rev) or I exon
(Im-Fw and Im-Rev) and another set that amplifies 0–C cDNA
(0-Fw and Cmr) or I-C cDNA (Im-Fw and Cmr) (Fig. 3A).
In what follows, we will use the term transcription initiation to
describe 0-amplified exon and I-amplified exon though strictly
speaking, it is only a rough reflection of transcription initiation.
Similarly, we will use the term transcription maturation by refer-
ring to 0–C- and I-C-amplified cDNAs although, as it will be
shown below, the situation is more complex in that it may include
both altered processing and premature termination of the primary
transcripts.
With regard to 0 transcription initiation, we found no signifi-
cant difference in the abundance of 0 transcripts from SN mice
compared to WT control. In both mice, 0 transcript levels were
diminished relative to Rag2−/− which is expected since any D to
JH rearrangement not involving DQ52 will delete the DQ52 pro-
moter/segment but not in Rag2−/− mice which do not rearrange
their endogenous locus. Regarding maturation, 0–C transcripts
in SN were ∼6-fold diminished compared to WT control (Fig. 3B
and C).
For I transcripts, a ∼3-fold decrease was found in the abun-
dance of transcripts that initiate from I promoter in SN mice
when compared to both WT and Rag2−/− controls (Fig. 3B and C)
(see Section 4). Classical I-C processed transcriptswere severely
diminished (∼35-fold) in SN mice but not in WT and Rag2−/−
controls (Fig. 3B and C). Surprisingly, a ∼1.9 kb-long fragment was
consistently amplified in SN mice but not in WT and Rag2−/−
mice (Fig. 3B). The size of the fragment fits with that of a chimeric
unspliced I-NeoR-C transcript. This was confirmed by sequence
analysis (see below). This transcript was clearly more abundant
than the classical I-C transcript although a comparison of the
two signals cannot be precisely done because of the difference in
size of the amplified fragments.
On the other hand and online with the FACS data, mature VDJ-
C transcripts were barely detectable by using consensus primers
that amplify either from proximal (7183 VH-family) or distal (J558
VH-family) VH segments (Fig. 3B and C).
These results suggest that0 expression in SN mice is not sig-
nificantly altered at early steps of transcription but probably at the
maturation step of the primary transcripts. In contrast, the replace-
ment mutation affects I expression more severely and virtually
abolishes  gene expression.
3.5. Impaired accumulation of SN B cells in the spleen
Morphological analysis showed that the mutant mice had no
identifiable Peyer’s patches and their spleens were of smaller size,
nearly half that of control littermates (not shown). A ∼5-fold
decrease was found in the B220+ population of SN spleen com-
pared to WT control (Fig. 4A). Accordingly, a reduced number of
IgM+ and IgD+ splenic B cells were found in SN mice (Fig. 4B and
C). Curiously, while the majority (>93%) of WT B220+ populations
expressed surface IgM or IgD, less than half SN B220+ population
was IgM+ or IgD+ (Fig. 4B and C) and a substantial proportion was
clearly B220+ but IgM− and IgD− (Fig. 4C and D) suggesting that
these populations may have lost their BCR expression. The use of
isotype controls, propidium iodide and gating on live cells excluded
the possibility of non-specific binding of the anti-sera to dead cells
(not shown).
Altogether, the data show that despite the severe impairment of
B cell development in the bone marrow, the block is not complete
and a small proportion of mutant B cells reach the spleen, part of
which does not seem to express IgM and/or IgD.
3.6. Normal pre-switch GL transcription of downstream isotypes
We previously showed that deletion of the major part of I-
C intron and of the selectable marker severely impaired but did
not block CSR. In contrast, pre-switch GL transcription which is
largely controlled by the 3′RR was normal (Khamlichi et al., 2004).
We asked if NeoR may somehow affect pre-switch GL transcription
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Fig. 4. Flow cytometric analysis of unstimulated spleen. Spleen cells from WT and SN were stained with anti-B220-APC (A), with anti-B220-APC and anti-IgM-FITC (B)
or with anti-B220-APC and anti-IgD-PE (C). Representative FACS plots are shown. In (B) and (C) the percentages of B220+IgM+ and B220+IgD+ double-positive cells and the
B220+IgM− and B220+IgD− single-positive cells are shown. The right panels show the statistical data for each staining. IgM (total) and IgD (total) denote the percentage of
IgM+ and IgD+ cells among total spleen cells. IgM (B220+) and IgD (B220+) total denote the percentage of IgM+ and IgD+ cells among the B220+ population. The standard
deviations are indicated (n=5).
of downstream isotypes which would be indicative of an inter-
ference with the 3′RR or other unknown elements. To this end,
purified splenic B cells were induced to switch to IgG3 or IgG2b
by LPS or to IgG1 by LPS/IL4 or anti-CD40/IL4. A massive cell
death occurred after 48h irrespective of stimulation conditions
(not shown). Therefore, analysis of CSR could not be carried fur-
ther. However, an RT-PCR analysis of pre-switch GL transcription
could be performed at day 2 in semi-quantitative conditions. The
analysis of3 and2bGL transcripts from LPS-activated B cells and
of 1 GL transcripts from LPS/IL4- or from anti-CD40/IL4-activated
B cells revealed no obvious difference between SN mice and WT
controls (Fig. 5 and data not shown). These results indicate that the
replacement mutation leads to a massive cell death of activated
IgM+ and/or IgD+ splenic B cells but has no detectable effect on GL
transcription of downstream isotypes.
3.7. LPS-induced expression of NeoR gene
Several studies showed that the “Neo effect” at the IgH locus
correlates with LPS-inducibility, a feature that was attributed to
the influence of the E enhancer or of the 3′RR within yet ill-
defined chromatin domains (e.g. Manis et al., 1998; Delpy et al.,
2002; Samara et al., 2006). To address this question, WT and SN
CD43− splenic B cells were first negatively sorted and total RNA
from either d0 or d2 post-stimulation was subjected to RT. NeoR
transcripts were amplified by using a pair of primers (ATG Neo and
Neo-Rev primers) that hybridize to NeoR coding sequence (Fig. 6A).
These primers mainly amplify NeoR transcripts that initiate from
NeoR gene promoter and from I promoter (in the form of chimeric
Fig. 5. Pre-switch GL transcription in stimulated splenic B cells. Total RNA was pre-
pared at day 2 from LPS- (top panel) or LPS+ IL4-activated B cells (low panel) and
reverse-transcribed. Undiluted samples of single-strand cDNAs or 5-fold serial dilu-
tions thereof were amplified by using appropriate primers. Actin primers were used
for normalization.
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Fig. 6. RT-PCR analysis of LPS-induced NeoR gene expression and its effect on I GL expression. (A) A scheme representing the targeted region (not to scale). The arrows
indicate the orientation of transcription that originates from I promoter or from NeoR gene promoter. DS and AS denote the canonical donor and acceptor splice sites,
respectively. cDS and cAS denote cryptic donor and acceptor splice sites, respectively. pA denotes polyadenylation sites of NeoR gene and of C region. Dashed lines indicate
the splicing of I exon on C1 exon that uses the canonical splice sites (DS and AS) and the splicing that uses the activated cryptic splice sites (cDS and cAS) upon LPS
activation. The filled triangles represent the loxP sites. The localization of the primers used in the assay is shown. (B) RT-PCR analysis on total RNA from unstimulated (d0) or
fromLPS-activated (d2)WT and SN splenic B cells. Undiluted single-strand cDNAs or 5-fold serial dilutions thereofwere subjected to PCR by using appropriate primers. Actin
primers were used for normalization. Minus RT (−RT) controls were used to exclude contamination by genomic DNA. (C) Quantification of transcript levels was performed
on 1/5 and 1/25 dilutions only. The table on the left reports the quantification of NeoR transcript levels. (D) The histograms show the results of I transcripts’ quantification
for which WT I transcripts’ level was set up as 100%. Standard deviations are shown (n=3). (E) Partial nucleotide sequence of the chimeric unspliced I-NeoR-C transcript.
The 666bp fragment corresponding to the spliced form uses the cryptic splice sites indicated in bold lower case letters and underlined. The 3′ part of I exon and the 5′
part of C1 exon sequences are shown in bold capital letters. The ovals surround the canonical donor and acceptor splice sites. The capital letters indicate the remaining
endogenous sequences, the lower case letters show part of the inserted cassette.
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unspliced I-NeoR-C transcripts) (see below) and perhaps from
some PVH promoters (in the form of  or / pre-messengers).
The results show a ∼6-fold increase in NeoR transcript levels at
d2 compared to d0 (Fig. 6B and C). A relatively stronger increase
(∼15-fold) was also detected by using ATG Neo and Cmr primers
which amplifyNeoR transcripts that runpast thepolyA sites ofNeoR
gene (Fig. 6A–C) and which may originate either from I promoter,
NeoR gene promoter or from PVH promoter. Interestingly, by using
Im-Fw and AK8 primerswhich amplify NeoR transcripts that derive
mainly from I promoter, a ∼24-fold increase in transcript levels
was found at d2 compared to d0 suggesting that LPS enhances I
transcription initiation in SN mice (Fig. 6A–C) (see below).
Although it was difficult to quantify precisely the absolute level
of induction because of the multiple transcripts generated in the
mutated  region, the results clearly show that NeoR gene expres-
sion in SN mice is induced by LPS suggesting an effect of IgH
enhancers.
3.8. Restoration of normal I transcript levels and activation of
cryptic splice sites upon LPS induction
Because of the functional NeoR gene promoter, its LPS-
inducibility and the presence of two polyA sites in the NeoR gene,
one might expect additional transcript species in addition to the
classical I GL transcripts. We used two pairs of primers: Im-Fw
and Im-Rev pair as an indication of I transcription initiation and
Im-FwandCmrprimers that flank the inserted sequence andwhich
should enable to amplify all the transcripts that originate from I
and terminate at the C polyA site (Fig. 6A). Concerning I tran-
scription initiation, we found a ∼3-fold decrease in SN compared
to WT at d0 (Fig. 6B and D). Strikingly, I transcription initiation
from SN increased to a level comparable to that of WT at d2 post-
stimulation. In contrast, I-Cprocessed transcriptswere very low
both at d0 and d2 post-stimulation (Fig. 6B and D). I expression
was not induced in WT controls regardless of the primer pair used
(Fig. 6B and D). Contrasting with I constitutive expression, I3
expression was clearly induced by LPS at d2 in WT and SN mice
(Fig. 6B).
By using Im-Fw and Cmr primers, we reproducibly amplified
three amplicons (245-, 666- and 1921-bp-long) irrespective of the
stimulation conditions (Fig. 6Banddatanot shown). Sequenceanal-
ysis of the three cDNAs confirmed the presence of the classical
I-C mature transcripts (245bp). The faint 666bp fragment cor-
responded to a spliced formof the chimeric I-NeoR-C transcripts
in which cryptic donor and acceptor splice sites were activated
in the intron-less NeoR cassette (Fig. 6E). The processed chimeric
I-NeoR-C transcripts were detected in independent stimulation
experiments, regardless of the stimulation conditions and from
independent sequence clones (data not shown) suggesting that
they are not a PCR artifact. These processed transcripts were not
detected in the bone marrow (Fig. 3B) or in unstimulated splenic B
cells of SN mice (Fig. 6B). The 1921bp fragment corresponded to
a chimeric unspliced I-NeoR-C sequence (Fig. 6E). This has been
checked by sequencing the cDNAs amplified by two other primer
pairs (Im-Fw and AK8; ATG Neo and Cmr) (Fig. 6A).
Thus, in activated SN B cells, the replacement mutation leads
to a complex pattern of  GL transcripts, restores normal levels of
I expression and may activate cryptic splice sites in the inserted
sequence.
4. Discussion
The homozygous mice in which the major part of I-C
intron was replaced by an expressed NeoR cassette in the sense-
orientation display a severe impairment of B cell development.
Early B cell development was characterized by an accumulation
of pro-B cells, a decrease in pre-B cell population and a nearly total
absence of immature IgM+ B cells. Accordingly, very few mature
VDJ-C transcripts were detected. However, the block is not com-
plete since we detect some IgM- and/or IgD-expressing B cells in
the spleen. This indicates that very few B cells have managed to
productively rearrange their IgH locus and express a BCR in SN
bone marrow.
Several hypotheses may be put forward to explain how the
replacement mutation affects B cell development and impairs 
gene expression. Onemight suggest that the NeoR cassette replaces
some unidentified regulatory sequences in I-C intron. However,
we think it is unlikely because deletion of the cassette has no effect
on  expression (Khamlichi et al., 2004). Another possibility is the
proximity of the cassette from C1 acceptor splice site which may
interfere with the splicing reaction. Although we cannot formally
exclude such interference, the finding that IgD expression was also
affected although  pre-messengers use the remote C1 acceptor
site suggests that the proximity of the acceptor splice site is not
the main issue. It should be noted that the NeoR cassette contains
two polyA sites thus enabling a premature termination of the pri-
mary transcripts across  region. Although we could not quantify
the relative proportion of the primary transcripts that end up at
NeoR polyA sites, it is reasonable to suggest that only the fraction
of the  primary transcripts for which there has been a transcrip-
tional read-through past NeoR polyA sites, and which would splice
accurately, would lead to the production of  HC enabling expres-
sion of the BCR and it is these cells that would survive and migrate
to the periphery. Alternatively, and in light of the normal V(D)J
assembly in SN mice, one might speculate that the accumulation
of pro-B cells in SN bone marrow may result from a reversal to
earlier developmental stage of immature B cells that either failed
to express a functional BCR or that lost their BCR as has been shown
previously (Tze et al., 2005).
The finding that IgM-expressing cells in the spleen of SN mice
represent less than half the B220+ population suggests that even
the IgM+ B cells that have successfully reached the periphery may
still loose BCR expression and ultimately die, an outcome that is
reminiscent of mature B cells that have been induced to loose their
BCR in vivo (Lamet al., 1997). Thismay explainwhy activatedB cells
massively die shortly after 48h in various stimulation conditions
(LPS, LPS + IL4 and anti-CD40+ IL4). In this context, LPS-induced
expressionofNeoRgenemayaffect the transcriptional elongationof
 pre-messengers, e.g., by providing premature termination sites,
affecting the splicing pattern or destabilizing the pre-messengers.
In thisway, and/or transcript levelswill bediminished and theB
cellswould loose IgM and/or IgD surface expression although other
scenarios are possible.
Leaving aside the premature termination parameter in SN
mice, V(D)J recombination events that do not involve DQ52 seg-
ment will delete DQ52 promoter/segment, in contrast to I
promoter/exon which remains intact regardless of the segments
involved. Hence, although we did not find a significant difference
between 0 GL transcription initiation between SN and WT con-
trols, we cannot exclude some subtle variations in 0 expression
that may have been easier to detect in a Rag-deficient background.
However, this does not alter our conclusion that, with regard to
transcription initiation, the replacementmutation has amore dras-
tic effect on I expression than on 0 expression. In contrast, 0
expression seems to be affected at some step downstream tran-
scription initiation,most likely through a premature termination at
NeoR polyA sites. Interestingly, premature termination of a fraction
of 0 transcripts does not seem to alter V(D)J recombination may
be becausewhat counts is the provision of accessible RSS to RAG1/2
complex through JH GL transcription regardless of the outcome of
0 transcriptional elongation downstream of E. Indeed, analy-
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sis of V(D)J rearrangement in sorted pro-B and pre-B cells showed
normal V(D)J assembly suggesting that the RSS are accessible to
RAG1/2 complex and that the mutation does not affect the accessi-
bility control function of E enhancer or other potential regulatory
elements.
Several studies showed that in the IgH C region, the LPS-
associated “Neo effect” altered the activating effect of the 3′RR on
GL promoters located upstream but not downstream of NeoR inser-
tion site (except maybe for I1) indicating a long-range polarized
effect of the 3′RR (reviewed in Manis et al., 2002). On line with the
above model, pre-switch GL transcription of downstream isotypes
in SNmicewas not affected suggesting that themutation does not
interfere with the activating effect of the 3′RR on downstream GL
promoters. With regard to I GL transcription, the finding that the
cassette interferes with I expression suggests that the regulation
of I expression may involve downstream regulatory elements.
Potential candidates include the 3′RR (Perlot et al., 2005; Wuerffel
et al., 2007), the ill-defined elements 3′ of C (Mundt et al., 2001;
Afshar et al., 2006) and perhaps other unknown elements. How-
ever, I expression was deregulated in a complex way. In the bone
marrow and unstimulated spleen, I transcript levels were clearly
decreased both at the initiation and maturation steps. In contrast,
upon LPS stimulation, transcription initiation from I GL promoter
was remarkably enhanced reaching that of WT controls whose I
expression was constitutive in agreement with previous reports (Li
et al., 1994; Rajagopal et al., 2009). Thus, in contrast with the “Neo
effect” in the IgH C region, addition of LPS rather seems to counter-
act a down-regulatory effect on I expression. How this is achieved
is unclear. Obviously, a role for a local effect of the NeoR gene with
its own regulatory sequences cannot be excluded. Nonetheless, we
favor the view that LPS-induced activation of I transcription is
effected by E enhancer. In this scenario, the 3′RR (and perhaps the
putative regulatory elements 3′ of C) would be more critical for an
optimal I transcription in developing B cells and in unstimulated
splenic B cells. In activated B cells, the E enhancer would become
the master element in the control of I transcription and the 3′RR
would focus on downstream GL promoters. Such division of labor
may ensure an enhanced transcription of S by E enhancer and of
thepartner S sequence by the 3′RR thus providing enough substrate
for activation-induced cytidine deaminase to trigger CSR.
Previous work led to the intriguing suggestion that the process-
ing of GL transcripts was an important factor for CSR (Lorenz et
al., 1995; Hein et al., 1998). Several observations indirectly support
this suggestion. For instance, replacement of I GL promoter by a
hypoxanthine phosphoribosyl transferase cassette generates novel
processed transcripts by using donor splice sites of the selectable
marker exons (Qiu et al., 1999). More significantly, mutation of I
donor splice site led to the activation of downstream cryptic sites
(Kuzin et al., 2000) and insertion of NeoR cassette 3′ of I3 GL pro-
moter activated cryptic splice sites downstream of the insertion
site and within the intron-less NeoR gene (Samara et al., 2006). In
the above cases, CSR was normal or slightly reduced. In the present
study, we describe two novel cryptic splice sites within the intron-
less NeoR cassette. These processed transcripts were not detected
in the bone marrow or in unstimulated spleen suggesting that the
cryptic splice sites are activated only when the NeoR expression is
boosted by LPS. Unfortunately, because of stimulation-induced cell
death, we could not analyze CSR. However, activation of cryptic
splice sites in the intron-less cassette in SN mice together with
previous findings (Lorenz et al., 1995; Hein et al., 1998; Qiu et al.,
1999; Kuzin et al., 2000; Samara et al., 2006) highlight the impor-
tance of GL transcript processing for an optimal CSR although the
precisemechanism and the biological significance of these findings
are still unknown.
In conclusion, replacement of I-C intron with an expressed
NeoR gene in the sense-orientation severely impairs B cell devel-
opment, has no apparent effect on V(D)J assembly or 0 GL
transcription initiation but partially inhibits 0 GL maturation
most likely through premature termination. NeoR gene expression
is induced by LPS. The most drastic effect targets I transcription
both at the initiation and the maturation steps, however, normal
levels of I transcription initiation are restored upon LPS-mediated
activation probably through the intermediary of E enhancer.
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Résumé: 
 
Le cycle de transcription comprend les étapes de pré-initiation, initiation, clairance du 
promoteur, élongation et terminaison. Les premières étapes ont été étudiées extensivement. 
Cependant, le rôle des enhancers durant l’élongation n’est pas clair. Une des nombreuses 
surprises de la délétion de la LCR (locus control region) de la β-globine est la démonstration 
qu’elle jouait un rôle primordial dans l’élongation de la transcription. 
Nous nous sommes donc intéressés au rôle potentiel de la 3’RR et d’Eµ dans ce 
processus en insérant une cassette de polyadénylation et de pause transcriptionnelle (pAp) en 
aval d’Iγ3 et de Iµ. A notre surprise, la CSR vers IgG3 était complètement abolie malgré 
l’initiation de la transcription d’Iγ3, excluant un rôle majeur de la 3’RR dans l’étape 
d’élongation. La deuxième surprise vint du fait que l’insertion de pAp en aval de Iµ résultait en 
un phénotype différent : les transcrits Iµ-Cµ étaient normalement épissés bien que diminués 
par rapport à la normale, résultant en une altération générale mais modérée dans la production 
de tous les isotypes. Comment rendre compte de cette différence entre pAp-µ et pAp-γ3? La 
première donnée est que les gènes µ et γ3 sont exprimés à des stades développementaux 
différents. La deuxième est que leur expression est contrôlée pour l’essentiel par des enhancers 
différents. La troisième donnée est que pour un gène µ réarrangé, deux transcrits sont générés, 
un à partir du PVH et l’autre à partir de Iµ, alors que pour le gène γ3 (après CSR), il n’y a qu’un 
transcrit initié au départe de PVH. 
Le point critique dans cette étude est que l’insertion de pAp dans le génome instaure un 
niveau d’arrêt de l’élongation et corrélativement une capacité relative à le surmonter, difficile à 
quantifier. Par conséquent, nous ne pouvons pas exclure à priori que la 3’RR joue un rôle dans 
l’élongation de la transcription, mais par rapport au seuil d’inhibition instauré par pAp et par la 
capacité des transcrits µ à surmonter le signal d’arrêt, le rôle de la 3’RR semble relativement 
minime. Nos datas démontrent que l’élongation transcriptionnelle à travers les séquences S est 
différentiellement régulée in vivo, ce qui fournit des preuves à une corrélation directe entre le 
taux de la transcription et l’efficacité du switch in vivo et suggère une nouvelle fonction pour 
l’enhancer Eµ qui peut avoir un rôle dans la stimulation de l’élongation transcriptionnelle. 
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 Abstract 
Class switch recombination (CSR) occurs between highly-repetitive sequences called switch 
(S) regions. CSR is preceded by germ-line (GL) transcription derived from promoters 
upstream of S regions. In the case of the universal switch donor site Sµ, the intronic Eµ 
enhancer acts both as a transcriptional enhancer and a GL promoter. We investigated the 
hypothesis that transcription elongation across Sµ region, promoted by Eµ enhancer, may be 
differentially regulated from that of downstream S regions in vivo. Two mouse lines were 
generated in which premature termination and pause sites (pAp cassette) were inserted 
upstream of Sµ or Sγ3 sequences, at approximately the same distance from their respective 
promoters. We found that γ3 GL transcription was severely impaired despite normal 
transcription initiation from Iγ3 promoter. CSR to IgG3 was completely and specifically 
abrogated. In contrast, GL transcription across Sµ region and CSR to downstream isotypes 
were only moderately diminished. The data demonstrate that transcriptional elongation 
through S sequences is differentially regulated in vivo, provide evidence for a direct 
correlation between the rate of transcription across S regions and the efficiency of CSR in 
vivo and strongly suggest that a novel function of Eµ enhancer may be to stimulate 
transcriptional elongation.    
 
 
 
 
 
 
 
Introduction 
The generation of primary repertoire of immunoglobulin (Ig) and T-cell receptor 
(TCR) requires a developmentally regulated and lineage-specific recombination between 
variable (V), diversity (D) and joining (J) segments, a process called V(D)J recombination. In 
B cells, V(D)J assembly is initiated at the IgH locus, first by rearrangement of a DH to a JH on 
both alleles followed by joining of a VH gene segment to the DHJH complex. A V to J 
rearrangement next occurs on Igκ and Igλ encoding light chains. V(D)J recombination is 
catalyzed by the lymphoid-specific complex RAG1/RAG2 that binds to conserved 
recombination signal sequences (RSSs) flanking the V, D, and J segments (Hesslein and 
Schatz, 2001; Krangel, 2003; Cobb et al., 2006; Perlot and Alt, 2009). V(D)J recombination is 
regulated by accessibility control elements including transcriptional promoters and enhancers 
which largely control RSS’s chromatin accessibility to the RAG-1/2 complex (Hesslein and 
Schatz, 2001; Krangel, 2003; Cobb et al., 2006; Perlot et al., 2009).  
The Eµ enhancer, located in the intron between JH segments and Cµ exons, plays a 
critical role in GL transcription of DH and JH segments and in V(D)J recombination (Perlot et 
al., 2005; Afshar et al., 2006; Bolland et al., 2007). The Eµ enhancer regulates a set of sense 
and anti-sense transcripts which are detected before DH to JH recombination: Iµ transcripts 
that initiate at the Iµ promoter associated with Eµ enhancer, µ0 transcripts that initiate at a 
promoter upstream of DQ52, the most distal DH segment and potentially DH and JH anti-sense 
transcripts.  In contrast, Eµ does not seem to control VH sense and anti-sense GL transcription 
(Perlot et al., 2005; Afshar et al., 2006; Bolland et al., 2007; Perlot et al., 2008). 
The IgH locus is the exclusive site of another type of gene rearrangement termed class 
switch recombination (CSR) that enables antigen-activated B cells to express downstream 
isotypes (IgG, IgE and IgA) (Stavnezer et al., 2008). CSR requires proliferation (Stavnezer et 
al., 2008), the single-stranded-DNA-specific cytidine deaminase AID (Neuberger et al., 2005) 
and GL transcription that initiates from GL promoters upstream of S sequences (Chaudhuri 
and Alt, 2004). GL transcription of S sequences generates secondary structures that provide 
accessible cytosines on single-stranded DNA. Deamination of cytosines into uracils triggers 
base excision and mismatch repair pathways that may lead to staggered DNA cleavages at S 
sequences (Chaudhuri and Alt, 2004). There is evidence that AID associates with the 
chromatin of the target S sequences in a GL transcription-dependent manner through a direct 
interaction with the transcription machinery (Nambu et al., 2003). In addition, there seems to 
be a correlation between the rate of GL transcription and the efficiency of CSR (Lee et al., 
2001). 
The transcription cycle involves several steps that include chromatin opening, 
preinitiation, initiation, promoter clearance, elongation and termination (Sims III et al., 2004). 
The first steps have long been the subject of extensive studies and the role of transcriptional 
regulatory elements in the activation of transcription initiation is relatively well understood 
(Lemon and Tjian, 2000; Szutorisz et al., 2005). In contrast, the molecular mechanisms that 
regulate the transcript elongation by RNAp II and their impact on the complex events leading 
to the biogenesis of a mature protein-coding mRNA are just beginning to emerge (Maniatis 
and Reed, 2002; Sims III et al., 2004; Proudfoot et al., 2002). Early studies involved 
enhancers in the stimulation of elongation past pausing or premature termination sites 
(Yankulov et al., 1994; Krumm et al., 1995). Analysis of several activators revealed different 
abilities to stimulate transcription elongation (Yankulov et al., 1994; Krumm et al., 1995; 
Blau et al., 1996; Brown et al., 1998). More recently, it was shown that the β-globin locus 
control region (LCR) played a major role in transcriptional elongation of the βmaj-globin gene 
(Sawado et al., 2003). 
The importance of transcriptional elongation for T cell receptor-α gene recombination 
has been demonstrated in vivo (Abarrategui and Krangel, 2006). In contrast, the regulation of 
transcriptional elongation has not been investigated at the IgH locus despite its potential 
importance. For example, the stable RNA-DNA hybrids that form during pre-switch GL 
transcription (Yu et al., 2003, Huang et al., 2007) may affect RNApII processivity and/or lead 
to an accumulation of RNAp II at S sequences (Rajagopal et al., 2009; Wang et al., 2009). In 
the context of V(D)J recombination, µ0 transcripts elongate for more than 10 kb, a mechanism 
might then exist to ensure that these transcripts run through the RSSs of the JH cluster and Sµ 
sequences and reach Cµ polyadenylation site. The seemingly long genic and intergenic 
antisense transcripts run across several genes presumably through a repressive chromatin 
(Bolland et al., 2004) before opening up the chromatin and priming the locus for V(D)J 
recombination (Johnson et al., 2004).  
In this study, we investigate the possibility that elongation across S sequences may 
differ in vivo and that Eµ enhancer may play a role in transcriptional elongation. To this end, 
we attempted a premature termination of GL transcription by inserting a pAp site downstream 
of either Iµ or Iγ3 GL promoters. We report the striking finding that in vivo, elongation past 
the pAp site is more efficient in µ locus than in γ3 locus suggesting a novel function of Eµ 
enhancer in transcriptional elongation. We discuss the potential physiological meaning of 
these findings for V(D)J recombination and CSR. 
Results 
 
Insertion of a pAp site in µ and γ3 regions. The pAp cassette was inserted either in µ intron 
168 bp downstream of Iµ splice donor site (the knock-in will be referred to as pApµ) or in γ3 
intron 251 bp downstream of Iγ3 splice donor site (hereafter pApγ) (Figure 1A, 1B). The 
corresponding targeting vectors were transfected in CK35 ES cell line and homologous 
recombinant clones were checked by Southern blot using external probes. GL transmission 
was obtained for both knock-in clones and checked by Southern blot with the same probes. 
The mice were floxed by breeding with Cre-expressing transgenic mice. Deletion of the 
selectable marker was checked by Southern blot using either an external probe for pApµ or an 
internal probe for pApγ (Figure 1C, 1D). 
 
Analysis of early B cell development in pApµ mice. Preliminary observations showed 
somewhat surprisingly no sign of immunodeficiency in pApµ mice which would be expected 
if GL transcription were completely shutdown. We therefore analyzed B cell populations in 
the bone marrow by flow cytometry. As shown in Figure 2A, the B220+ population was 
decreased in homozygous ∆/∆ mice (~22%) compared to wt controls (~59%). Double positive 
B220+IgM+ population was decreased by half in ∆/∆ bone marrows (~6%) compared to wt 
controls (~13%) (Figure 2B and data not shown). In developing B cells, a slight accumulation 
was found for mutant pro-B cells (B220+IgM-CD43high) (~30% for ∆/∆ and ~20% for wt), and 
a decrease in pre-B cell population (B220+IgM-CD43low) (~70% for ∆/∆ and ~80% for wt) 
(Figure 2C). The results show that insertion of the pAp cassette in µ intron impairs but does 
not block early B cell development.  
V(D)J recombination in pApµ mice. In order to characterize further the step at which the 
impairment occurs, we analyzed V(D)J recombination at the IgH and Igκ loci. Genomic DNA 
was prepared from sorted pro-B cells (B220+IgM-CD43high) and pre-B cells (B220+IgM-
CD43low) and subjected to PCR using a set of specific markers. As shown in Figure3, a slight 
decrease was detected in D to JH rearrangement in ∆/∆ pro-B cells (quantif?).  In contrast, 
VH to DHJH rearrangement was normal be it for the proximal VH7183 or the distal VHJ558 
gene families. VκJκ was likewise normal indicating that the mutation at the IgH locus has no 
effect on the Igκ locus (Figure 3). Overall, apart from a slight effect on DH to JH 
recombination, the mutation has no obvious effect on V(D)J recombination.  
 
Analysis of GL transcription in the bone marrow. The slight effect of the mutation on DH 
to JH recombination led us to investigate whether the defect correlates with a decrease in GL 
transcription. In addition, given that the insertion site of the premature pAp lies downstream 
of Eµ enhancer, one might expect that the mutation would affect elongation rather than 
initiation of µ0 and Iµ transcripts. To tackle these questions, pApµ mice were first brought 
into Rag2-deficient background, then total RNA was prepared from bone marrow purified 
CD19+ B cells and subjected to RT-PCR using primers that are specific for µ0 or Iµ exons 
(reflecting initiation) or for the spliced forms of µ0 and Iµ transcripts (reflecting elongation) 
(Figure 4A). It will be seen from Figure 4 that while initiation of µ0 (primers µ0F-µ0Rev) and 
Iµ (primers IµF-IµRev) transcripts in pApµ/Rag2-/- mice was comparable to that of Rag2-/- 
controls, a slight decrease (~1.5 fold) was detectable for both µ0 and Iµ spliced transcripts 
(µ0F-Cµ and Iµ-Cµ respectively) in pApµ/Rag2-/- mice versus Rag2-/- controls (Figure 4B, C). 
The data indicate that pApµ mutation has a mild effect on GL transcription very likely at the 
elongation step but not at the initiation step. 
 
Analysis of splenic B cells in non-immunized pApµ mice. A different picture emerged from 
spleens of mutant mice. The mutant B cells resplenished normally the spleen at levels 
comparable to wt controls. In fact, we consistently found a slight but reproducible increase in 
B200+ population in ∆/∆ pApµ spleens compared to wt controls (Figure 5A). The increase 
was relatively more obvious for the double B220+IgM+ population in ∆/∆ spleens (Figure 5B). 
The same pattern holds true for mature B220+IgD+ B cells (Figure 5C). 
Altogether, the data show that resplenishment of the mutant spleens occurs normally perhaps 
with a slight accumulation of B220+ population, thus excluding any major alteration of late B 
cell homeostasis in pApµ mice. 
 
Decreased CSR in activated pApµ splenocytes. We then asked if and how the pApµ 
mutation would affect CSR to downstream isotypes. To this end, we resorted to ex vivo 
activation of purified splenic B cells from wt, pApµ and AID-/- mice. B cells were cultured in 
the presence of LPS+anti-IgD-dextran which induce switching to IgG3 and IgG2b, or of anti-
CD40+IL4 which induce switching to IgG1 or of LPS+TGF-β+B-LYS which induce 
switching to IgA. Surface expression was monitored by flow cytometry using an anti-B220 
antibody and anti- IgG3, anti-IgG1 or anti-IgA antibodies. As shown in Figure 6A, surface 
expression was decreased ~1.3- to ~2.3-fold for all isotypes tested but was clearly not 
extinguished in ∆/∆ pApµ activated splenic B cells. In contrast, only background levels were 
detected in AID-deficient mice (Figure 6A, B). The defect in CSR was also checked at the 
genomic level by DC-PCR of Sµ-Sγ1 switching. In agreement with FACS data, CSR to IgG1 
was clearly decreased but not inhibited in pApµ mice (Figure 6C). Thus, insertion of the pAp 
cassette downstream of Iµ exon results in a generalized defect in surface expression of 
downstream isotypes but clearly does not completely abrogate it.  
 
 Analysis of GL transcription in activated pApµ splenocytes. Total RNA at day 2 from 
LPS+anti-IgD-dextran- or anti-CD40+IL4-activated wt and ∆/∆ splenocytes was 
retrotranscribed and amplified in semi-quantitative conditions using isotype-specific GL 
transcript primers. Iγ2b-Cγ2b and Iγ3-Cγ3 GL transcripts were readily detected in wt and ∆/∆ 
LPS+anti-IgD-dextran-activated splenocytes at comparable levels. The same holds true for 
Iγ1-Cγ1 GL transcripts in anti-CD40+IL4-activated splenocytes (Figure 7A, C). Crucially, 
with regard to µ transcripts, Iµ exon transcripts (~initiation) were equally abundant in wt and 
∆/∆ splenocytes. Additionally, we used IµF and pA1 primers that would detect unspliced 
transcripts that end up at the pAp site (and may be some µ pre-mRNAs that reach Cµ polyA 
site). Transcripts in the form of Iµ-pA1 (485 bp) were clearly present in both LPS+anti-IgD-
dextran-activated and anti-CD40+IL4-activated ∆/∆ splenocytes but not in wt controls (Figure 
7A and data not shown) although in the mutant splenocytes, we can not distinguish between 
short and full-length µ pre-mRNAs. In contrast, spliced Iµ-Cµ GL transcripts were decreased 
(~3-fold decrease in activated ∆/∆ splenocytes compared to wt controls (Figure 7A, C) 
regardless of the stimulation condition (not shown).  
The FACS analysis showed a general defect of CSR to downstream isotypes. To further 
characterize this defect at the GL transcription level, we analyzed post-switch GL transcripts 
in the form of Iµ-Cx (Cx being any switched isotype). These transcripts are readily detected in 
B cells undergoing CSR and are a good marker of the efficiency of CSR. Given the location 
of the pApµ insertion site, one might expect that the vast majority of CSR events will 
preserve the pAp cassette in the newly generated hybrid Sµ-Sx regions. Thus the defect in 
CSR can be directly correlated to the effect of the mutation. In order to analyze post-switch 
transcripts, total RNA at day 4 post-stimulation was prepared from wt, pApµ and AID-
deficient mice and amplified with Iµ-Cx primers (x being µ, γ1, γ3, γ2b or pA1). Post-switch 
transcripts corresponding to all isotypes tested were readily detectable. However, they were 
clearly decreased (2 to 3-fold decrease depending on the isotype) in pApµ mice compared to 
wt controls (Figure 7B, C). As expected, no such transcripts were detected in CSR-deficient 
AID-/- controls (Figure 7B). Again, unspliced Iµ-pA1 transcripts were detected in pApµ mice 
but not in control mice (Figure 7B).      
The results demonstrate that the pApµ mutation has no effect on downstream pre-switch GL 
transcripts, that a substantial fraction of µ and post-switch GL transcripts can elongate past 
the pAp site and splice normally. Thus, the premature pAp site impairs but does not 
completely stop elongation of µ GL transcripts and post-switch GL transcripts.  
 
Specific abrogation of CSR in pApγ mice. In order to analyze the effect of pApγ mutation 
on CSR, we resorted to ex vivo activation of pApγ splenocytes by culturing them in the 
presence of LPS+anti-IgD-dextran or anti-CD40+IL4 as a control. Surface expression of IgG3 
and IgG1 was monitored by flow cytometry using an anti-B220 antibody and anti-IgG3 or 
anti-IgG1 antibodies. AID-deficient splenocytes were used as a negative control. As shown in 
Figure 8A, surface expression of IgG1 was comparable in wt and ∆/∆ pApγ splenocytes when 
activated with anti-CD40+IL4 which induce switching to IgG1. In contrast, while surface 
expression of IgG3 was readily detectable in wt splenocytes activated with LPS+anti-IgD-
dextran, that of their ∆/∆ pApγ counterparts was completely absent and indistinguishable from 
AID-/- controls (Figure 8B). The results show that premature termination of γ3 GL 
transcription leads to a specific extinction of IgG3 surface expression and that the block is B-
cell autonomous and can not be ascribed to some inhibitory signals in vivo.  
 
Analysis of GL transcription in pApγ splenocytes. Total RNA at day 2 from LPS+anti-IgD-
dextran-activated wt or ∆/∆ splenocytes was retrotranscribed and amplified in semi-
quantitative conditions using isotype-specific GL transcript primers. Iγ2b-Cγ2b pre-switch GT 
transcripts that are also induced by this stimulation protocol were used as an internal control, 
and found to be comparable in wt and mutant splenocytes (Figure 9A, C). The pattern was 
completely different for γ3 GL transcripts; a drastic decrease was found for spliced Iγ3-Cγ3 in 
∆/∆ splenocytes despite normal transcription initiation (Iγ3f-Iγ3R primers) (Figure 9A, C). In 
contrast, transcripts in the form of Iγ3-pA1 (570 bp) were readily detected (Figure 9A) further 
demonstrating that Iγ3 promoter is in an open configuration and that most detectable 
transcription that initiates from Iγ3 fails to circumvent the block imposed by the pAp site. 
Hence, the low abundant levels of γ3 GL transcripts that run across Sγ3 are clearly not 
sufficient for detectable CSR to IgG3 in pApγ3 mice.  
We also analyzed post-switch transcripts at day 4 post-stimulation. γ2b post-switch transcripts 
were equally abundant in wt and mutant splenocytes (Figure 9B, C). In contrast, γ3 post-
switch transcripts were barely detectable in pApγ splenocytes (Figure 9B, C). Conversely, 
post-switch IµF-pA1 transcripts were not detected in pApγ splenocytes further confirming the 
lack of CSR to IgG3 in pApγ splenocytes (Figure 8B).  
Altogether, these data demonstrate that transcription initiation from Iγ3 promoter is intact and 
that the transcripts fail to efficiently elongate past the pAp site leading to a premature 
termination of γ3 GL transcription. Hence, failure to efficiently transcribe Sγ3 region accounts 
for the specific lack of CSR to IgG3 in pApγ mice.    
 
 
Discussion 
 
The major finding in this study is that efficient premature termination of γ3 GL transcription 
through pAp cassette severely impairs transcription across Sγ3 resulting in a total and specific 
abrogation of CSR to IgG3 whereas µ GL transcriptional elongation is much less affected in 
similar conditions, resulting in a moderate decrease of CSR to downstream isotypes. We 
conclude that transcription elongation across Sµ and Sγ3 GL transcripts is differentially 
regulated in vivo.  
 Despite the structural similarities between µ and γ3 transcription units, there are some 
important differences. In particular, Eµ enhancer acts both as an enhancer and a GL promoter 
at µ locus whereas Iγ3 GL promoter has no known enhancer function. Additionally, while Sµ 
is transcribed throughout B cell development, Sγ3 is selectively transcribed after B cell 
activation. Another difference stems from the fact that Eµ/Iµ-derived transcription is 
constitutive (Li et al., 1994; Rajagopal et al., 2009; Haddad et al., 2010) whereas Iγ3-derived 
transcription is inducible.  
 Analysis of early B cell development in pApµ mice revealed ~2.5-fold decrease in 
B220+ population. Such a mild decrease excludes any major alteration of B cell homeostasis 
in the bone marrow and the possibility that we may be merely dealing with rare clones that 
have acquired a selective advantage. The only alteration that was relatively obvious in our 
V(D)J recombination assay was a slight decrease in DH to JH recombination. The fact that µ0 
GL transcription was moderately impaired at the elongation step suggests that the decrease in 
DH-JH recombination may be due to a decrease in GL transcription through the JH cluster. 
Therefore, one possibility is that there are relatively less accessible RSSs of the JH cluster in 
pApµ developing B cells compared to their wt counterparts. It is also possible that premature 
termination of µ GL transcripts may lead to a subtle delay in V(D)J recombination resulting in 
a delayed B cell development that is not readily detected by the sensitivity limits of our 
assays. Alternatively, failure to reach the Cµ exons by a fraction of µ GL transcripts may 
result in a decrease of µ HC protein production, and therefore to a compromised signalling for 
survival, which may lead to apoptosis, hence the relative drop in B cell population in the bone 
marrow. We note that the three possibilities need not be mutually exclusive. In any case, the 
effect of the mutation is clearly mild which may account for the slight accumulation of pro-B 
cells and the subsequent decrease in pre-B and immature B cells in pApµ mice.  
Our results have implications for V(D)J recombination. In light of the finding that Vα-
Jα recombination and chromatin remodelling are suppressed when transcriptional elongation 
is blocked through the Jα array of the T cell receptor-α locus (Abarrategui and Krangel, 
2006), it is plausible that enhanced transcriptional elongation is critical at early B cell 
developmental stages. Given the correlation between transcription of GL gene segments, their 
rearrangements and their chromatin status (Roth and Roth, 2000), activation of transcriptional 
elongation would enhance the accessibility of RSSs to RAG1/2 recombinase. The C-terminal 
domain of RAG2 was shown to interact with the core histones H2A, H2B, H3 and H4 (West 
et al., 2005) and more specifically with H3K4me2 (Matthews et al., 2007; Liu et al., 2007). It 
could be that the transcriptional elongation complex potentiates the imprinting of specific 
post-translational modifications of the chromatin over RSSs thus enhancing their 
recombination potential. Therefore, the control of transcriptional elongation may be another 
mechanism by which Eµ enhancer controls the accessibility of the locus. 
 In the spleen, the mutant B cells accumulate and mature normally. Thus, surface 
expression of IgD on unstimulated splenic B cells from pApµ mice was comparable to that 
from wt mice and perhaps even increased. IgD is produced through a post-transcriptional 
mechanism involving a differential polyA usage and alternative splicing of µ-δ pre-mRNA, 
but the Iµ-Cµ intron including the pAp cassette is common to both µ and δ pre-mRNAs. 
Therefore, the effect (if any) of the mutation on PVH-derived transcription is unlikely to be 
drastic. Clearly, this topic requires further analysis.  
Upon activation of pApµ splenocytes, CSR to downstream isotypes was decreased but 
not abrogated indicating that the ability to elongate past the pAp block is an intrinsic feature 
of the pApµ B cells and not the result of complex cell-cell interactions or of some inhibitory 
signals in vivo. We showed that µ GL transcripts in pApµ mice bypass, at least in part, the 
pAp site, run through Sµ sequence, undergo splicing and enable some CSR. Thus only the 
transcripts that bypass the pAp site will ensure accessibility of Sµ to AID. Given the recent 
demonstration of stalling and accumulation of RNAp II molecules at Sµ and Sγ3 regions 
(Rajagopal et al., 2009; Wang et al., 2009), it is possible that Eµ-promoted transcription 
elongation through Sµ is catalyzed by increased number of RNAp II molecules compared to 
transcription elongation through Sγ3 region which lacks an upstream enhancer. Whether this 
is achieved through specific modifications of RNAp II and Sµ chromatin or through the 
recruitment of facilitating elongation factors requires further investigations.  
The premature termination of γ3 GL transcription completely and specifically inhibits 
CSR to Cγ3. Thus, the majority of γ3 GL transcripts end up at the pAp site precluding Sγ3 
transcription, hence its accessibility to AID. The failure of RNAp II molecules to bypass the 
pApγ site is likely due to the lack of an enhancer element and not to the nature of Sγ3 per se. 
In support of this interpretation, we find that in pApµ mice, post-switch transcripts though 
decreased, are readily detectable irrespective of the acceptor switch site or the stimulation 
condition. Therefore, the most likely explanation is that Eµ enhancer which remains intact in 
any CSR event continues to stimulate transcription elongation of the hybrid Sµ/Sx sequences. 
 Using an inducible switch substrate in a B lymphoma cell line, it was suggested that 
there exists a linear correlation between transcription of Sα and the efficiency of switching to 
IgA (Lee et al., 2001). Our results provide support to this notion and extend it to Sµ and Sγ3 
in vivo. Indeed, the decrease in µ GL transcription in pApµ mice leads to a corresponding 
decrease in CSR to all isotypes and the nearly total extinction of γ3 GL transcription leads to a 
shut down of CSR to IgG3.  
It is noteworthy that given the location of pAp insertion sites in pApµ and pApγ mice, 
Iµ- and Iγ3-derived transcription successfully generates the donor splice sites on the nascent 
transcripts. These sites are clearly functional since Iµ-Cµ, and less so Iγ3-Cγ3, spliced 
transcripts could be detected in pApµ and pApγ mice respectively. The lack of switching to 
IgG3 in pApγ mice suggests that activation of the donor splice site is not sufficient and that 
the critical parameter is transcription of S sequences in order to provide accessible substrates 
for AID. Yet, the pApγ model does not enable us to conclude about the role of the acceptor 
splice site since most of the transcripts end up at the pApγ site, nor exclude a role for splicing 
machinery in the targeting of AID to S regions. It will be interesting to insert the pAp cassette 
downstream of Sγ3 in order to dissociate transcription of Sγ3 from activation of the acceptor 
splice site. 
 Our results raise an intriguing question related to the role of the 3’RR. Previous work 
showed that GL transcription from Iγ3 is activated by the distant 3’RR (Pinaud et al., 2001; 
Dunnick et al., 2009). On the other hand, it was shown that the β-globin LCR plays an 
important role in transcriptional elongation. The effect on elongation extended up to ~600 bp 
downstream of the polyadenylation site of the β-globin gene (Sawado et al., 2003). Given the 
various similarities between the β-globin LCR and the IgH 3’RR (discussed in Khamlichi et 
al., 2000), it was tempting to speculate that the 3’RR would similarly enable an efficient 
bypass of pApγ. The results reported in this study suggest that, in contrast to the β-globin 
LCR and Eµ enhancer, the 3’RR has no major effect on the elongation of γ3 GL transcripts. It 
should be stressed that once inserted, the pAp site sets up the threshold of transcriptional 
termination and elongation past it. Consequently, we can not definitively exclude a minimal 
role for the 3’RR in transcriptional elongation. Nonetheless, the phenotype in pApγ mice is so 
severe that if such a role existed, it would be less critical than that of Eµ enhancer. That would 
imply that IgH enhancers differ in their ability to stimulate transcription elongation. Why then 
is the 3’RR so inefficient at the elongation step of γ3 GL transcription despite active 
transcription initiation from Iγ3 promoter remains to be investigated.  
 
 
 
Materials and Methods 
 
Targeting vectors and mice. The pApµ targeting construct was generated by using a plasmid 
(kindly provided by M. Cogné) containing a ~7.9 kb EcoRI-SalI fragment spanning a region 
from upstream of DQ52 segment up to an AseI site in Sµ sequence. The AseI site was 
modified into SalI site. The pAp site has two components, the SV40 late polyA signal 
(Carswell and Alwine, 1989) and a modified synthetic polyA and transcriptional pause sites 
derived from the rabbit β-globin gene (Levitt et al., 1989). Both components were amplified 
from the pGL3-Basic vector (Promega) and cloned upstream of the neor gene flanked by two 
loxP sites in a modified pBluescript II KS- (Stratagene). The whole cassette was then eluted as 
an SpeI fragment and inserted into SpeI site downstream of Iµ exon. An HSV tk gene was 
inserted in SalI site for negative selection. 
For pApγ targeting construct, the SphI site downstream of Iγ3 exon was first modified into 
SpeI site in a vector containing a ~6.2 kb XhoI-HindIII fragment spanning Iγ3 and Sγ3. The 
SpeI cassette (pAp-neor) described above was then cloned into the generated SpeI site. The 
new XhoI-HindIII fragment was then inserted in a vector containing the ~1.9 kb HindIII-
BamHI distal part of γ3 intron.  
The ES cell line CK35 (kindly provided by C. Kress, Institut Pasteur, Paris) was transfected 
by electroporation, and selected using G418 (300 µg/ml) and gancyclovir (2 µM). 
Recombinant clones were identified by Southern blot analysis after a BamHI digest with an 
external probe (a 0.7 kb fragment spanning Cµ1) for pApµ construct, or after an EcoRI digest 
with two external probes, a 1 kb EcoRI-XhoI fragment upstream of Iγ3 region (5’ probe) and 
a 1.7 kb BamHI-SphI fragment spanning Cγ3 (3’ probe). Two ES clones showing 
homologous recombination for pApµ and pApγ constructs were injected into C57Bl/6 
blastocysts, the male chimeras were then mated with C57Bl/6 females. Germline transmission 
of the mutation was checked by Southern blot by using the same digests and probes. 
Homozygous N/N mutant mice were mated with EIIa-cre transgenic mice. The progeny was 
checked by Southern blot for Cre-mediated deletion using the same digest and probe for pApµ 
mice, and a BamHI+EcoRI digest and an internal probe (the ~1.9 kb HindIII-BamHI distal 
part of γ3 intron) for pApγ mice. The experiments on mice have been carried out according to 
the CNRS Ethical guidelines and approved by the Regional Ethical Committee. 
 
Flow cytometry analysis of bone marrow cells. Bones from 6- to 8-week-old mice were 
flushed with 10% FCS–containing RPMI 1640. After disaggregation and washing, cells were 
stained 1) with APC-conjugated anti-B220 (BD Biosciences Pharmingen) alone, 2) with 
APC-conjugated anti-B220, phycoerythrin-conjugated anti-CD43 and FITC-conjugated anti-
IgM and gated on the IgM- population or 3) with APC-conjugated anti-B220 and FITC-
conjugated anti-IgM. Data were obtained on 1.5 x 104 viable cells by using a Coulter XL 
apparatus (Beckman Coulter, Fullerton, CA). 
 
V(D)J rearrangement assay. B cells from bone marrow were first sorted by using CD19-
magnetic microbeads and LS columns (Miltenyi Biotec) and labeled with APC-conjugated 
anti-B220, PE-conjugated anti-CD43 and FITC-conjugated anti-IgM. The sorted pro-B (IgM-
B220+CD43high) and pre-B (IgM-B220+CD43low) cell fractions were harvested and genomic 
DNAs were prepared by using Puregene Core Kit A (Qiagen). Genomic DNAs were 
resuspended and diluted for the PCR assay. The primers used to detect V(D)J rearrangements 
and normalization of DNA amount in the diluted samples were as described (Haddad et al., 
2010). The purity of the sorted populations was checked by FACS and by the rearrangement 
status of the κ locus. 
 
GL transcription in the bone marrow. B cells from bone marrow were first sorted by using 
CD19-magnetic microbeads and LS columns (Miltenyi Biotec). Total RNA was then prepared 
from the CD19+ population and subjected to RT-PCR.  
 
Spleen cell cultures. For ex vivo stimulation, the single-cell suspension was incubated with 
anti-CD43 magnetic beads, naïve B cells were purified by magnetic cell sorting using LS 
columns (Miltenyi Biotec). Negatively sorted B cells were activated ex vivo at a density of 106 
cells/ml in RPMI 1640 medium supplemented with 15% FCS, 100 µM β-mercaptoethanol 
and 25 µg/ml of LPS and anti-IgD-dextran at 2 ng/ml or 1 µg/ml of anti-CD40 and 20 ng/ml 
of IL4 or 25 µg/ml of LPS and 2 ng/ml of TGF-β and 2 ng/ml of B-LYS. At day 2 and 4, 
aliquots of cells were removed for RNA preparation.  
 
Flow cytometry analysis of spleen cells. After removal of red blood cells, a single-cell 
suspension from spleens of 6- to 8-week old mice was obtained. Unstimulated splenocytes (5 
x 105 cells/assay) were labeled by using APC-conjugated anti-B220, FITC-conjugated anti-
IgM and PE-conjugated anti-IgD (Biolegend).  
 
DC-PCR. Negatively sorted B cells were activated with anti-CD40+IL4 as described above. 
At day 4.5, live cells were sorted with dead cell removal kit (Miltenyi) as per manufacturer’s 
instructions. Genomic DNA was purified and subjected to DC-PCR essentially as described 
(Chu et al., 1992). Primers used: 3'Imu-R2 : ATTTGCGGTGCCTGGTTTCGGA (Tm = 71.6 
°C); 3g1 NP-Fw : GCTGGTATAGGTGACAGGATGGGGG (Tm = 69.2 °C); nAChRe-Fw : 
CGGTCGACAGGCGCGCACTGACACCACTAAG (Tm = 69.8 °C); nAChRe-Rev : 
GCGCCATCGATGGACTGCTGTGGGTTTCACC0CAG (Tm = 69.2 °C). 
 
Oligonucleotides and RT-PCR analysis of GL transcription 
The primers, the RT-PCR conditions and the expected sizes of the PCR products have been 
described (Pinaud et al., 2001; Khamlichi et al., 2004; Haddad et al., 2010). 
pA1 : GATGGAGAGCGTATGTTAGTAC 
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Legend to Figures 
 
Figure 1. Insertion of pAp site in µ and γ3 introns. 
(A) Structure of the targeted µ locus: scheme of a wt allele showing an unrearranged IgH 
locus and highlighting the 3’RR (not to scale), cEµ and IµEx stand for the core Eµ enhancer 
and Iµ exon respectively. The structure of the targeting construct is shown. The pAp-neor 
cassette (the two loxP sites are shown as filled triangles) were inserted into the SpeI site 
downstream of the Iµ exon (not to scale), ‘Sµ stands for the 5’ part of Sµ. The homologous 
recombination event leads to the insertion of the cassette between Iµ exon and Sµ. The 
structure of the floxed allele is shown as well as the position of the 3’ probe. A: AseI, B: 
BamHI, R: EcoRI, S: SalI, Sp: SpeI.  
(B) Structure of the targeted γ3 locus: scheme of a wt allele showing a rearranged IgH locus 
and highlighting the 3’RR (not to scale). The legend is as described in 1A. The position of the 
external probes as well as the internal probe (∆ probe) is shown. B: BamHI, R: EcoRI, Sh: 
SphI, Sp: SpeI, Xh: XhoI. 
(C) Southern blot analysis of genomic DNA from pApµ mice. The digests used are indicated. 
The position of the 3’ probe for pApµ is shown in 1A. 
 (D) Southern blot analysis of genomic DNA from pApγ mice. The digests used are indicated. 
The positions of the 5’ and 3’ probes as well as that of the ∆ probe are shown in 1B. 
 
Figure 2. Analysis of early B cell development by flow cytometry. 
(A). Bone marrow cells were stained with APC–conjugated anti-B220. Representative 
profiles from one wt and two ∆/∆ pApµ mice are shown. Right panel: the histograms’ panel 
shows the standard deviations (n=3). 
(B). Bone marrow cells were stained with APC–conjugated anti-B220 and FITC-conjugated 
anti-IgM. Right panel: the histograms’ panel shows the standard deviations (n=3). 
(C). Bone marrow cells were stained with APC–conjugated anti-B220, PE-conjugated anti-
CD43 and FITC-conjugated anti-IgM, gated on IgM- population and detected as B220+IgM-
CD43high for pro-B cells and as B200+IgM-CD43low for pre-B cells. Right panel: the 
histograms’ panel shows the standard deviations (n=3). 
 
Figure 3. V(D)J rearrangement assay.  
Genomic DNAs were prepared from sorted pro-B and pre-B cells and were subjected to PCR 
to amplify D to JH and VH to DJH rearrangements. The PCR was performed on serial three-
fold dilutions. PCR products were detected and quantified after SYBR1 green staining. A 
PCR on HS4 enhancer from the 3’RR was used for normalization of DNA input and kidney 
DNA was used as a negative control. A PCR for VκJκ rearrangement was performed to check 
for the purity of sorted populations. 
 
Figure 4. Analysis of GL transcription in the bone marrow. 
(A). CD19+ cells were sorted from the bone marrows of pAPµ/Rag2-/- and Rag2-/- mice and 
RT-PCR was performed on total RNA from CD19+ cells. The PCR was performed on five-
fold serial dilutions. Contamination by genomic DNA was excluded by using a minus RT 
control for each reaction. The λ5 surrogate light chain transcript was used for normalization 
of single-strand DNA input. (B). Transcript levels were quantified on 1/5 or 1/25 dilutions 
only. For GL transcription, µ0 and Iµ GL transcript levels from Rag2-/- controls were set up as 
100%.   
 
 
Figure 5. Analysis of splenic B cells in non-immunized pApµ mice. 
Single-cell suspensions of splenocytes were labelled with APC–conjugated anti-B220 alone 
(A) or together with FITC-conjugated anti-IgM (B) or PE-conjugated anti-IgD (C). 
Representative profiles from three independent experiments are shown. 
 
Figure 6. Cell surface immunoglobulin expression on stimulated pApµ splenocytes.  
Splenocytes from wt, ∆/∆ or AID-/- mice were cultured for 4.5 days and stained with anti-
B220 and anti-IgG3 for LPS+anti-IgD-dextran-stimulated splenocytes (A), with anti-B220 
and anti-IgG1 for anti-CD40+IL4-stimulated splenocytes (B), or with anti-B220 and anti-IgA 
for LPS+TGF-β+B-LYS-stimulated splenocytes (C). The percentages of switched splenic B 
cells are indicated on the top right of the quadrant. The data shown are representative of three 
independent experiments. (D). Genomic DNA from anti-CD40+IL4-activated wt or pApµ B 
cells was subjected to DC-PCR. Three-fold dilutions of circularized DNAs were subjected to 
DC-PCR. Samples were normalized using nAchRe EcoRI DC-PCR.   
 
Figure 7. Analysis of GL transcription in activated pApµ splenocytes.  
(A). RT-PCR was performed on wt or ∆/∆ GL transcripts from LPS+anti-IgD-dextran-
activated pApµ splenocytes’ RNA (day 2) for pre-switch IµF-IµR, IµF-CµR, IµF-pA1, Iγ3-
Cγ3, or Iγ2b-Cγ2b, and from anti-CD40+IL4-activated pApµ splenocytes’ RNA for pre-
switch Iγ1-Cγ1. Single-stranded cDNAs or dilutions thereof (1/5, 1/25 and 1/125) were 
subjected to PCR using appropriate primers.  
(B). RT-PCR was performed on wt or ∆/∆ GL transcripts from LPS+anti-IgD-dextran-
activated pApµ splenocytes’ RNA (day 4) for post-switch IµF-CµR, IµF-pA1, IµF-Cγ3, or 
IµF-Cγ2b, and from anti-CD40+IL4-activated pApµ splenocytes’ RNA for post-switch IµF-
Cγ1. PCR conditions are as in (A).  
Figure 8. Cell surface immunoglobulin expression on stimulated pApγ splenocytes.  
Splenocytes from wt, ∆/∆ or AID-/- mice were cultured for 4.5 days and stained with anti-
B220 and anti-IgG1 for anti-CD40+IL4-stimulated splenocytes (A), or with anti-B220 and 
anti-IgG3 for LPS+anti-IgD-dextran-stimulated splenocytes (B). 
 
Figure 9. Analysis of GL transcription in activated pApγ splenocytes.  
(A). RT-PCR was performed on wt or ∆/∆ GL transcripts from LPS+anti-IgD-dextran-
activated pApµ splenocytes’ RNA (day 2) for pre-switch Iγ3F-Iγ3R, Iγ3F-pA1, Iγ3-Cγ3 or 
Iγ2b-Cγ2b. Single-stranded cDNAs or dilutions thereof (1/5, 1/25 and 1/125) were subjected 
to PCR using appropriate primers.  
(B). RT-PCR was performed on wt or ∆/∆ GL transcripts from LPS+anti-IgD-dextran-
activated pApµ splenocytes’ RNA (day 4) for post-switch IµF-pA1, IµF-Cγ3 or IµF-Cγ2b. 
PCR conditions are as in (A).  
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Résumé: 
 
La protéine MSH2 est impliquée dans le mécanisme de réparation des mésappariements 
(MMR). Son rôle précis dans la CSR est encore inconnu, sa déficience provoque une faible 
diminution de la CSR. Le modèle en vogue stipule qu’elle jouerait un rôle crucial dans les 
cassures double brin générées en dehors des motifs répétés des régions S. 
Pour tester ce modèle, on a analysé la CSR dans des souris déficientes en MSH2 et en 
motifs répétés de la région Sµ. L’analyse des souris mutantes a montré que la double déficience 
abolissait complètement la CSR. Ce blocage n’est pas du à une inhibition de la transcription des 
régions S ni à un défaut de prolifération (deux pré-requis a la CSR) mais plutôt a l’absence de 
cassures au niveau de l’ADN malgré la présence de « points chauds » pour AID. Par ailleurs, nos 
résultats montrent que le domaine d’action de MSH2 dans la région Sµ s’étend bien au-delà des 
domaines délimités par les boucles R. 
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Summary  
Class switch recombination (CSR) is mediated by G-rich tandem repeated sequences termed S 
regions. Transcription of S regions generates single-stranded R loops that provide substrates 
for Activation-Induced cytidine Deaminase (AID). Mice deficient in MSH2 have a mild 
defect in CSR. Analysis of their switch junctions led to a model in which MSH2 is more 
critical for switch recombination events outside the tandem repeats. Deletion of the whole Sµ 
region severely impaired but did not abrogate CSR despite the lack of detectable R loops. 
Here, we demonstrate that a combined deficiency of MSH2 and Sµ region completely 
abolishes CSR and that the abrogation occurs at the genomic level. This finding further 
supports the crucial role of MSH2 outside the tandem repeats. It also indicates that during 
CSR, MSH2 has access to AID targets in R-loop-deficient Iµ-Cµ sequences rarely used in 
CSR suggesting an MSH2-dependent DNA processing activity at Iµ exon that may taper with 
transcription elongation across Sµ region.  
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Introduction 
In the mouse, the rearranged IgH locus is organized as follows: 5’-VDJ-Cμ-Cδ-Cγ3-Cγ1-
Cγ2b-Cγ2a-Cε-Cα-3’. Upon antigen challenge, SHM is targeted to the VDJ region and 
introduces mutations that allow generation of higher affinity antibodies. CSR enables 
proliferating IgM- and IgD- expressing B cells to switch their isotype profile to IgG, IgE or 
IgA. At the genomic level, CSR is mediated by G-rich sequences termed S regions located in 
the intron between GL (I) promoters and IgH C region genes (except for Cδ). All the S 
regions are composed of tandem repeats, but the sequence and the size of the repeats vary. 
Those of Sμ contain predominantly GAGCT and GGGGT pentamers that are also found in Sε 
and Sα whereas Sγ regions mainly exhibit 49 bp tandem repeats that contain some GAGCT 
and GGGGT pentamers [1, 2]. CSR is a deletional process that enables fusion of distant 
partner S regions [1, 2]. Analysis of a large panel of S junctions showed that switch 
recombination occurs between non-homologous sequences in the absence of a clearly defined 
motif at the breakpoint sites [3-6]. 
 The importance of S regions for CSR was demonstrated in vivo by targeted deletion of 
Sμ and Sγ1 regions. Deletion of Sγ1 essentially abolished CSR to Cγ1 [7]. Deletion of the 
core Sμ region comprising the highest density of tandem repeats (SμTR-/-mice) led to a mild 
reduction in CSR [8]. A larger deletion that removed all the pentamers (SμΔ/Δ) led to a more 
severe decrease in, yet did not completely abrogate, CSR [9]. 
 Several proteins are involved in SHM and CSR. The most critical is AID which is 
absolutely required for both processes [10, 11]. AID preferentially deaminates cytosines on 
single-stranded DNA to create uracils [12]. AID signature is detectable after ~100 bp 
downstream of the promoter [13, 14] but how does AID specifically target the Ig loci and 
more specifically V(D)J and S regions while sparing the C regions is still unclear [15]. Other 
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proteins are involved including the MMR proteins, MSH2, MSH6, MLH1, PMS2 and EXO1. 
Mice deficient in these proteins have a mild defect in CSR [16].  
 In the specific case of MSH2-deficient mice, analysis of switch recombination sites 
revealed a marked shift towards the use of the pentamers suggesting that joining of tandem-
distal breaks is MSH2-dependent whereas joining of breaks that involve the tandem repeats is 
MSH2-independent [17]. This notion was further strengthened by the finding that CSR was 
nearly ablated in mice with a combined deficiency of MSH2 and SµTR leading to the 
proposal that MSH2 may recruit nucleases required for the processing of putative flap DNA 
ends [18]. Besides the function of MSH2 in post-cleavage steps during CSR, there is evidence 
that MSH2 can recognize, in the absence of UNG, the AID-initiated dU:dG lesion, providing 
an MSH2-dependent backup pathway [19]. Thus, while the implication of MSH2 downstream 
of AID in CSR is well established, the precise mechanism by which MSH2 acts and the 
molecular cascades that involve this protein and its partners are still unclear. 
 The GL transcription of S sequences is required for CSR [1, 2]). GL transcripts form 
an RNA/DNA heteroduplex with the template strands whereas the non template strands 
generate single-stranded R loops [20] and probably other structures that provide optimal 
substrates for AID in vivo [12]. Interestingly, R-loop formation correlates well with the 
efficiency of CSR and the extent of various Sµ deletions. While R loops were readily found in 
Iµ-Cµ region of SµTR-/- mice, no R loop could be detected in Iµ-Cµ region of SμΔ/Δ mice 
[21]. In addition, in both SµTR-/- and SµTR-/-MSH2Δ/Δ mice, the breakpoints within Iμ-Cμ 
intron essentially fall within R loop forming-domains, which is clearly not the case for SμΔ/Δ 
mice [21]. This leaves it unclear how does AID target these R-loop-deficient domains and 
whether MSH2 is required at sequences that presumably provide poor, if any, AID-substrates 
during CSR.   
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 In this study, we show that joint deficiency of MSH2 and Sµ region leads to a total 
abrogation of CSR indicating that MSH2 activity during CSR extends beyond DNA domains 
capable of generating R loops.  
 
2. Results and Discussion 
 
2.1. B cell proliferation and GL transcription in the absence of MSH2 and Sμ region 
It is well established that B cell proliferation and GL transcription are required for CSR [22, 
23]. We first sought to check the proliferative capacity of SμΔ/Δ MSH2Δ/Δ B cells and GL 
transcription across Sµ and Sγ1 regions. Negatively sorted B cells were first incubated with 
CFSE, then induced to switch to IgG1 with LPS+IL4. Their proliferation ability was tracked 
by FACS at days 0, 2 and 4 post-stimulation. It will be seen from Fig. 1A that the activated B 
cells proliferate equally well irrespective of their genotype.  
 To study GL transcription, resting B cells of different genotypes were induced to 
switch to IgG1 with LPS+IL4, and pre-switch μ and γ1 GL transcripts were analyzed at day 2 
by RT-PCR in semi-quantitative conditions. We found no obvious decrease in GL 
transcription regardless of the genotype (Fig. 1B).  
 Thus, any potential impairment of CSR in the absence of MSH2 and Sμ region can not 
be ascribed to a defective proliferation or to a diminished GL transcription but is likely to 
reflect a lack of recombination between partner sequences. 
 
2.2. Effect of the joint deficiency in MSH2 and Sμ region on CSR 
To study CSR, negatively sorted B cells were cultured in the presence of LPS+IL4. This 
combination induces switching to IgG1 but not to IgG3. Surface expression of IgG1 and of 
IgG3 was monitored by FACS at day 4 post-stimulation. In agreement with previous reports 
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[17, 24, 25], deficiency in MSH2 (MSH2Δ/Δ) led to a mild (2 to 3 fold) decrease in CSR 
efficiency as monitored by IgG1 surface expression (Fig. 2A, B). The decrease was not 
affected by a mono-allelic deletion of Sμ region (SμΔ/+ MSH2Δ/Δ) (Fig. 2A, B). In contrast, 
only background levels were detected for B cells with a joint homozygous mutation (SμΔ/Δ 
MSH2Δ/Δ) (Fig. 2A, B). This abrogation of CSR was clearly distinguishable from the severely 
diminished but still detectable CSR levels in B cells with only a homozygous deletion of Sμ 
region (SμΔ/Δ) (Fig. 1A, B) [9]. Accordingly, IgG1 titers in SμΔ/Δ MSH2Δ/Δ culture 
supernatants were comparable to background levels while those in their SμΔ/Δ counterparts 
were comparatively higher (Fig. 2C).  
 The abrogation of CSR was also confirmed by the analysis of post-switch GL 
transcript levels (Iµ-Cx where x is any downstream switched isotype) which correlate well 
with ongoing CSR [26]. While Iµ-Cµ transcripts were equally abundant for all genotypes, Iµ-
Cγ1 transcripts were barely detectable in SμΔ/Δ B cells but were totally absent in SμΔ/Δ 
MSH2Δ/Δ B cells within the sensitivity limits of our assays (Fig. 2D).  
 
2.3. Abrogation of CSR at the genomic level in SμΔ/Δ MSH2Δ/Δ B cells 
While the above data strongly suggest that the joint deficiency in MSH2 and Sµ region leads 
to a shut down of CSR, it is critical to demonstrate that the abrogation actually occurs at the 
genomic level. To this end, we took advantage of B cell activation protocols with anti-
CD40+IL4 that allow high percentage of switching to IgG1 [27] and make the DC-PCR 
approach [28] more reliable. We first confirmed the lack of switching to IgG1 in SμΔ/Δ 
MSH2Δ/Δ mice by FACS (Fig. 3A). In stark contrast to wild-type mice, DC-PCR analysis 
clearly showed a complete absence of recombination in SμΔ/Δ MSH2Δ/Δ mice and AID-/- 
control mice (Fig. 3B). Attempts to amplify potential switch junctions by using a highly 
sensitive nested PCR were unsuccessful (not shown), therefore, analysis of the junctions 
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could not be carried further.  Altogether, the above data show that CSR is ablated in SμΔ/Δ 
MSH2Δ/Δ mice and that this ablation occurs at the genomic level. 
 
 We previously showed that in SμΔ/Δ mice, the breakpoints used in the residual CSR 
were located in (66 %), or in the immediate vicinity (34 %) of, Iµ exon [9]. This region lies 
just downstream of Eµ/Iµ GL promoter and largely falls within AID mutation domain [14]. In 
addition, more than 38 % of the breakpoints occurred within RGYW/WRCY (R = A or G; Y 
= pyrimidine; W = A or T) AID hot spots, and nearly half the remaining breakpoints were in 
their immediate vicinity (< 4 bp), which is reminiscent of a SHM-like mechanism. Yet, this 
region is rarely involved in switch recombination in wild-type mice [4, 6] and clearly does not 
form any detectable R loop during CSR [20] although mutations can readily be detected in 
this region in a UNG/MSH2-deficient background [14] but very rarely in wild-type 
background [6, 9]. The fact that the deficiency in MSH2 extinguishes the residual CSR in 
SµΔ/Δ mice indicates that MSH2 does have access to Iµ exon breaks and is involved in CSR 
involving Iµ exon and its immediate flanking intronic sequence. On the other hand, the 
finding that MSH2 was largely dispensable for breakpoints involving tandem repeats may be 
interpreted as a hampered access of MSH2 to DNA breaks that occur in the core Sµ domain. 
  
 3. Concluding remarks 
In this study, we provide evidence that the combined deficiency in MSH2 and Sµ region leads 
to a complete abrogation of CSR. This effect can not be explained by a lack of proliferation or 
an altered GL transcription. The inhibition rather occurs at the genomic level.  
 Recent work showed that elongating RNA polymerase II molecules stall at the core Sµ 
hindering the access of DNA polymerase η to Sµ sequence [29]. In this context, it may be 
noteworthy that MSH2 physically interacts with DNA polymerase η in cell extracts [30]. 
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 Our results may be interpreted within the framework of a model in which AID 
associates with the transcription machinery and slides along Iµ region where it deaminates 
cytosines at the relatively few hotspots that are efficiently repaired by UNG/MSH2 pathways 
[14, 31]. In R loop-forming regions that are increasingly richer in hot spots, the AID/RNA 
polymerase II complexes stall, AID deaminates cytosines but MSH2-containing complexes 
(and perhaps other DNA repair proteins) may not have an easy access to DNA breaks 
probably because of the hindrance of RNA polymerase II complexes or because they are 
overwhelmed by the density of hot spots as was suggested for DNA polymerase β activity at 
S regions [32]. This speculative model does obviously not preclude a role for MSH2 in 
recruiting nucleases that process flap DNA ends [18], just that it suggests a transcription-
associated repair activity involving MSH2. Thus the DNA breaks most often used in CSR 
may be seen at least in part as the products of inefficient repair.  
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4. Materials and methods  
Mouse strains. SμΔ/Δ, AID-/- and Msh2-/- mouse lines were described previously [9, 10, 33]. 
The experiments on mice have been carried out according to the CNRS Ethical guidelines and 
approved by the Regional Ethical Committee. 
FACS analysis of activated B cells. Purified naïve B cells were activated with LPS + IL-4 
[34] or with anti-CD40 + IL4 [27]. At day 4, the cells were stained with anti-B220-APC and 
anti-IgG1-FITC or anti-IgG3-FITC (Biolegend).  
ELISA. Culture supernatants were collected at day 4 post-stimulation and analyzed as 
described [34]. 
Proliferation assay. Unstimulated splenic B cells were prepared by MACS depletion using 
anti-CD43 microbeads (Miltenyi), labelled with CFSE (Molecular Probes) according to the 
manufacturer’s instructions, and induced to switch with LPS + IL4 [34]. The number of cell 
divisions was measured by flow cytometry at days 0, 2 and 4.   
RT-PCR. At day 2 or 4 post-stimulation, aliquots of cells were removed for total RNA 
preparation. The primers and RT-PCR conditions w re described [34]. 
DC-PCR. Negatively sorted B cells were activated with anti-CD40+IL4 [27]. At day 4, live 
cells were sorted with dead cell removal kit (Miltenyi) as per manufacturer’s instructions. 
Genomic DNA was purified and subjected to DC-PCR [28]. Primers used: 3'Imu-R2 : 
ATTTGCGGTGCCTGGTTTCGGA (Tm = 71.6 °C); 3g1 NP-Fw : 
GCTGGTATAGGTGACAGGATGGGGG (Tm = 69.2 °C); nAChRe-Fw : 
CGGTCGACAGGCGCGCACTGACACCACTAAG (Tm = 69.8 °C); nAChRe-Rev : 
GCGCCATCGATGGACTGCTGTGGGTTTCACC0CAG (Tm = 69.2 °C). 
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Figure legends  
 
Figure 1. Proliferation of activated B cells and pre-switch GL transcription. (A). 
Negatively sorted B cells from mice with the indicated genotypes were labelled with CFSE, 
then induced to switch with LPS+IL4, and their proliferation ability at the indicated days 
tracked by flow cytometry. (B). Levels of pre-switch GL transcripts were estimated by RT-
PCR in semi-quantitative conditions. Total RNA was prepared at day 2 from LPS+IL4-
activated B cells and reverse-transcribed. Undiluted samples of single strand-cDNAs or five-
fold serial dilutions thereof were amplified by using Iμ-Cμ or Iγ1-Cγ1 specific primers. Actin 
primers were used for normalization (n=3).       
 
Figure 2. Analysis of CSR in Msh2Δ/Δ SμΔ/Δ mice. (A). Negatively sorted splenic B cells 
from mice with the indicated genotypes were induced to switch to IgG1 with LPS+IL4. At 
day 4 post-stimulation, the cells were stained with anti-B220-APC and anti-IgG1-FITC, or as 
a control, with anti-B220-APC and anti-IgG3-FITC. Representative FACS plots from the 
same experiment are shown. (B). The histograms’ panel shows the standard deviations (n=3). 
* denotes a significant difference (p<0.05, Student’s test), ** denotes highly significant 
difference (p<0.01, Student’s test). SμΔ/+ (11.7±0.94, p=0.013), SμΔ/Δ (2.17±1.43, p=0.019), 
Msh2Δ/Δ   (7±0.40, p=0.021), SμΔ/+ Msh2Δ/Δ   (6±1.87, p=0.048), SμΔ/Δ Msh2Δ/Δ   (0.21±0.14, 
p=0.006). (C). Culture supernatants of LPS+IL4-stimulated B cells were collected at day 4 
post-stimulation and IgG1 production was monitored by standard ELISA (n=3). (D). To 
analyze post-switch GL transcription, negatively sorted B cells from mice with the indicated 
genotypes were induced to switch to IgG1 with LPS+IL4. At day 4 post-stimulation and after 
removal of dead cells, an aliquot was used to prepare total RNA. Levels of post-switch GL 
transcripts were estimated by RT-PCR in semi-quantitative conditions. Total RNA was 
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reverse-transcribed. Undiluted samples of ss-cDNAs or five-fold serial dilutions thereof were 
amplified by using Iμ-Cγ1 specific primers. Actin primers were used for normalization (n=3).  
 
Figure 3. (A). Negatively sorted splenic B cells from mice with the indicated genotypes were 
induced to switch to IgG1 with anti-CD40+IL4. At day 4 post-stimulation, the cells were 
stained with anti-B220-APC and anti-IgG1-FITC, or as a control, with anti-B220-APC and 
anti-IgG3-FITC. AID-deficient B cells were used as a negative control. Representative FACS 
plots from the same experiment are shown (n=2). (B). Genomic DNA from activated B cells 
with the indicated genotypes was subjected to DC-PCR. Genomic DNA from AID-deficient B 
cells was used as a negative control. Three-fold dilutions of circularized DNAs were 
subjected to DC-PCR. Samples were normalized using nAchRe EcoRI DC-PCR (n=2). 
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Supplementary figure legend. 
(A). Summary scheme of the different deletions at Sµ locus. The core Sµ sequence deleted 
in SµTR-/- mice is depicted by a black oval. The core contains the highest density of tandem 
repeats. Scattered repeats outside the core Sµ sequence and included in the larger SµΔ/Δ 
deletion are not shown. cEµ: the core Eµ enhancer; Iµ: Iµ exon; Cµ: the Cµ constant region. 
H: Hind III; S: SpeI. (Not to scale). 
(B). Switch efficiency to IgG1 in SµTR-/- and SµΔ/Δ mice in the presence or absence of 
MSH2. The table summarizes the percentages of CSR to IgG1 of mice with the indicated 
genotypes. Switching to IgG1 in WT mice was taken as a reference (100 % of CSR). The 
values were compiled from the following references: 
 
1. Luby, T. M., Schrader, C. E., Stavnezer, J. and Selsing, E. The mu switch region 
tandem repeats are important, but not required, for antibody class switch recombination. J. 
Exp. Med. 2001. 193: 159-168. 
 
2. Min, I. M., Schrader, C. E., Vardo, J., Luby, T. M., D'Avirro, N., Stavnezer, J. and 
Selsing, E. The Smu tandem repeat region is critical for Ig isotype switching in the absence of 
Msh2. Immunity 2003. 19: 515-524. 
 
3. Khamlichi, A. A., Glaudet, F., Oruc, Z., Denis, V., Le Bert, M. and Cogné, M. 
Immunoglobulin class switch recombination in mice devoid of any Sμ tandem repeat. Blood 
2004. 103: 3828-3836. 
 
4. Zhang, T., Franklin, A., Boboila, C., McQuay, A., Gallagher, M. P., Manis, J. P., 
Khamlichi, A. A. and Alt, F. W. Downstream class switching leads to IgE antibody 
production by B lymphocytes lacking IgM switch regions. Proc. Natl. Acad. Sci. U S A. 2010. 
107: 3040-3045. 
 
5. This study. 
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DISCUSSION AND PROSPECTS 
 
In the first article, we studied the effect of the replacement of the major part of Iµ-
Cµ intron by an expressed neo
r
cassette. The mutation led to a severe impairment of B cell 
development; however, the block was not complete. Indeed, few B cells have certainly 
managed to migrate into the secondary lymphoid organs since we detect some IgM- 
and/or IgD-expressing B cells in the spleen. 
In the bone marrow, initiation of µ0 and Iµ transcripts is diminished but the 
maturation step across µ region is even more decreased. This is likely due to a premature 
termination at the two neo
r
 pA sites. Regarding the Neo effect, alteration of Iµ 
transcription may indicate a possible interaction of the 3’RR with Eµ/Iµ in the regulation of 
this process. It is well established that an expressed neo
r
 gene blocks transcription to 
upstream but not to downstream promoters relative to the insertion site of neo
r
 gene at 
the IgH constant locus 
(388)
. In agreement with this notion, downstream pre-switch 
transcripts were normal in SµN mice.  
Strikingly, Iµ GL promoter did not respond to neo
r
 effect in the same way as did 
downstream GL promoters.  Indeed, in the bone marrow and in non-stimulated spleen, 
the initiation of Iµ transcripts was downregulated. However, upon LPS stimulation, 
transcription initiation from Iµ GL promoter reached that of WT controls. Thus, activation 
with LPS seems to counteract a down-regulatory effect on Iµ expression. One might 
speculate that LPS-induced activation of Iµ transcription is somehow mediated by Eµ 
enhancer. This led us to consider the possibility that the dynamic interaction between Eµ 
and the 3’RR is biphasic. One phase is developmentally regulated, stimulus-independent, 
in which the 3’RR regulates Iµ transcription at a time when Eµ controls V(D)J 
recombination and a subset of transcripts of the variable domain. In the second phase 
which coincides with LPS stimulation en route to CSR, the 3’RR would focus on activating 
downstream GL promoters while Eµ will ensure constitutive levels of Iµ transcripts (as a GL 
  75
promoter) and high levels of Sµ transcription through activation of PVH (as an enhancer). 
But how Eµ achieves this dual function at the same time is still unknown. 
 
Among several possibilities, it could be that Eµ enhancer is a particularly efficient 
entry site for RNAp II, transcription factors and histone-modifying enzymes. By focusing on 
S regions, one might suggest that the above properties of Eµ may confer to Sµ some 
features that would be missing in downstream S regions. More specifically, we wished to 
investigate the hypothesis that Eµ enhancer may play a role in transcriptional elongation 
across S regions. While the role of IgH enhancers in the regulation of GL transcription 
initiation has been relatively well studied in vivo; their role at the elongation phase has 
not, to our knowledge, been addressed before. 
This topic is potentially of great importance because several critical processes for 
CSR occur at the elongation phase of GL transcription. For example, the specific targeting 
of AID coincides with the transcriptional elongation step across the target S sequences. 
Indeed, AID signature is detectable some 150 bp downstream of the transcriptional start 
site 
(389)
. In addition, it has been shown that AID associates with the elongating 
transcription machinery across the intronic S sequences 
(343)
 and interacts with the 
spliceosome-associated factor CTNNBL1 
(379)
. Thus, one might hope that the elucidation of 
the molecular mechanisms at work during transcription elongation would help to better 
understand how AID is specifically targeted to S regions while sparing neighboring 
sequences and how this leads to the (de)regulation of CSR. 
 
One way to functionally approach the role of transcription elongation during CSR is 
to “impose” a premature termination of GL transcription in vivo. To this end, we 
generated two KI mouse lines; one line bears a pAp site between Iµ and Sµ (pApµ mice) 
and the other bears the same pAp cassette between Iγ3 and Sγ3 (pApγ mice).  
In pApµ mice, CSR was impaired but not inhibited in vivo and ex vivo. The relatively 
mild effect of the mutation correlates well with a decrease in µ GL transcription. Indeed, 
although we did not quantify it precisely, a substantial fraction of these transcripts could 
readily be detected as spliced forms clearly indicating that their precursors could elongate 
past the pAp site and reach Cµ acceptor splice site. 
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In contrast, CSR to IgG3 was completely and specifically shut down in pApγ mice 
both in vivo and ex vivo. Accordingly, spliced forms of γ3 GL transcripts were barely 
detectable despite normal transcription initiation. 
At one level, these results indicate that in vivo, there exists a direct correlation 
between the transcription rate across S sequences and the efficiency of CSR. Although this 
notion has been previously suggested on the basis of inducible switch substrates in a B cell 
line, this is, to our knowledge, the first direct demonstration in vivo.  
Perhaps more importantly, our results demonstrate that elongation across S 
regions is differentially regulated. They also strengthen the notion that Sµ has some 
specific features that distinguish it from downstream S sequences. One of these features 
could be the proximity of Eµ enhancer. Given that Sγ3 lacks any known enhancer 
associated with Iγ3, our results suggest but do not prove that Eµ enhancer may be 
involved in the efficiency of elongation through Sµ. They also suggest that the 3’RR has (if 
any) a minimal role in transcription elongation. This hypothesis can now be directly tested 
in a mouse line whose 3’RR was mutated 
(176)
.  
The differential elongation across Sµ (in pApµ mice) and Sγ3 (in pApγ mice) is 
obviously correlated with the differential capacity of RNAp II molecules to “ignore” the 
pAp site. One possibility is that the CTD domain of RNAp II is differentially phosphorylated 
at Ser2 at the elongation phase of Sµ and Sγ3 GL transcription. However we favour the 
view that the difference lies, at least in part, in the enhanced recruitment of RNAp II 
molecules by Eµ/Iµ compared to Iγ3. In other words, a higher density of RNAp II molecules 
will elongate more efficiently past the pAp site and may better protect against cleavage 
and degradation of the downstream transcripts during polyadenylation reaction. 
It should be stressed that Sµ region is transcribed throughout B cell development. 
In contrast, downstream S regions are transcribed only when the B cell has been activated 
upon antigen challenge. That means that Sµ chromatin is in an open configuration during 
the whole B cell development, running through several transcription cycles.  It is 
conceivable that such a state of continuous transcription may imprint on Sµ chromatin 
some marks that distinguish it from the other S regions. Clearly, this topic requires further 
investigations.      
As usual with biological processes, the situation is certainly more complex. In our 
study, we focused on sense transcripts. But the description of anti-sense (AS) transcripts 
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at Sµ and Sγ regions 
(119)
 is likely to introduce other levels of complexity regarding the 
regulation of GL transcription, AID targeting and CSR.  
Luckily enough, the pAp cassette we used is bidirectional (it is derived from SV40 
polyadenylation sequence) (Figure 19-A) and analysis of AS transcription is underway in 
our mice. One might anticipate, at least with regard to Sγ3 region, that AS transcription of 
Sγ3 is not sufficient for CSR and that it is the sense transcription that is more critical, 
although more complex scenarios may be envisaged.  
A black box in the field of CSR stems from the following observation: AID targets 
and deaminates cytosines exposed by single-stranded R loops (or other structures) but 
CSR clearly require DSBs. Moreover, extensive analysis of unrepaired S sequence 
mutations specifically initiated by AID clearly shows that the template strand is also a 
target of AID 
(389)
. Therefore, during these dynamic processes, AID must somehow get 
access to the protected cytosines of the template strand, which forms a stable duplex with 
GL transcript 
(328)
.  
How does AID achieve this function is presently unknown. There are at least four, 
non-mutually exclusive possibilities: 1) during sense transcription reaction, RNAp II may 
generate short single-stranded bubbles that may be sufficient for AID attack 2) 
intracellular RNase H may degrade the RNA of the duplex releasing the template strand 
which then becomes accessible to AID 
(328)
, 3) the anti-sense transcripts in the S regions 
may trigger some RNAi-related mechanisms 
(119)
, and 4) splicing of the GL transcripts may 
itself be involved in the collapse of the DNA-RNA duplex.  
In the latter context, previous work from Radbruch’s laboratory showed that 
mutation of the splice donor site of Iγ1 exon inhibits CSR to IgG1 despite normal GL 
transcription 
(320)
. We showed that insertion of pAp upstream of Sγ3 specifically abrogated 
CSR to IgG3. Why was CSR to Sγ3 abrogated? The simplest explanation is that in the 
absence of Sγ3 transcription, no R-loop (or other structures) could form; hence AID had no 
access to its substrate. But since the splice acceptor site was not activated, the splicing of 
the transcript did not occur. Thus, this model does not enable us to assign the prominent 
role to Sγ3 transcription per se, to the processing of the transcripts, or to both in the 
efficiency of CSR. Therefore, it seemed logical and pertinent to pursue the work by 
inserting the relevant sequence between Sγ3 and the splice acceptor site.  
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We thus generated a mouse line in which the pAp cassette was inserted between 
Sγ3 and Cγ3. In this way, Sγ3 should be transcribed but, assuming that the inserted signal 
will be as efficient downstream of Sγ3 as it was upstream of Sγ3, the elongating RNAp II 
should not efficiently reach Cγ3 splice acceptor site. Hence, we should expect the 
generation of AID substrates but few GL transcripts should splice. In addition, this model 
should enable us to check that it is indeed the sense transcription that counts for CSR 
since AS transcription of Sγ3 should be inhibited (Figure 19-B).   
  
Iγ3 Sγ3 Cγ3
P
ASDS
pA
Iγ3 Sγ3 Cγ3
P
ASDS
pA
A.
B.
 
Figure 19: Schematic representation of the insertion sites of pAp cassette upstream and 
downstream of Sγ3. The big red dots represent the exogenous pAp sites upstream and downstream of 
Sγ3, the small red dots represent the endogenous pA sites downstream of Cγ3. The filled lines represent 
the sense transcripts and the dashed lines represent the antisense transcripts. 
 
With this model, we will ask 1) if and how transcribed Sγ3 will promote CSR in 
potential absence of splicing and AS transcription, 2) how the mutation will affect AID 
targeting to Sγ3 and 3) if there are specific histone modifications that mark transcribed 
Sγ3 in the absence of splicing and AS transcription.  
These studies should hopefully shed some light on the complex molecular 
mechanisms that lead from the biogenesis of GL transcripts to DNA recombination during 
CSR. 
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RESUME 
Les gènes des immunoglobulines (Ig) s’expriment spécifiquement dans les cellules B. Pour 
devenir fonctionnels, les gènes d’Ig murins subissent deux types de réarrangements intra-géniques : 
les réarrangements V(D)J aux stades précoces du développement de la lignée B et la commutation 
isotypique (CI), restreinte au locus des chaînes lourdes (IgH), suite à une rencontre avec un antigène. 
Ces deux processus contribuent à l’extrême diversité des anticorps et à la vigueur de la réponse 
immunitaire. 
La CI nécessite l’intervention d’une enzyme appelée AID (Activation-Induced cytidine 
Deaminase) et la transcription des gènes cibles. Au niveau cellulaire, la CI se traduit par une 
transition de cellules B exprimant des IgM à des cellules B exprimant IgE, IgA ou une des quatre sous-
classes d’IgG. Au niveau moléculaire, la CI est médiée par des séquences particulières (dites régions 
S, pour switch). L’accessibilité des séquences S aux recombinaisons est précédée de leur transcription 
dite transcription germinale (GL). Cette dernière facilite la genèse de structures secondaires qui 
fournissent des substrats pour AID. Mais les mécanismes de ciblage spécifique d’AID sont toujours 
inconnus.  
Dans une première étude, nous avons remplacé dans une lignée murine l’intron Iµ-Cµ par un 
gène de sélection Neo
R
. La mutation entraine un blocage drastique dans le développement B.  
Cependant, les réarrangements V(D)J sont normaux. L’analyse des transcrits nous a permis de mettre 
en évidence des interactions complexes entre activateurs transcriptionnels du locus IgH, en fonction 
du stade de développement et de l’état d’activation des cellules. 
Dans une deuxième étude, nous avons analysé l’élongation transcriptionnelle à travers les 
séquences Sµ et Sγ3 dans deux modèles murins dans lesquels l’élongation a été altérée par 
l’insertion d’un site de polyadénylation et de pause transcriptionnelle en amont de Sµ ou de Sγ3. La 
transcription GL de Sγ3 est bloquée malgré une initiation normale. La CI à IgG3 est complètement et 
spécifiquement bloquée. Par contre, la transcription GL à travers la région Sµ et la CI aux différents 
isotypes sont seulement diminués. Nos résultats démontrent que l’élongation à travers Sµ et Sγ3 est 
régulée de manière différentielle in vivo et suggèrent des capacités différentes des activateurs 
transcriptionnels à contrôler l’élongation transcriptionnelle au locus IgH. 
 
SUMMARY 
Immunoglobulin genes (Ig) are expressed specifically in B cells. In order to become 
functional, mouse Ig genes undergo two types of intra-genic rearrangements: V(D)J recombination in 
early developing B cells which is antigen-independent and class switch recombination (CSR),  specific 
to the heavy chains locus, which may occur after antigen encounter. These two processes contribute 
to the extreme diversity of antibodies and the strength of the immune response. 
CSR requires the intervention of the Activation-Induced cytidine Deaminase (AID) and the 
transcription of targeted genes. At the cellular level, CSR translates the transition from IgM-
expressing B cells to B cells expressing IgE, IgA or one of the four sub-classes of IgG. At the molecular 
level, CSR is mediated by special sequences called switch regions (S). CSR is preceded by germline 
(GL) transcription of target S sequences. The GL transcription is thought to favor the generation of 
secondary structures that provide optimal substrates for AID. However, the mechanisms responsible 
for AID targeting are still unknown. 
In a first study, we have replaced in a mouse line the intron Iµ-Cµ by the selectable marker 
NeoR gene. The mutation led to a drastic block in B cell development. However, V(D)J 
rearrangements was normal. Transcripts’ analysis revealed complex interactions between 
transcriptional enhancers of the IgH locus that depend on the B cell developmental stage and 
activation status. 
In a second study, we analyzed the transcriptional elongation through Sµ and Sγ3 sequences 
in two murine models in which elongation was altered by the insertion of a polyadenylation and 
transcriptional pause sites upstream of Sµ or Sγ3. GL transcription of Sγ3 was abrogated despite 
normal initiation. CSR to IgG3 was totally and specifically blocked. In contrast, GL transcription 
through Sµ region and CSR to different isotypes was only diminished. Our results show that 
elongation through Sµ and Sγ3 is differentially regulated in vivo and suggest different capacities of 
IgH transcriptional enhancers to control elongation through IgH locus. 
